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Abstract
Cancer is the most common cause of death in the UK. Due to its aging population, the rate
of cancer diagnoses is expected to rise dramatically in the coming decades. Currently cancer
treatments have harsh side effects that cannot be well tolerated by the elderly, hence there
is a need to develop new methods of cancer therapy which offer substantially better patient
experiences. One such route is the use of near infrared–absorbent gold nanorods (AuNRs),
which offer suitable optical and thermal properties to enable their use in techniques such as
photothermal therapy and photoacoustic imaging. In this thesis we will explore the use of
AuNRs in these roles as cancer theranostic agents.
This is addressed in three core areas; firstly the seedless production of AuNRs using binary
surfactants. It is demonstrated how the morphology and optical properties of such particles can
be manipulated through the inclusion of a co–surfactant. As well as yielding improvements
in the monodispersity, shape yield and scalability of the protocol. Secondly, the surface func-
tionalisation of AuNRs with phospholipids, we demonstrate the effective removal of CTAB,
a toxic surfactant used in the synthesis, this is demonstrated through the use of 1H nuclear
magnetic spectroscopy, surface enhanced Raman spectroscopy and pH–dependent zeta potential
measurements, this is present alongside stability studies of AuNRs of different coating, demon-
strating the improved stability of AuNRs prepared with phospholipids. Finally, the application
of phospholipid–coated AuNRs in cancer therapy is explored. We show that these particles are
non–toxic in vitro and in vivo. We also explore their efficacy as photothermal conversion agents,
measuring the achievable temperature rises under CW illumination, as well as imaging them
using multispectral optoacoustic tomography of the particles in phantoms. In vivo measurements
of the effects of heating these AuNRs under CW and nanosecond lasers on human carcinoma
cell lines were also investigated. Finally the biodistribution of these particles was explored,
when passively targeted or functionalised with cancer specific adhirons though ICP–MS analysis
of ex vivo murine samples.
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Gold nanoparticles (AuNPs) offer a set of exciting set of material properties which has led to them finding
application in a large number of fields. AuNPs have highly tunable surface chemistry (whilst being relatively
nonreactive), that can strongly absorb and scatter light at visible and near–infrared (NIR) wavelengths, and
generate strongly localised electric fields. They can be synthesised relatively easily in a wide range of sizes
and shapes. This has meant they have proved very versatile; finding a wide range of applications, such as
catalysis, biosensing, and SERS probes [39]. A particularly popular application is their use as photothermal
conversion agents in the therapy and imaging of cancer. This is the application that this thesis will explore.
Cancer is the most common cause of death in the UK, causing 28.1% of all deaths in 2017 [93].
Because of the aging population now found in Western countries, it is expected that number of new cancer
diagnoses per year will increase by over 80% in the next 20 years [350]. Current treatment methods, such
as radiotherapy and chemotherapeutic drugs, present significant problems such as causing harmful damage
to healthy tissue, and presenting high levels of toxicity, respectively. Elderly patients show much lower
tolerances to current methods for the treatment of cancers such as chemotherapy [373]. Hence there is a
need to develop new treatment modalities, which are significantly less detrimental to patient experience over
the course of treatment and can be more readily used in elderly patients. This is an extremely active area of
research interest with many new methods being proposed, such as therapeutic microbubbles [227], targeted
drug delivery [354] and viral therapies [179].
Gold nanoparticles with their unique combination of optical, photothermal and chemical properties
offer one such route to potentially achieve this. This is discussed more thoroughly in this chapter. In brief,
gold nanorods (AuNRs) can be synthesised such that they strongly absorb light in the near–infrared, at
these wavelengths penetration of light into human tissue is significantly increased. AuNPs very efficiently
convert absorbed light into heat, hence these particles when deployed in vivo can be used to remotely heat
surrounding tissue upon illumination with NIR light, without the need for invasive surgery. It is possible
to generate temperatures high enough to induce the death of cells via this route, and thus it is hoped that
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by generating locally high concentrations of such particles within tumours, that this heating can be used to
thermally treat tumours with minimal damage to surrounding healthy tissue. A large number of challenges
are still left to be addressed before implementation of this technique will be realisable, these are discussed
later in this chapter, alongside the theoretical underpinnings that enable this technique to be considered.
Chapter 2, presents a summary of the experimental techniques and materials used in this thesis. Further
details of the theory and reasoning for the methods used are also given where it was felt that it was required.
This thesis contains three experimental results chapters, the first of which, Chapter 3, describes progress
made in the synthesis of AuNRs using binary surfactants and how this produces more monodisperse
AuNRs with high yield and can simultaneously be used to control the morphology and optical properties of
synthesised AuNRs. The effects of controlling other parameters in the synthesis have also been investigated.
Attempts have been made to understand the formation process of AuNRs during the synthesis and specific
role that the two surfactants play.
In the second results chapter, Chapter 4, we functionalise our nanorods with phospholipids, and
demonstrate the removal of hexadecyltrimethylammonium bromide from the surface of the AuNRs, via
surface enhanced Raman spectroscopy, nuclear magnetic resonance spectroscopy and pH–dependent zeta
potential measurements. We also investigate the colloidal stability of these particles in various physiological
media and demonstrate their suitability for use in in vitro and in vivo experiments.
In the final results chapter, Chapter 5 we look to the biomedical applications of these particles. We
demonstrate that the phospholipid coatings show improved biocompatibility compared to commonly used
polymer coatings, as well as investigating their uptake into cells. We demonstrate their suitability for use as
photothermal conversion agents by measuring the heat generation under NIR illumination. The particles
were then used in a pre–clinical photoacoustic imaging system. In vivo experiments were performed in mice,
to demonstrate their in vivo biocompatibility and biodistribution. Finally, an initial attempt at targeting the
AuNRs to a tumours were made.
In the rest of this introduction, a discussion of the theoretical background to this project is given, with a
focus on the optical and thermal properties of AuNPs, alongside the applications they have found in medicine.
Also discussed are the methods to synthesise AuNPs (in particular gold nanorods), and the methods used to
manipulate their surface chemistry.
1.2 Optical Properties of Gold Nanoparticles
1.2.1 Electrons in Metals
It is impossible to discuss the interaction of light with such particles without first discussing the electronic
structure of metals. Conduction electrons within metals are ‘quasi-free’, able to move freely relative to the
positively charged lattice resulting in properties such as their high electronic and thermal conductivities and
high reflectivity in the visible region. This behaviour is approximated by the Drude model [80], which is an
application of Lorentz’ dipole oscillator model to bulk metals [213]. Under this model conduction electrons
are considered to be free oscillators with no restoring force provided by the surrounding nuclei, and hence
because of this, there is no natural resonance frequency, ω0, as seen in dielectric materials.
4
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This model does not account for all the optical effects seen in gold, such as intraband transitions (which
explain why many metals are have colour). However the model provides a good approximation of the major
electronic–optical effects in metals. The high density of free carriers in Au (NAu = 5.9 · 1028 m−3), means
even at the nanoscale electronic energy levels are effectively continuous relative to thermal excitations kBT
at room temperature [217]. Hence quantum effects which are important in nanoscale structures made from
materials, with low free carrier densities, such as semiconductors can be ignored and Drude’s model can be
used as an accurate description of the electronic properties of nanoscale gold.
Under this model the electronic response of Au to a driving oscillating electric field of frequency, ω, can
is described as:


















N is the free electron density of the metal, e is the charge of the electron and m∗ is the effective mass of
the electron within the medium. τ as a parameter contains all the scattering processes which damp any
charge oscillations in the plasma, these include electron–electron, electron–phonon, electron–defect, and
electron–surface scattering all of which have their own characteristic timescales. This model makes a number
of important predictions, firstly it can be seen from eq. (1.2) that for ω < ωp the real part of the εr is ∼ 1 and
rapidly decays to 0 above ωp. Hence metals display high reflectivity below ωp, before becoming rapidly
transparent above it. We can also calculate the absorption coefficient from this expression for the dielectric















The absorption coefficient for metals is thus very high (5 – 7 ×107 m−1) preventing the penetration of
light into the interior of the metal. Electric field strength decreases in strength from the surface exponentially









Hence the excitation of electrons within bulk metals is restricted to immediate vicinity of the metal
surface, whilst electrons within the bulk of the metal are effectively screened from external AC electric fields
above ωp. The frequency dependence of the skin depth is plotted in fig 1.1. This effect is fundamental to
the existance of surface plasmon resonances (SPR) in gold, the driving of an evanescent wave at a metallic
surface. However, the ability to excite electrons at a metallic surface produces significantly more interesting
optical effects when the metal object is restricted in size to dimensions less than or similar to the skin depth.
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Figure 1.1: Skin depth of Au in the visible and NIR part of the spectrum.
Calculated using permittivity values for Au from ref [156].
In these circumstances, incident light fields are able to drive collective oscillation of all electrons within such
an object.
1.2.2 Intraband Transitions
There are limits to the Drude model which become important when considering the optical properties of
AuNPs. The Drude model does not account for the band structures of metals, and the most important effect
that emerges from this, intraband transitions. It can be from the density of states of Au (fig. 1.2 (a) that the
Fermi energy, EF of bulk Au falls within the 6s conduction band, with a large population of electrons in the
5d valence band, ∼ 2 eV below EF , an energy that corresponds to a wavelength of ∼ 600 nm. Hence photons
below this can excite electrons from the 5d band into the unoccupied energy levels within the 6s–p band.
The effect of this is very apparent in the dielectric function of gold when compared directly to the Drude
model (fig. 1.2 (b)).
There is a noticeable difference between the empirically derived values and the Drude model below 600
nm, as the unaccounted for absorbance driven by intraband transitions becomes an increasingly important
process. Incidentally this absorbance below 600 nm explains why Au has it characteristic yellow hue, instead
of acting as a mirror at all wavelengths of light above the plasma frequency. This absorbance becomes
an important consideration in optical properties of AuNPs, as intraband transitions will create electron–
hole pairs simultaneously with any plasmonic excitation, significantly increasing the e − e scattering rate,
ultimately damping the plasmon. The impact of damping from scattering processes is normally considered
through the plasmonic quality factor, QSPR = ε′/ε′′, which is plotted in fig. 1.2 (c) as function of excitation
wavelength for both the Drude model and empirically derived permittivity values. The significance of the
damping can readily be seen in the rapid drop off of the quality factor below 600 nm. As will be show in
section 1.2.3, the expected plasmon band of small nanospheres falls within this range, leading to significant
damping of the plasmon. Hence to truly realise the plasmonic potential of gold nanoparticles, we must
attempt to use AuNPs with resonances >600 nm, where QSPR is maximised.
This highlights the need to use empirically-derived permittivities in the calculations of the optical
properties of Au due to limitations of the Drude model below the band edge wavelength. The model is
incapable of explaining the observed damping of plasmons in Au below 600 nm and fails to predict the
6
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Figure 1.2: Intraband transitions in Au. (a) Density of states of bulk Au [46]. (b) Experimental permittivity
values for Au and water compared with the calculated Drude permittivity (ωp = 2.18 PHz and 1/τ = 18.0
THz). (c) Plasmonic Q–factor as calculated from experimental data and the Drude model. Permittivity data
for Au and water taken from refs [156] and [117] respectively.
absorbance of Au below ωp. Regardless, the Drude model serves as a good starting point from which to
understand the origins of plasmonic behaviour in metals, and accurately describes the electronic behaviour
of Au in the NIR, above its band edge wavelength.
1.2.3 Localised Surface Plasmon Resonances – Mie Theory1
Whilst named after the effect seen at continuous metal surfaces known as SPR, and emerging from the same
physics; localised surface plasmon resonances (LSPR) should be considered distinct phenomena. LSPRs are
the collective oscillation of all the free carriers within a metal nano–object. They emerge as a result of the
spatial confinement of an electronic plasma to length scales at or around the skin depth, and the resultant
behaviours of such systems are substantially different from those seen in SPR experiments.
Classical solutions already exist for the interaction of a electric plane wave and a metallic sphere using
Maxwell’s equations. First formulated in 1908, Mie theory was the first rigorous mathematical treatment
of the interaction between metallic particles and light [228]. In its original formulation the solutions are
given as an expansion of multipolar contributions to the electric field generated by the electronic response of
the particle (fig. 1.3). Without derivation, solutions to this problem are typically given in the form of two






















P1n are the Legendre polynomials of the first degree. am and bm are scattering coefficients to be determined
1The equations in this section are largely adapted from Bohren and Huffman [36].
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Figure 1.3: Multipolar contributions: Electric and magnetic field lines generated at the surface of a metal
spheroid when interacting by light polarised in the vertical axis. Figure adapted from [228].
which dictate the contribution of each multipolar contribution. These require the most computation in

















σext = σabs + σscat
(1.8)
1.2.4 The Quasistatic Approximation
For particles with diameters in the range 10 – 60 nm only the dipolar contributions (m = 1) need to be
considered to accurately calculate their optical properties. For particles larger than this, quadrupole and
higher order multipole contributions can no longer be considered negligible. Whereas small particles
less than 10 nm in diameter exist at scales below the typical electronic mean free path in metals leading
electron–surface scattering becoming the dominant electronic interaction which will damp any plasmon
resonance.
This is known as the dipolar or quasistatic approximation. Under which only the m = 1 terms in the
above sum are considered. Examination of the known boundary conditions allows it to be shown that the only






where a is the radius of the particle, ε (= ε1 + iε2) is the permittivity of the particle and εm is the permittivity
of the surrounding medium. Combining this with eq. (1.8) yields the following relations:
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Figure 1.4: (a) Plot of the Frölich condition for Au in an aqueous environment showing a global minima
at 518 nm. (b)-(d) Generated spectra in the quasistatic approximation for 10, 50, and 100 nm AuNPs
respectively. Permittivity values for gold and water taken from refs [156] and [117] respectively.





 σext = σabs + σscat (1.10)
where k is the wave vector given by k = 2πεm/λ. From eq. (1.9) it can be seen that both σabs and σscat are at
a maximum when |ε + 2εm| is minimised, this is known as the Fröhlich condition [99]. It can be calculated
from experimentally obtained permittivity values for gold that the expected absorbance peak will be found at
a wavelength of ∼520 nm (fig. 1.4 (a)) [156].
These relations provide a good approximation for particles with diameters in the range 10–60 nm and
closely match experimentally obtained spectra. It can be see that absorbance scales with a3, and scattering
scales with a6, with scattering becoming the dominant extinction mode for particles with a > 50 nm. The
rapid increase in scattering cross–section with particle radius has important implications for applications
such as darkfield microscopy which are unable to resolve particles below some critical diameter. From
these relations and experimentally obtained permittivity values, spectra can be calculated showing the single
predicted resonance predicted from the Frölich condition with some redshifting of the resonance with particle
diameter (fig. 1.4 (b)–(d)).
In the quasistatic limit, it is also possible to calculate the local electric field as a result of the induced
9
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dipole [17]. This can be expressed outside of the particle as follows:
~Eind = 3





where r̂ is radial unit vector, ~p is the dipole moment given by ~p = α~E0, and r is the distance from the
centre of the particle. It can be seen that field decays with the third power of the radius and increases
linearly with the incident field. The maximum induced field will thus be at the particle surface, aligned
with the axis of excitation and equal to |Eind |max = 2p/4πε0εma
3. For a 50 nm AuNP this field maximum
is approximately 14× greater than E0 [234]. This field enhancement seen at the surface of nanoparticles
makes them particularly appealing as probes for surface enhanced Raman spectroscopy (SERS), where the
SERS enhancement scales with the fourth power of this enhancement, enabling the detection of molecular
species bound to nanoparticles resonant at the incident laser wavelength with high sensitivity [171]. This is
discussed further in section 1.2.8, and can be improved substantially by tuning the nanoparticle morphology.
1.2.5 Gans’ Solution
Often incorrectly referred to as a theory, in 1912 Gans provided a solution of Mie theory for ellipsoids
in the quasistatic approximation [101]. The significance of this solution comes from its prediction of the
optical properties of elongated particles 80 years in advance of their first synthesis [94]. In summary Gans’







εm + L j(ε1 − εm)
(1.12)
where ax and ayz are lengths of the major and minor axes of the ellipsoid respectively. ε1 is the real part of
the permittivity of the medium and εm is the permittivity of the surrounding medium. L j is the shape factor
























an important feature of these factors is that they are only dependent on the aspect ratio of the particle, rather
than the individual dimensions themselves, although this is only true for particles small enough for the
dipolar moment to dominate. It is also notable that as the aspect ratio of the particle tends to unity (i.e.
Lx = Ly = Lz = 13 ), eq. (1.12) returns the sphere polarisability. Using the above relations, eq. (1.10) can be
10
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Figure 1.5: Gans’ solution predicted absorption spectra for ellipsoids at a range of aspect ratios. The particle
volume has been held constant at 21000 nm3. Inset is a plot of the peak absorbance as a function of aspect,
demonstrating the linear dependence of the LM on the aspect ratio of the particle. Values for the permittivity
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 σext = σabs + σscat (1.15)
Spectra generated using these relations tend to display several common characteristics, firstly there exists
two modes of excitation for these particles, a smaller doubly degenerate transverse mode (TM), at 520 nm or
lower, associated with excitation by light with a polarisation orientated along the minor axes of the ellipsoid.
This mode decreases in intensity and is slightly blue shifted with increasing particle aspect ratio. A second
much larger longitudinal mode (LM) associated with excitation by light with its polarisation orientated along
the major axis of the particle. This mode dramatically increases in intensity and red shifts with increasing
aspect ratio. Typically for the size of particle for which Gans’ solution is valid (de f f <60 nm), scattering is
negligible and can be ignored. Example spectra generated by this theory are given in fig. 1.5.
Gans’ solution can be used as an effective estimate of the optical properties of small AuNRs. However in
comparison with the observed spectra the LM peak is always significantly blue–shifted due to differences
in morphology between an ellipsoid and an actual AuNR. Also Gans’ solution fails to account for effects
such as surface–electron scattering, which acts as a damping term at resonance leading to broadening of this
peak. The relative ease of these calculations, compared with computational simulations still makes them a
relatively attractive option as a crude but effective estimation of the optical properties of AuNRs.
11
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Further extensions to Mie Theory
There are a number of other notable extensions to Mie theory allowing calculations to be made for particles,
notably Aden and Kerker’s solution for concentric spherical shells which can accurately model the optical
properties of gold nanoshells and can be extended further to include coated ellipsoids [3], and Lind and
Greenberg’s solution for infinite cylinders, applicable to metal nanowires [205].
1.2.6 Computational Simulation of Gold Nanoparticles
Beyond the few morphologies given above, there are no other simple solutions to Mie theory, instead the
problem must solved computationally. This offers the ability to predict the optical response of any given
particle morphology in an arbitrarily complex environment. Several common methods appear in the literature,
detailed as follows:
Direct Dipole Approximation - DDA
The discrete dipole approximation, these calculations represent an arbitrary–shaped particle as a cubic
lattice of N point dipoles each with a local polarisability, αi, leading to a set of 3N coupled linear equations
[76, 77, 281]. These equations are then typically solved numerically using the conjugate gradient method
[79]. DDA is currently the most popular simulation technique for metal nanoparticles, and offers simple
parameterisation and only requires that the particle volume be discretised [239]. However the simulations
typically require large amounts of computation time and are limited by the fact the accuracy suffers with
increasing refractive index, requiring finer meshing increasing N to often computationally prohibitive levels
for Au in the NIR. Freely distributed codes such as DDSCAT and OpenDDA make these simulations
relatively straightforward to implement.
Finite–Difference Time–Domain – FDTD
Finite–difference time–domain, these calculations provide numerical solutions to wave equations using the
Yee algorithm [397]. The entire space over which solutions are sought is modeled as a 3D–grid over which
Maxwell’s equations are discretised based on finite steps in time and space. The electric and magnetic field
over each finite volume are calculated and solved at a given instant in time and then stepped until steady-state
behaviour is achieved. This method is very processor and memory intensive, but given a fine enough mesh
and that the wavelength is much larger than the physical dimensions of the particle, can accurately provide
solutions to Maxwell’s equations over all space. These simulations are fairly easy to implement, but require
large amounts of computation time. It also requires that the permittivity be expressed as the sum over
multiple Lorentzians, which can make inclusion of experimentally determined values of ε(ω) more difficult
[239]. The most commonly utilised software distribution for these calculations in the literature is Lumerical.
Boundary Element Modelling – BEM
Boundary element modelling, which models the physical situation as a series of 2D elements situated on the
interface of materials and at the boundaries of region of interest; a set of differential equations can then be
solved for each element by minimising an error function [150, 336]. It can accurately calculate the optical
response of plasmonic nanostructures, and generally over a shorter timescale than other methods, since
12
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Figure 1.6: FEM simulated spectra of AuNRs varying aspect ratio, R, and end–cap eccentricity, e. Spectra
have been calculated for values of e between 0 and R (i.e. a cylinder and an ellipsoid) for AuNRs with aspect
ratios of (a) 3, (b) 4, (c) 5, and (d) 6. Inset are diagrams showing the crossection through the major axis of
each AuNR and a diagram showing the values with with e were calculated. Permittivity data for Au taken
from refs [156] and εH2O was assumed to be 1.77.
solutions only have to found for the interfaces in the system. This comes at the cost of losing information on
the volumetric distribution of calculated quantities, such as the electric field. Beyond this, BEM techniques
are limited to solving linear differential equations, any non–linear couplings are thus not calculable via this
technique. BEM is better suited to dealing with simple morphologies with low surface–to–volume ratios, as
increasing surface area results in increasing number of elements per particle. The computational requirements
of these simulation scale with the square of the number of elements (compared with FEM which increases
linearly with the number of elements), hence higher surface area particle morphologies increase computa-
tion time significantly. MNPBEM is a commonly used MATLAB plugin for the purposes of these simulations.
Finite Element Modelling – FEM
Finite element modelling, is a volume–discretisation technique, using a (typically irregular) mesh. Solutions
to differential equations throughout the volume can then be solved using variational methods from the calculus
of variations to solve each finite element. Typically solutions are coupled to neighbouring elements and thus
several runs must be completed to minimise the associated error. Typically the associated error is minimised
through the use of algorithms such as the Runge–Kutta method. Solutions for simple problems may require a
large amount of memory and computation time compared with BEM, but additional information is garnered
on the variation of individual parameters over the entire volume. For more complex geometries with a high
surface–to–volume ratio typically are solved faster in this formalism. Common FEM simulation packages
used for these calculations are COMSOL and ANSYS. These packages offer the additional benefit of being
bundled as multiphysics packages allowing the simulations of other physical phenomena to be considered
alongside plasmonic resonances such as heating or fluid dynamics.
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Figure 1.7: Simulated absorbance crosssections of AuNRs calculated using the method published by Yu
et al [401]. Spectra have been calculated for cylinders (e = 0, dashed lines) and hemispherically–capped
AuNRs (e = 1, solid lines) for aspect ratios between 1 and 6. Permittivity data for Au taken from refs [156]
and εH2O was assumed to be 1.77. The parameter sets used to calculate these spectra are those given in ref.
[401].
Example FEM simulated spectra calculated using COMSOL are shown in fig. 1.6.
1.2.7 Extensions to Computational Simulation
A more recent approach has been to create simple numerical model which can generalise the results of the
above methods to all similar nanoparticle shapes. Yu et al have shown it is possible to calculate the optical
response on certain metal NPs from a set of four parameters which can be extracted from computational
simulations, after which all NP of similar form can be calculated with minimal computational resources
[401]. The method is limited to the quasistatic limit, and hence can only be applied to simple with a single
electrostatic dipolar mode per symmetry axis.
These four parameters are ε j, the resonant permittivity, which describes the effects of geometry as an
effective permittivity. It can be extracted from fitting of the peak strength and postion of mode j from
several simulated absorption spectra. Secondly, V1, the electrostatic mode volume, and particle polarisability
expansion coefficients, a12 and a14, which can be calculated from the simulations of the induced electric
field. Sets of these parameters have to be calculated for each excitation modes of a given particle. These
numbers are independent of particle size (under the quasistatic limit), composition and environment, and
hence once calculated can be used to calculate the optical properties of particles of the same shape, but of
different characteristic dimensions (with in the limits of the quasistatic approximation).














where s is the shape factor defined by
√
εmL/λ, and A j(s) is function which describes retardation effects due
to the finite size of the particle relative to the wavelength of light defined by A j = a j2s2 + 4π
2iV
2L3 s
3 + a j4s4 + ....
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This polarisability can be inserted into the relations for σabs, σscat, and σext given in eq. (1.15) to give the
optical response of a given particle.
Once the four requisite parameters described above have been calculated, they can be inserted into
eq. (1.16). and subsequently eq. (1.15), enabling calculation of spectra in fractions of a second. However, the
calculated results are only as good as the simulations used to calculate the particle properties. It is also not
suited for any study which requires even relatively minor morphological changes to be made to the particle
geometry (such as end–cap modification of AuNRs) as a large number of simulations need to be performed
in order to arrive at each parameter set. Example spectra calculated using this method for cylindrical and
hemispherically–capped AuNRs are given in fig. 1.7 (using the parameter sets given in [401]).
1.2.8 Other Plasmonic Effects
Local Field Enhancement
As discussed in section 1.2.4, a metal NP excited close to its plasmonic resonance will induce a local
field in the surrounding enviroment. The near–field generated on the particle surface is greatly enhanced
compared to the excitation field, E0. This is true for all plasmonic nanostructures and has found a variety
of applications. The induced field can be greatly enhanced by fine tuning of the particle morphology to
maximise the plasmonic Q–factor, in the case of AuNPs by tuning the particle resonance above 700 nm
(fig. 1.2(c)). Presented in fig. 1.8(a) is the calculated field enhancement surrounding a (16 × 60) nm AuNR,
excited at resonance (λLS PR = 803 nm), it can be seen that an enhancement factor in excess of 70× is expected.
By comparison a 60 nm AuNS excited at resonance (λLS PR = 536 nm) has an expected enhancement factor
of 14 [234]. It can also be seen that the field becomes localised to areas of high curvature, in the case of the
AuNR above, this falls close to the intersection between the body of the AuNR and tip (fig. 1.8(b)&(c)).
These high field intensities close to the particle surface greatly enhance electronic transitions of optical
emitters and absorbers, leading to enhanced signal from electronic processes such as Raman scattering
[144]. The actual enhancements of the Raman signal is proportional to the fourth power of the electric field




Figure 1.8(b)&(c) gives emGSERS as calculated along various axes and contours within the model, with a
maximum value of emGSERS of 2×107 being predicted by the model. These significant enhancements in
Raman signal intensity have wide use in applications requiring high sensitivity such as the detection of
explosives, pollutants and biomolecules [34]. Raman spectroscopy thus also provides a robust method to
with which to characterise the surface coatings of plasmonically active NPs.
Plasmonic Coupling (and Aggregation)
When multiple particles are considered in close proximity this induced field becomes important as it will
interact with surrounding particles. Calculations become more involved, as a universal plane electric field
can no longer be considered to be the only excitation source. Hence neighbouring particles will experience
plasmonic coupling. Under such conditions The field felt by an individual nanoparticle can be considered to
15
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Figure 1.8: Local electric field during excitation of the LSPR of a AuNR. (a) FEM simulated map of the
ratio of amplitudes of the local field and excitation field (|E|/|E0|) around a (16 × 60) nm AuNR (λLSPR = λ0
= 803 nm). The excitation wave was polarised along the major axis of the AuNR and traveling into the plane
of the image. (b) Plots of the local field enhancement factor, emGSERS along lines located (1) along the major
axis of the AuNR, (2) parallel to the particle surface originating from the intersection of the half–ellipsoid
and cylindrical sections of the AuNR, (3) perpendicular to the particle surface from the same point, and (4)
along the minor axis of the AuNR. For clarity, each of this vectors have been marked on the inset diagram.
(c) emGSERS along the surface contour shown in (a). The points along the contour which intersect with the
major and minor axis have been marked on the figure, as well the intersections between the half-ellipsoidal
caps and cylindrical sections of the AuNR. Diagrams above each section of the curve indicates which the
section of the contour corresponds with that section of the curve. The electrical response of the AuNR was
rotationally symmetric about the long axis of the AuNR, hence the contours perpendicular to this axis have
not been plotted as they can be determined from (c).
be ~E = ~E0 +
∑
i Ei,n f , where ~E0 is the excitation field and Ei,n f is the near field response of an individual
nanoparticle. These calculations are complicated as the near–field response of each particle is altered by the
presence of the others.
The net result of this are well–documented, in the simplest case, the spectral response of two NSs will
become increasingly red–shifted as the interparticle distance is reduced and the peak is seen to broaden. The
resulting colour change is significant enough that it has been widely exploited as a method of colourimetric
biosensing (e.g. see refs [10, 116, 233, 317]). In the case of anisotropic NPs, consideration of the relative
orientation of each particle must be given. Figure 1.9(a)&(b) shows FEM simulated extinction crosssections
of pairs of AuNRs as a function of interparticle distance. Showing how longitudinal alignment leads to
red–shifting of the plasmon and transverse alignment leads to blueshifting (it should be noted that transverse
alignment is significantly more energetically preferable) and that the magnitude of this shift is inversely
dependent on the interparticle distance.
In order to preserve the optical properties of a colloidal suspension of plasmonic NPs, the stability of the
particles must thus be maintained. Hence a great detail of consideration is given to functionalising particles
with suitable ligands to prevent aggregation and thus plasmonic coupling. This is particularly problematic in
the cases of large clusters of particles where the observed broadening can lead to complete suppression of
any observable plasmonic behaviour.
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Figure 1.9: FEM simulated extinction cross–sections for pairs of coupled AuNRs organised in (a) side-to-
side and (b) end-to-end configurations at a range of particle separations. (c) Plot of the observed plasmon
shift in both cases as a function of interparticle distance.
1.3 Photothermal Properties of Gold Nanoparticles
1.3.1 Heat Generation by Gold Nanoparticles
As in any physical system with a resonance condition, some form of damping must be present in the system
to prevent catastrophic failure of the system. In this case, the complete disassociation of the electrons from
the metallic lattice of the AuNP. Hence damping in plasmonic NPs occurs through electron thermalisation,
which can happen through two primary means, photoluminescence or resistive heating. Gold does not have a
band gap and hence presents quantum yields 1%, thus thermalisation must occur predominantly through
resistive heating of the particle. Thus, to a good approximation all light absorbed by a NP is converted
into heat [149]. Resistive heating occurs through electron scattering, primarily electron–phonon (e–ph,
>85%), but also through electron-electron (e–e, <15%). Hence, e–ph scattering is the main means by
which excited electrons in the AuNP exchange heat with the lattice, this process has a typical timescale of,
τph ∼ 1 ps, and thermal equilibrium between the electrons and lattice will be achieved in 10–50 ps [84].
For excitations longer than these timescales it can be assumed given the high thermal diffusivity of gold
(αAu = 1.27 × 10−4 m2 · s−1) that the heat distribution through the particle will be uniform. The particle
surface and surrounding medium (presumed to be water in this case) will equilibrate over a time scale of
several 100 ps though phonon-phonon scattering (ph–ph). Typically for CW or pulse widths larger than
several nanoseconds these processes effectively happen simultaneously and a steady state of heat flow out of
the NP occurs throughout the entire pulse. On the assumption all absorbed light is converted into heat, the




where I is the intensity of the incident light field and ~E is the electric field inside the nanoparticle.
In the case of steady-state heating (i.e. for pulses > 1 ns), the temperature distribution around a spherical
particle is given by the solution to the classical heat equation with an additional source term, Q(~r, t):
1
α
∂tT (~r, t) = ∇2T (~r, t) + Q(~r, t) (1.19)
where α is thermal diffusivity of the medium. For a particle of effective radius, r0, under illumination, this
17
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equation has a solution of form:


















where κ is thermal conductivity of the surrounding medium and erfc(x) is the complementary error function
[256, 388]. This solution has been computed for a AuNR under continuous wave illumination in fig. 1.10.
The resulting temperature rise for a single AuNR is <1 mK, at a beam power of 1 W·cm2. This superficially
seems very low, but NPs are very rarely seen in isolation (i.e. the typical NP concentration in a AuNR
synthesis is ∼1011 ml−1), much more substantial temperatures are achieved in colloidal solutions.
Accounting for multiple particles in close proximity makes the heat equation significantly more complex,
because heat can now flow between particles, reducing the heat flow out of neighbouring particles, in turn
increasing the temperature of the particle and the medium. The heat source term, Q(~r, t), in the heat equation
is replaced by a sum over all particles ΣiQi(~r, t). The accumulative effect of several particles can yield
significant increases in temperature [113], this has been calculated theoretically for arrays of AuNSs [288]
and demonstrated experimentally though changes in the melt rates of frozen colloids a a function of AuNS
concentration [290].
1.3.2 Illumination Modes
The choice of light source used to heat the particles significantly affects the temperatures and mechanism of
action on surrounding tissue. With two options being most commonly used in the literature, continuous wave
(CW) lasers and nanosecond–pulsed lasers.
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Figure 1.10: (a) Calculated temperature profiles for a single randomly–orientated AuNR under 1 W·cm−2
continuous wave illumination at resonance (LSPR = 800 nm) calculated as the solution of the heat diffusion
equation. The particle ‘radius’ (dashed line) is given at the effective spherical radius, 17.1 nm. Inset is the
temperature at a point 10 nm from the particle surface, showing a steady state temperature distribution is
achieved after ∼1 µs. (b) & (c) FEM simulated temperature profiles in the lateral plane of a AuNR excited
by a single Gaussian nanosecond laser pulse (τp = 7 ns, fluence = 13 mJ·cm−2) on resonance (LSPR = 800
nm). Times are given relative to the centre of the pulse (i.e. t = 0 is during the peak intensity of the laser
pulse). The curves during the heating of the particle are given in (b) and the subsequent cooling is shown in
(c). Inset in (b) is the temperature of a point 10 nm from the particle surface demonstrating the transient
nature of the heating.
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Continuous Wave Illumination
Continuous wave sources are commonly used due to them being cheaper than pulsed sources, with suitable
high intensity single wavelength diode lasers being available for around 5–6× less than the cheapest suitable
nanosecond sources. However these are not useful in all medical applications and typically require greater
exposure times or total fluences to achieve suitable levels of cell death. From the calculated thermal profile
in fig. 1.10(a), it can be seen that the temperature distribution for a single NP effectively achieves equilibrium
heating after ∼1 µs. At this point, the thermal gradient has a characteristic length of ∼1 µm. Whilst this
increase may seem small initially, the mean inter–particle distance for a typical colloidal AuNR solution
(∼ 1011 ml−1) is 0.13 µm1, hence these thermal gradients overlap. Illumination of a solution with a continuous
wave light source should hence be considered a bulk heating effect, with local temperature variations due to
plasmonic excitation are typically less than ∼1 mK based on these calculations.
Similarly whilst 1 mK superficially seems like a tiny temperature increase, the high number of particles
in solution means that cumulatively they can increase the bulk temperature of a solution significantly. For an
infinite bulk solution of AuNRs at a concentration of 1011 ml−1, under 1 W·cm−2 illumination, we would
expect an increase in the bulk temperature of ∼2.4 °C·s−1, however the finite volume of any solution means
that heat losses to the surrounding environment will diminish the rate of localised heating with increasing
temperature.2. Heating colloidal solutions with continuous wave sources can generate bulk temperature
increases of several 10°C over several minutes of illumination.
Nanosecond–Pulsed Illumination
The other laser sources typically used in medical applications of AuNPs are nanosecond pulsed sources.
These are normally Nd:YAG laser pumped optical parametric oscillators, which usually offer ∼100 mJ pulses,
2 – 20 ns in duration, at repetition rates between 10 and 30 Hz (there is a lot of variability between lasers).
These can usually deliver similar laser average powers to continuous wave lasers, but have very small duty
cycles (∼10−5%). Significant heat diffusion cannot occur over the timescale of a single pulse. Hence such
lasers achieve temperatures increases that are restricted in both time and space. Often reaching temperatures
that are several times higher than the boiling point of water in a volume highly localised to the excited
nanoparticle. The transient temperature increases caused by such lasers are capable of instantaneously
denaturing proteins and cavitating nanobubbles in the surrounding medium, providing strong mechanical
agitation alongside the extreme heat profiles provided, hence these lasers are generally significantly more
effective at inducing cell death than CW lasers at the same average power.
Figure 1.10(b)&(c) show FEM–simulated temperature profiles around an AuNR under a typical Nd:YAG
OPO laser pulse. Comparison with the solution for CW heating (fig. 1.10(a)) shows how radically different
these heating regimes are. With a maximum temperature increase of ∼350°C expected for a 7 ns, 13 mJ·cm−2
Gaussian pulse. These simulations do not account for phase change of the surrounding medium, and hence
the insulating effects steam would have on the particle; it is expected in reality the particle would increase in
temperature further than calculated here in the case of nanobubble generation.
1Defined by the Wigner–Seitz radius: 〈r〉 = (3/(4πn))1/3.
2∂tT = Pmc where P is the power of heat generation, m is the mass of the heated volume and c is the specific heat capacity
19
1. Introduction and Theoretical Background
1.3.3 Thermal Reshaping
A major issue faced by nanoparticles when heated in this manner is that of thermal stability. Gold nanoparti-
cles have been observed to thermally reshape under both continuous wave and nanosecond pulsed lasers
[121]. This is often erroneously attributed to melting point depression, the reduction in the melting point of
nanoparticles with decreasing radius (as expressed by the Gibbs–Thompson equation). This is only really
an effect seen for particularly small nanoparticles (i.e. r  10 nm) [271], the majority of nanorods in the
literature are of a size that would be expected to have melting points very close to bulk Au.
Instead this phenomenon is almost entirely driven by surface migration of atoms at elevated temperatures.
[276, 287, 341, 371]. With surface atoms located at high energy, high curvature sites at the tips of AuNRs
preferentially moving towards to more energetically preferable sites along the edge of the AuNR. The net
result of this for AuNRs is reduction in aspect ratio. The effects can be observed at temperatures as low as
50°C [247], and more rapidly change shape with increasing temperature above this [162]. The threshold for
thermal reshaping is sensitive to both surface coating [127, 162] and NP size, with smaller particles being
expected to reshape less readily than larger particles [51, 162, 174].
This phenomenon is extremely problematic for applications that are dependent on the optical properties
of AuNPs. These properties are shape–dependent and, for instance, any reduction in the aspect ratio of
AuNRs will result in a blue–shift of the LSPR peak. Given how spectrally narrow most laser sources are, this
will likely result in the absorbance peak no longer overlapping the excitation source, resulting in little, or no,
plasmonic activity. Hence, this represents a major concern facing the application of AuNRs as photothermal
conversion agents. Hence, an area of active research interest is to find strategies to prevent this, including the
use of stabilising surface capping agents such as silica [31, 53, 59, 60, 157, 216, 382], or optimisation of the
particle morphology [51, 173].
1.3.4 Photoacoustic Pulse Generation
Another interesting phenomenon that emerges from the intense heating generated by AuNPs under illu-
mination is that of sound generation. This is the result of the photoacoustic effect, first recognised by
Alexander Graham Bell in 1880, in which he observed that a selenium disc exposed to a modulated beam of
light produced an audible sound at the frequency of modulation [32]. This effects stems from the thermal
expansion due to heating driven by optical absorption by the material, resulting in an oscillating thermal
expansion at the frequency of modulation. The strength of this effect is thus proportional to the absorbance
of the material at particular wavelength and can be used to distinguish between materials [33]. The advent of
much more intense light sources in the form of lasers in the 1960s led to the development of photoacoustic
spectroscopy enabling detection of parts–per–trillion concentrations of analytes based on their absorbance
spectra [295].
In the case of AuNPs, the combination of their extremely large absorbance cross–sections, high pho-
tothermal conversion efficiency and very small size means that they are effectively point sources from which
acoustic pulses can be generated.
Before consideration of the photoacoustic response of AuNPs, the stress confinement time should be
discussed, τs, which characterises the time for a sound wave to cross the heated region. Any sudden increase
in stress which occurs below this timescale, will result in a localised buildup of stress. This will then be
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dissipated as acoustic pulse equal in width to τs. It is expressed as τs = l/vs, where l is the characteristic
length of the heated region and vs is the speed of sound in a medium. When a nanoparticle is illuminated
it will produce heat and the particle and its surroundings will expand linearly with ∆T , with coefficient
of proportionality, β, this also creates stress in the material which is dissipated as a pressure wave. If the
heating occurs in less than τs, localised stress will build up in the heated region. The greater the heating the
more severe the stress gradient within the heated region. For pulsed excitations, with τp  τs, this will be
dissipated as a broadband acoustic pulse which will propagate in all directions at velocity, vs. For such a
pulse generated by plasmonic exciting a AuNP, the majority of the signal will be generated in the medium,
since heat diffuses out of the particle within ∼50 ps [271], and the stress relaxation time for water/biological
media will typically be ∼ 1 µs; hence the nanoparticles act as the heat source for pulse generation1.
We will consider heating a distribution of particles throughout a volume. The photoacoustic wave











where p(~r, t) is the pressure field, and Cp is the specific heat capacity at constant pressure. Q(~r, t) is the
heating function describing the cumulative effect of a spatial distribution of absorbers. For a single AuNR it
is given by eq. (1.18), but is normally given as Q(~r, t) = α(~r)F(~r), for a distribution of absorbers under pulsed
illumination (where α(~r) is the absorption distribution and F(~r) is the local laser fluence). The photoacoustic













From this we can take that the maximum pressure will be achieved by minimising |~r−~r′|, hence reducing
displacements due to thermal expansion, by restricting the excitation pulse width to significantly below the
stress confinement time. The maximum pressure is linearly proportional to the energy of the pulse, where
the peak pressure can be calculated as:
p0 = Γ(T )Q(~r
′
, t) (1.23)
= Γ(T )α(~r)F(~r) (1.24)
where Γ is the Grüneisen parameter. Hence it can be seen that the photoacoustic response of a system is
linearly proportional to laser fluence and the absorbance cross-section of the absorber. Combining this
with the expressions for σabs in eq. (1.15), it can be seen for a distribution of AuNRs the photoacoustic
response should be linearly proportional to the concentration of Au. Hence the primary means of maximizing
the photoacoustic response, is to optimise the monodispersity of the sample to yield the highest possible
absorbance at the illumination wavelength.
The twin requirements of high pulse fluence and pulse widths τs, have led to led to Nd:YAG pumped
OPO lasers becoming particularly popular for this application, offering pulse widths of a few nanoseconds,
over a very broad range of wavelengths with extremely high pulse energies of several hundred mJ available.
1A pulse is actually generated by the nanoparticle, but is typically < 1% of the total signal.
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(peak powers of 0.1–1 MW). There has been work however attempting to use diode lasers as cheaper
alternative light sources, they suffer from the key disadvantage of having significantly much lower peak
powers/pulse energies1, but are considerably less costly, being typically 10% the cost of Nd:YAG OPOs, are
very compact and offer variable pulse widths and repetition rates. The ability to vary the repetition rate is key
since it offers the opportunity to sample acoustic pulses at many times the rate offered by a Nd:YAG pumped
OPO (10–30 Hz), allowing significantly better averaging to be performed, increasing the signal–to–noise
ratio substantially. These systems have been successfully implemented by Beard’s group at UCL for in vitro
tests [14, 15, 16, 192, 193].
1.4 Applications of Gold Nanoparticles in Cancer Nanomedicine
The optical and thermal properties discussed above have been utilised as agents for both the treatment and
imaging of cancer. Discussed here are the relevance of those properties and the some of the most prolific
methods utilising them in the literature.
1.4.1 The Near–Infrared Biological Window
The primary interest in AuNRs over other particle morphologies and materials is their strong absorbance
peaks which are tunable throughout the near infrared (NIR). They fall into what is known as the first NIR
window in biological tissue, a range of wavelengths at which light sees increased penetration into tissue. The
first NIR window falls on a wavelength range2 between 650 and 850 nm, a second window between 950 and
1400 nm has also attracted increasing attention in recent years [323]. As shown in fig. 1.11 between 650
and 900 nm haemoglobin (Hb), oxyhaemoglobin (HbO2), and water and have their lowest absorbance in
the UV-vis-NIR region [376]. At such wavelengths the penetration depths of light at increased from 1 – 1.5
mm at blue/green wavelength to 1–2 cm at 800 nm [344]. Hence AuNPs can be made such that they absorb
strongly at wavelengths which can penetrate in vivo and can thus be used as in vivo photothermal conversion
agents in theranostic applications.
1.4.2 Plasmonic Photothermal Therapy
Using NIR–absorbent particles thus offers a potential method to remotely heat localised regions within
the body without significant damage to surrounding tissue along the light path. As discussed above,
plasmonic nanoparticles irradiated at their resonance wavelength will rapidly heat up, diffusing heat into
the surrounding environment. Living cells cannot withstand temperatures beyond a few degrees beyond
homeostasis, hence remotely heating them using plasmonic nanoheaters irradiated with NIR light offers a
non–invasive, collateral–free and potentially non-toxic route to destroy tumours within the body.
The increasingly severe effects of increasing temperature on human tissue are shown in fig. 1.12.
Prolonged exposure to elevated temperatures of around 42–43°C will induce cell necrosis, this is already
widely exploited in current hyperthermia treatments [215]. Hence, the temperature range between 42 and
48°C is often referred to as the ‘clinically relevant’ regime. Above this the thermal damage is severe and
1The highest available peak power nanosecond–pulsed diode was 650W/100µJ at the time of writing
2Other limits to this range are given in the literature, 850 nm has been given as the upper limit as it is the point at which the
detrimental effects of water absorption begin to be see in photoacoustics.
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Figure 1.11: Optical absorbance of key in vivo chromophores. There is clear reduction in absorbance for all
components between 650 and 850 nm known as the first NIR biological window in tissue. Hb/HbO2 values
taken from ref. [340], H2O values taken from ref. [270], Fat values were taken from ref. [353], and Melanin
values were taken from refs. [65] and [305].
instantaneous, prolonged heating at such temperatures is not clinically safe without good control of the local
distribution of the heat generation [149, 357].
Hence the use of thermal conversion agents have become a widely investigated method to deliver heat in
a highly localised manner, either through tumour–specific targeting or direct intratumoural injection, with
AuNPs being identified to as a one potential candidate. Alternatives include organic fluorophores such as
indocyanine green [56, 57, 58], which whilst NIR–absorbent, are significantly less efficient at generating
heat. Typically fluorophores have an absorption cross section six orders of magnitude smaller than a typical
AuNP. They also cannot be targeted to the tumour site efficiently (given the much larger size of targeting
ligands) and hence require significantly higher doses of photothermal agent for safe levels of radiation to be
maintained due to the reduced heating efficiency and lack of specificity [1].
In looking to optimise the effectiveness of photothermal heat generation an inspection of eq. (1.18),
points to the immediate dependence on absorption cross–section, and hence its morphological dependence.
Currently AuNRs offer the highest known σabs–to–volume ratio of all AuNPs1, typically with σabs an order
of magnitude higher than AuNSs or AuNShs at equivalent volumes of Au per particle, and come with a
smaller effective radius [145]. This smaller effective radius increases the allowed high penetration of tissue
and small blood vessels and hence improves the efficacy of AuNP accumulation at specific target sites [83],
although these suggested benefits are still under investigation.
The first attempts at utilising the photothermal effects of AuNPs to destroy cancer cells came in 2003,
when Hirsch et al used gold nanoshells (AuNShs) to selectively kill cells in vitro upon illumination with
NIR light. With the first in vivo murine model following in the next year, when O’Neal et al used multiple
treatments of intravenously injected PEGylated AuNShs followed by illumination with a 850 mW diode laser,
to completely destroy tumours containing CT26.WT cells; after 90 days all treated mice were still alive [261].
A number of reports on the use of AuNShs in vivo has followed these reports [54, 197, 212, 225, 369]. This
has ultimately culminated in the first human trials utilising AuNShs (branded as AuroShell) for photothermal
treatment of prostate neoplasms, delivered via intratumoural injection [190].
The first in vitro photothermal experiments using AuNRs came later in 2006 [141, 338]. Despite the better
theoretical optical properties of nanorods, the synthetic protocols and surface functionalisation strategies
1There are some simulations that suggest nanobipyramids might be better, although the improvement is marginal at best
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Figure 1.12: The effects of different temperatures on cells within the body. Adapted from: [149].
required to make them in bulk and use them in biological contexts only emerged in the mid–2000s (discussed
in section 1.5 and section 1.6). In the first photothermal studies Huang et al achieved selective killing of
HSC and HOC cells at intensities below 15 W·cm−2 using EGFR–targeted AuNRs with a LM of 800 nm
[141]. There have been a large number of studies since demonstrating that heat generation from AuNRs can
induce death in Human cell lines since (i.e. [11, 138, 251, 380]). AuNRs have also been heavily studied
in vivo, with most treated mice showing improved mortality (i.e. [111, 203]) or reduced tumour volumes
[55, 61, 198] after the combined administration of AuNRs and NIR exposure.
This is not to say that the technique is not without difficulties, a number of issues remain. The largest
is that of actually delivering the particles to the tumour site. The easiest solution to this is intratumoural
injection, but this cannot always be implemented depending on the location of the tumour. Instead many
studies using intravenously administered AuNPs rely on what is known as the enhanced permeability
and retention effect (EPR). This is the effect whereby intravenously administered small molecules are be
disproportionately taken up by tumours, which would be a panacea for drug delivery researchers. However
the EPR effect remains controversial, with open questions about its veracity, having often proved unreliable
in murine models [249], and further questions about how translatable any observed EPR effect in murine
model is to humans [68, 249]. The other strategy left open is that of targeting, but the results of these
strategies in the literature are also fairly inconsistent. A recent review article by Willhelm et al found that
the average delivery of non–targeted particles to tumour sites was 0.6% of the injected dose (%ID), by
comparison particles functionalised with a targeting ligand achieved just 0.7% [379]. There was a large
degree of variability in the reviewed papers with both non–targeted and targeted particles having a %ID in
the literature of ∼10.5%. As it stands there is no intravenous delivery strategy that results in consistent and
significant uptake of the injected nanoparticles.
Beyond delivery other issues exist, such as maintaining colloidal stability in vivo and preventing in-
tracellular aggregation after endocytosis [2, 314, 406], which can potentially destroy the useful optical
properties of AuNPs. Alternatively there are the competing priorities of preventing the immune system
too rapidly collecting administered particles whilst simultaneously preventing particles remaining in the
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body indefinitely [11]. These are all issues that also affect the next technique to be discussed, photoacoustic
imaging.
1.4.3 Photoacoustic Imaging
As discussed above, the photoacoustic effect only really found use in spectroscopy for most of the 20th
century [295]. In 1981, Bowen was the first to suggest the potential of photoacoustics in biomedical imaging
[38]. The technique was developed during the early to mid 1990s (e.g. [187, 264]) predominantly using
NIR–absorbent dyes as the contrast agent.
Using the photoacoustic effect to generate images relies on pulse generation as described in section 1.3.4.
Fluorophores heated under a nanosecond pulsed laser will effectively act as a point source for acoustic
pulse generation. The generated pulse will travel with a group velocity equal to the speed of sound in the
surrounding medium vs. Hence the position of the pulse can be calculated using time–of–flight measurements
from multiple transducers allowing the source to be located in space with a theoretical maximum precision
equal to vsτp, where τp is the pulse width, for a 1 µs wide pulse the highest resolution achievable is thus
∼1 mm. Imaging a complex distribution of pulse sources requires use of specialist time–of–flight imaging
algorithms able to convert the complex signals recorded by an array of transducers into a 2D dimensional
slice. It is thus possible to map the biodistribution of an administered dose of NIR absorbent–chromophore
within an animal due to the increased penetration of light.
It is possible to extend this further using a technique known as multispectral optoacoustic tomography.
By choosing a series of wavelengths at the major turning points in the spectra of water, Hb, HbO2 and
the chromophore of choice, it is possible to map the distribution of all four components simultaneously.
Deconvolution algorithms can be used to ‘spectrally unmix’ each pixel of the obtained image. This process
is optimised by choosing a chromophore with a large, narrow absorbance peak between 800 and 850 nm,
where all other components are at minimum absorbance. Hence AuNRs are well suited to this role, with
their tunable absorbance peaks and high photothermal conversion efficiency.
Figure 1.13: Schematic showing the key processes and the involved timescales used in in–vivo photoacoustic
imaging. An optical pulse < 10 ns illuminates a target leading to heating of the target and the surrounding
medium. This leads to localised thermal expansion and ultimately at high enough intensities is dissipated as
an acoustic pulse. Such pulses can be located in space through time–of–flight measurements allowing the
formation of an image of the target absorber within the medium.
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The first studies using AuNPs as photoacoustic contrast agents were in 2001, which demonstrated the
efficacy of AuNSs as photoacoustic contrast agents in phantoms [161, 265]. In particular, it was shown that
AuNS’ ability to cavitate nanobubbles in the surrounding medium significantly increases the amplitude of
the generated PA signal. In 2004 the first NIR–absorbent particles were used for PAI, where non–targeted
AuNShs were used to image a rat brain in vivo [369].
Some early work demonstrated that AuNRs could generate strong PA pulses in biosensing systems,
showing their potential for use in photoacoustics [199, 200]. The first in vivo use of AuNRs for PAI did
not occur until 2007, allowing whole body imaging of a mouse [83]. Since these early studies, there have
been a large number of improvements in utilising AuNPs in photoacoustics, including three dimensional
mapping [169], and the observation of both passive [284] and targeted [55, 327] uptake of AuNRs into
tumours. A wide range of other AuNP morphologies have found application in PA imaging [201], including
other NIR–absorbent morphologies such as nanocages [389], nanoprisms [26] and nanotubes [393].
Photoacoustic imaging utilising AuNRs suffers many of the same limitations as photothermal therapies,
its efficacy is significantly reduced by any effect that will change the optical properties of the photothermal
contrast agent, such as thermal reshaping or aggregation (plasmonic coupling). The lasers required to
generate the required pulse intensities are typically Nd:YAG–pumped OPOs, the intense fluence of these
lasers has been regularly observed to result in the reshaping of AuNRs (and hence the loss of their optical
properties) [121, 127, 162, 337]. This is also a problem faced by photothermal therapy if a nanosecond
pulsed laser is used. Hence a number of strategies have been devised to cope with this such as coating
the AuNRs in a silica shell which does not so easily thermally reshape [31, 59], or optimising the nanorod
morphology to minimise thermal reshaping [51, 174]. In relation to prevention of aggregation, silica coating
offer a potential solution to this if made thick enough to prevent plasmonic coupling [62]. Alternatively
targeting AuNPs to extracellular sites, in an attempt to prevent endocytotic uptake and ultimately intracellular
aggregation [348].
1.4.4 Other Medical Applications of Gold Nanoparticles
PPTT-Assisted Chemotherapy
There are several potential methods to extend to PPTT which could significantly increase its effectiveness,
firstly, AuNPs offer a potential delivery vehicle through which to deliver chemotherapeutic drugs to a
tumour site. Delivery of these drugs would be hugely beneficial; current chemotherapeutic drugs are very
effective at killing cancer cells, but they are also toxic resulting in significant collateral damage to healthy
cells and a severe depreciation of the quality of life of patients. A large proportion of these suffer from
solubility problems, with around 40% of currently available drugs and 90% of upcoming drugs showing poor
water–solubility, preventing delivery to the tumour site [159]. Hence there is now a concerted effort to devise
in vivo delivery mechanisms to overcome these problems such as targeted AuNPs. These have the potential to
allow a significant reduction in required dosage and increased efficacy due to the proximity of drug release to
tumour sites. Beyond this chemotherapeutic drugs when used alongside thermal therapy become significantly
more effective, due to the increased vascular permeability (encouraging local drug delivery) and increased
cellular pore size (allowing large-molecule drug absorption) brought about by localised heating of tissue. For
example, Yavus et al have developed a drug delivery based on gold nanocages coated in a smart polymer,
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which when irradiated in the NIR contracts to allow the release of drug molecules contained inside [392]. In
vitro tests showed a 40% decline in cell viability after drug release showing the potential effectiveness of this
alongside PPTT in ensuring cell death.
Biosensing
The strong optical properties of gold nanoparticles makes them potentially useful as colourimetric biosensors.
The proposed methods tend to fall under two schemes of based either on specific binding or induced
aggregation in the presence of a molecule of interest. The former are generally simple lateral flow assays
in which AuNPs functionalised with an antibody will bind to another antibody–functionalised strip in the
presence of an analyte (i.e. ref. [168]). Alternatively, deliberately induced aggregation in the presence of an
analyte of interest can be used [10]. If the analyte present several binding sites multiple AuNPs can be bound
to it leading to rapid aggregation in the presence of enough analyte. These changes can be easily detected
through UV-vis spectroscopy, enabling rapid quantification of the analyte concentration.
The other significant form of biosensing is that of single particle SERS, especially in the case of AuNP
dimers, or particle–on–a mirror configurations [158, 322]. Which enable huge enhancement of the Raman
signal from single molecules. For example enabling sensitive monitoring of trace levels of hormones such as
dopamine in urine and correspondingly allowing dosage of medication to be made directly in response to
actual physiological levels of biomarkers.
1.5 Chemical Synthesis of Gold Nanoparticles
The discussion here is limited to the liquid–phase synthesis of gold nanoparticles using chemical reducing
agents, a number of other methods exist but are not well suited to the bulk production of nanoparticles for
the applications discussed here.
1.5.1 A Brief History of Gold Nanoparticle Synthesis
The earliest reported nanoparticle synthesis in the scientific literature remains that of Faraday in 1857
[87]. In the course of preparing gold films, Faraday inadvertently synthesised a red colloidal suspension
through the reduction of NaAuCl4 by white phosphorus. Faraday correctly identified the origin of this colour
emerging from the optical properties of suspended particles. However the study of gold colloidal suspensions
languished for most of the next century, with only a few notable exceptions, such as the work of Zsigmondy,
who created liquid–suspensions of gold nanospheres through the reduction of gold salts by tin chlorides
and studied their optical properties through darkfield microscopy [412]. Also the work of Turkevich in
1951, further developed by Frens in the early 1970s [97, 98, 349], which developed the most commonly
used method the synthesis of AuNSs currently used today. This was the single step reduction of HAuCl4 by
sodium citrate at elevated temperature, leading to the production of relatively monodisperse citrate capped
AuNSs 10–20 nm in diameter.
From the late–1980s there was an increased interest in the synthesis of AuNPs, with a number of
important synthetic protocols emerging. Including the development of the polyol process in 1989 [89, 90],
where by metal salts are reduced in a α–diol such as 1,2-ethanediol (ethylene glycol) at high temperature
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(210°C). It is a widely used process due to the relatively facile synthesis and ease–of–scalability, it has
also notably been adapted for the synthesis of metal nanowires ([332, 333, 334]). The early 1990s saw
the publication of the Brust–Schiffrin method, an important method for the organic phase synthesis of
monodisperse alkanethiol–capped AuNPs with diameters less than 10 nm [42]. It was also in this period that
the first NIR–absorbent gold nanoparticles were synthesised in the liquid–phase with in the form of gold
nanoshells, initially on Au2S cores in 1994 [409], but rapidly followed by the use of silica cores in 1998
[260].
The earliest liquid–phase syntheses of AuNRs appeared during this period via photochemical [86] and
electrochemical [400] methods. Both protocols used a shape directing agent called cetyltrimethylammonium
bromide (CTAB) to yield AuNRs in solution. The real surge in interest in the synthesis of AuNRs appeared
after the publication by Jana et al of a protocol, which seeded the reaction with pre-synthesised AuNPs and
used a weak reducing in tandem CTAB to yield AuNRs in solution [148]. This protocol suffered from high
polydispersity and poor shape yield, requiring a large number of rounds of shape separation by centrifugation
in order to produce AuNRs in high yield. Following this an number of additional improvements were made to
the synthesis, through the inclusion of silver nitrate [253] and the optimisation of the reaction pH [12]. More
recently trends have focused on the inclusion of aromatic additives, such as salicylate [307, 395], dopamine
[209], hydroquinone [355] or resveratrol [367], or through the inclusion of co-surfactants such as BDAC
[253] and oleic acid [396]. Other strategies have involved controlling micellular structure through inclusion
of Hofmeister salts [269] or the use of alternative surfactants such as dodecylethyldimethylammonium
bromide [16, 253, 359] and gemini surfactants [385]. A discussion of the formation processes of AuNRs and
the effects of these is given in section 1.5.2 and the following sections.
1.5.2 Control of Colloidal Synthesis
The typical starting point from which to consider the product of any chemical process is that of kinetic and
thermodynamic products. Often in a chemical reaction there exist competing pathways to the formation
of multiple products, the composition of which are determined by the reaction conditions. Typically these
are grouped into either ‘thermodynamic’ products, that is the product which exists at the global Gibbs free
energy minimum, ∆G0; or ‘kinetic’ products, which exist at a higher Gibbs free energy, ∆G0′, but have a
lower energetic barrier, E′a to formation.
In the archetypal case (fig. 1.14), there exists a higher energetic barrier to the formation of the thermody-
namic product, such that Ea > E′a, and hence control over the reaction temperature and reduction potential,
allows for direct control of the composition of the resulting populations of the thermodynamic and kinetic
products. Under such conditions the lower activation energy of the kinetic product leads to higher rate of
product formation, and simultaneously the thermodynamic product forms at a lower rate due to the kinetic
barrier to formation. The ratio of the rates of formation, kx, is determined by the difference in the activation










However, if this reaction is reversible (i.e. A + B −−−⇀↽−− C), the thermodynamic product (A + B −−−⇀↽−− D)
will form at a lower rate due to its higher activation energy, but simultaneously is more stable than the kinetic
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Figure 1.14: Typical representation of the energy profiles involves in kinetic vs. thermodynamic processes.
In the example reaction two possible products can emerge as a result of the reaction i.e. A + B −−−⇀↽−− C ∨ D,.
Firstly, the thermodynamic product, D, which has the lowest chemical potential, but there exists a large
activation energy, Ea, providing a kinetic barrier to its formation. Alternatively, the kinetic product, C,
which has a lower activation energy, E′a, but whose final product, C, sits at a higher potential energy than
D. The lower activation energy of C leads to it forming at much faster rate than D. It can be seen for hot
reactions, such that kBT & Ea + ∆G0′ that the thermodynamic product will dominate, whereas below this the
kinetic product will be preferable. It is possible for a product to be both kinetically and thermodynamically
preferable.
product as result of its lower Gibbs free energy. Hence if the reaction is allowed to continue for an increasing
amount of time we expect to see thermodynamic products make up a increasingly larger fraction of the
products. Ultimately reaching a stable ratio of product concentrations, known as the equilibrium ratio, Keq,








A number of factors can be utilised to control the resultant product from such reactions. For instance,
the concentration of kinetic products can maximised, by reducing the reaction temperature to the minimum
required for kinetic product formation, restricting the reaction time and controlling the reduction potential.
Conversely, long and high temperature reactions will maximise the number of thermodynamic products that
are formed.
It is worth noting that it is possible for a single product to be both kinetically and thermodynamically
favourable, in which case no control over the reaction can be achieved. Simultaneously if a kinetic product is
irreversibly formed (i.e. A + B −−−→ C), then no thermodynamic control can be exerted once this product
has formed.
Kinetic vs. Thermodynamic Considerations in Nanoparticle Synthesis
These considerations have important implications to the synthesis of AuNPs, however unlike the above
system nanosynthesis typically involves the complex interplay of kinetic and thermodynamic processes.
Factors ranging from the minimization of surface energy, energies of individual crystal facets (and the
respective binding affinities of ligands to them), ligand–ligand packing density, and interactions between the
29
1. Introduction and Theoretical Background
nanoparticle, ligand and surrounding solvents all must be considered in understanding the formation of a
nanocrystal.
Foremost, the thermodynamic shape is usually that which minimises the surface energy, (i.e. that which
minimises the surface–to–volume ratio). For a liquid droplet the solution is simple, it is a sphere; but in the
case of solids there exist cohesive interactions between atoms, requiring a consideration of both the surface
free energy, γi, and strain energy [368]. Atoms at the surface with the highest number of neighbors have
the lowest surface free energies, hence it follows that specific surface facets are energetically preferable to
form and in the case of fcc–metals, γ(111) < γ(100) < γ(110) < γHI (HI = higher index) [370]. These energies
can be modified through use of facet–specific capping agents enabling direct morphological control to be
achieved. Generally speaking, for such materials, the shapes that predominantly present {111} and {100}
facets are typically global thermodynamic structures [220], such solutions are called Wulff constructions.
For Au these comprise of monocrystalline icosahedra, octahedra, truncated octahedra, cubes, truncated cubes
and cubooctahedra; or penta–twinned decahedra [29]. Hence in general it can be said that anisotropic AuNP
morphologies are kinetic products [220], and thus a great degree of thought must be put into controlling the
reaction conditions to yield them.
The simplest methods for controlling the growth kinetics of such reactions include temperature and pH,
the effect of each on the reduction potential, Eh, of a reaction is readily expressed in the Nernst Equation
[244, 245, 246]:






where E0 is the reference potential, R is the universal gas constant, T is temperature, F is the Faraday
constant, h is the number of protons transfered, and n is the number of electrons transfered in the reaction.
It can be seen that Eh increases linearly with T , and decreases linearly with pH. Under standard reaction
conditions (T = 25 °C), RT/F = 59.16 mV; we expect a linear decrease in Eh with pH, with a gradient of
-59.16 h/n mV.
More generally when discussing particle synthesis, it is typical to frame it in terms of monomer generation,
with the initial barrier to achieving particle formation being that of nucleation itself. This emerges from a
consideration of the Gibbs free energy; for a sphere this is given by ∆G = 4πr2σ − 4/3πr3Gv, where Gv is the
energy per unit volume and σ is the surface energy per unit area. It can be seen that a critical radius exists at
r∗ = 2σ/Gv below which we expect dissolution of any forming nucleus and above which particle growth is
preferable. For many materials this means that supersaturation of monomers in solution must be achieved
before large enough nuclei can form that are stable (i.e. for calcite, r∗ = 1–3 nm [132]). However, in the
case of most metal salts, the critical radius is effectively non-existent at common synthesis temperatures and
dissolution of small clusters need not be considered, with even metal dimers remaining stable in solution
[241]. Hence formation of most metal nanoparticles can occur stably even at relatively low concentrations of
metal salts.
The classic example of a thermodynamically controlled nanoparticle synthesis is that of the Turkevich
synthesis [97, 98, 349]. This is the simplest possible case, a two component system containing a metal salt
(HAuCl4) and a reducing agent (sodium citrate). The whole reaction is heated close to boiling, run over a
long period of time providing enough energy to clear any kinetic barriers to complete reduction of the metal
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salt resulting in a homogeneous population of thermodynamic products (in this case amorphous spheres).
The main challenge which emerges under these conditions is that continuous nucleation will occur, leading
to nuclei forming at different time points, and hence having varied growth times, resulting in a polydisperse
population. The entire reaction is thus performed under very rapid stirring to encourage collisions between
freshly–formed monomer units and already–formed particles, leading to more homogeneous particle growth.
The size of the particle can be controlled between 10 and 150 nm through variation of the Au:citrate ratio,
additional of additional surfactants and control of the reaction pH [311].
The alternative is a kinetically controlled nanoparticle synthesis. That is a reaction performed as rapidly
as possible to deplete free monomers units in solution, preventing further particle growth. A good example of
this is the Creighton method for the preparation of gold seeds [64]. In this system a HAuCl4 solution under
vigorous stirring is rapidly reduced by a strong reducing agent in the form of NaBH4. The result of this
reaction, if performed properly1 is to yield very small monocrystalline particles (<4 nm), instead of the more
thermodynamically stable penta–twinned morphologies which present only {111} facets. Another example
of this is the so-called “hot injection” technique used in quantum dot synthesis, in which one precursor is
injected at lower temperature relative to the main reaction vessel, resulting in an initial burst of nucleation
followed by a slower growth phase as the temperature drops [274]. The net result of this is to achieve growth
directly onto the initially kinetically favoured product.
The final consideration is that of shape–directing capping agents, ligands can be added to a growth
system which will bind to specific facets which high affinity. Examples of commonly used capping agents
selected for this role include citrate, which preferentially binds to {111} facets or poly(vinyl pyrrolidone)
which preferentially binds to {100} [404]. The net result of including either capping agents allows generation
of structures that present majority {111} or {100} facets (in the case of Au, decahedra or cubooctahedra
respectively). Hence, control over what is considered the kinetic product of a reaction can be tuned through
the inclusion of additional additives in the growth solution.
Separation of Nucleation and Growth
As alluded to above, a large number of nanoparticle syntheses require the synthesis of seed particles, that is
an initial particle from which to grow the rest of the particle. These are typically prepared under completely
different reaction conditions to the final product. Seeding fits under a broader strategy deemed separation of
nucleation and growth which applies equally as a description to seeded and so–called ‘seedless’ synthetic
protocols. The discussion here will be limited to gold nanorods, but seed synthesis protocols have much
wider use in the synthesis of other particle morphologies such as plates, bipyramids and decahedra.
The synthesis of seeds is typically achieved via the Creighton method, albeit normally assisted by the
inclusion either CTAB or citrate. In short a mixture of HAuCl4 and either citrate or CTAB is prepared. The
HAuCl4 is then rapidly reduced by NaBH4 under vigorous stirring. In these cases the choice to do these
syntheses rapidly is due to the desire to keep particles small and monodisperse, rather than to achieve kinetic
or thermodynamic control of the morphology.
CTAB has a high affinity for the {100} facets of Au compared with citrate and will considerably lower
their surface potential upon binding, leading to preferential formation of these facets alongside {111} facets
1Using just NaBH4 is typically unreliable, and so CTAB is usually adding to stabilise the {100} facets not seen on penta-twinned
seeds
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and hence produce monocrystalline seed particles. Such particles can be used in the synthesis of particles
such as monocrystalline AuNRs and nanoplates. As stated above, the decahedral seed morphology is the
thermodynamic product and hence populations of monocrystalline seeds synthesised using CTAB, can be
converted to penta–twinned decahedra through thermal annealing post–synthesis [303]
Whereas citrate has higher affinity to {111} facets [272], and particle formation in its presence will lead
to morphologies which maximise these facets, in the case of gold this is penta–twinned decahedra. Such
particles have five twinned defect planes dividing monocrystalline regions which only present outward {111}
facets. Such particles are crucial to the formation of particles such as bipyramids, penta–twinned nanorods
and decahedra, all of which present fivefold symmetry.
The synthesis of penta–twinned AuNRs would not be possible if the seeds were produced in the same
growth solution the rest of the growth was performed because this second step is done in the presence of
CTAB (which has a higher affinity for Au than citrate). Hence separation of nucleation and particle growth
is a requirement of such syntheses. By comparison the CTAB–directed seeds can be produced in the same
growth solution, this is the basis of the so–called seedless and one–pot recipes. A small volume of NaBH4 is
added to the CTAB containing growth solution, to nucleate a limited number of particles relative to the total
amount of available gold. Under such a procedure the nucleation and growth are effectively separated, due to
the seeds being generated by a different reducing agent to that which drives the growth. It should be noted
that seedless protocol tend to generate small nanorods than those grown from seeds.
Inducing Anisotropy – Synthesis of Gold Nanorods
The actual growth process of AuNRs is still not fully understood, but fairly robust models have been estab-
lished which appear to explain the main observed processes. The actual growth processes of monocrystalline
AuNRs and penta–twinned AuNRs are different in the processes that drive anisotropic growth, but share
certain common features
Seeds are typically added to a solution containing a growth mixture of HAuCl4, CTAB, and ascorbic acid
(AA). Mixing HAuCl4 with CTAB in solution leads to rapid formation of AuBr−4 through a halide-exchange
reaction (4 CTAB + AuCl –4 −−−→ CTA−AuBr4 + 4 Cl
– + 3CTA+). AuBr−4 is more stable than AuCl
−
4 and
hence less easily reduced which appears to be key to controlling the growth kinetics during the synthesis.
AuBr−4 readily forms a complex with CTA
+ ions in solutions resulting in the mixture becoming a distinct
orange colour1. Addition of AA, a mild reducing agent, then results the reduction of Au3+ to Au1+ via the
following two–step reaction2 [164]:










2 + C6H6O6 + H
+ + Br–
This is visible during the course of the reaction due to the disappearance of broad absorbance band at 395 nm,
leading the solution to turn from a semi-transparent orange to near completely clear [316]. Under the pH and
temperature conditions of a typical growth solution, reduction of AuCl−2 cannot occur without presence of a
surface potential to catalyze the reaction. Hence at this point the reaction is normally initiated by addition
1CTA-AuBr−4 has a characteristic broad absorbance band at 395 nm
2Ascorbic acid and dehydroascorbic acid can fulfill the role of reducing agent in either step.
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of seed particles (or in the case of seedless syntheses addition of a much stronger reducing agent such as
NaBH4 which can nucleate seeds in situ).
There is a debate around the specific role that ascorbic acid plays in the synthesis beyond this. Some have
suggested that growth of the AuNRs occurs primarily through a autocatalytic disproportionation reaction of
form:
3 AuCl –2
Au0 sur f ace
−−−−−−−−→ AuCl –4 + 2 Au
0 + 2 Cl–
in which the ascorbic acid primarily performs the role as a scavenger, reducing the AuCl−4 produced from
this reaction to AuCl−2 , allowing all ionic Au in solution to be reduced on to the surface of the forming AuNR
[82]. However, this does not seem to be the case, if the synthesis is performed in the presence of weaker
reducing agents such as salicylic acid [307] or oleic acid [189, 292, 396], without AA, no growth onto the
AuNRs is observed. Both of these molecules are capable of reducing Au3+ to Au1+, and are hence capable of
performing the Au3+ scavenging role suggested in the above scheme. Instead the ascorbic acid is suggested
to play a direct role in reducing Au1+ onto the particle surface in the following autocatalytic reaction:
CTA−AuBr –2 + C6H8O6
Au0 sur f ace
−−−−−−−−→ Au0 + C6H7O
–
6 + CTA
+ + H+ + 2 Br–
Also counter to proposed disproportionation reaction, other studies have suggested that in the presence of
CTAB, the reverse comproportionation reaction is actually more preferable (i.e. Au3+ + 2 Au0 −−−→ 3 Au1+)
[275, 294]. This process is essentially oxidative etching of the nanoparticle surface, and probably does occur
during synthesis, but is largely outpaced by the much faster parallel reduction of Au driven by the large
excess of AA in solution [390]. It is possible to use other mild reducing agents to drive this growth (i.e. refs
[81, 91]), although AA is by far the most commonly used reducing agent.
Regardless of the exact mechanism, the presence of AA leads to reduction of the AuBr− in solution onto
the surface of a seed particle. In order to achieve anisotropic growth with both penta–twinned seeded AuNRs
and monocrystalline seeds, a shape directing agent in the form of CTAB1 is required (and in the case of
monocrystalline seeds the presence of Ag ions) to direct anisotropic growth.
The precise role of CTAB was similarly misunderstood for along time, with a number of the early
papers attributing its role to that of a soft template in which nascent AuNRs could form. Hence there
was a large emphasis placed on the requirement for the formation of ‘needle’– or ‘rod’–like micelles (e.g.
[148, 238, 254]). It is now widely accepted that the actual growth mechanism occurs through preferential
adsorption onto {110} facets located the edge of the AuNRs (and {100 facets in single crystalline AuNRs}
[25]. Although this preferential binding on its own is not enough to ensure uniaxial growth. Hydrophobic
interactions between surfactant molecules are important too, studies looking at the impact of the hydrocarbon
chain length attached to the N+[CH3]3 headgroup have found shorter chains (H21C10–TAB) only create
AuNSs. Whilst longer chains allow the synthesis of rods of increasing aspect ratio up to C16 (CTAB), after
which the aspect ratio decreased alongside the rod yield decreased2 [103] .This appears to result from the
optimised bilayer packing density providing better suited growth rates on each facet. The counterion is also
crucial, replacement with iodide results in binding to the surface becoming too stable inhibiting particle
1Alternative shape directing agents to CTAB have been used in the literature, such as dodecylethyldimethylammonium bromide
[16], gemini surfactants [385], and hydrogen peroxide [361] (the latter is yet to be replicated in literature and reported very low shape
yield). CTAB is by far the most commonly used shape–directing agent in synthesising AuNRs.
2This seems to result from the effect decreased solubility of C18TAB rather than and inability to pack on the AuNR surface.
33
1. Introduction and Theoretical Background
Figure 1.15: Schematic: Formation of penta–twinned AuNRs.
growth, whereas replacement with chloride results in too weaker binding of CTAB to the particle surface
[211].
The specific role of CTAB in the synthesis of penta–twinned AuNRs vs. that of monocrystalline AuNRs
is worth considering. In the penta–twinned case the initial seed has no {110} facets present hence initial
particle growth is required to create {110} facets along the plane of symmetry in the seed. CTAB molecule
can then bind to this nascent surface stabilising it and slowing the rate at which Au can be reduced on to
it. This process is shown in fig. 1.15, whereby CTAB is able to consistently bind to the forming {110}
facets whilst reduction continues at the {111} facets at the tips. CTAB also plays another important role
in this process, by supplying bromide ions, which help further encourage uniaxial growth by oxidatively
etching the {111} facets. This oxidative etching dually prevents the binding of CTAB at the tips (encouraging
uniaxial growth), and offers kinetic inhibition slowing the rate at which Au is deposited at the tips [25, 381].
The resultant AuNRs are thus pentagonal in cross–section and can be hypothetically grown indefinitely to
produce very high aspect ratio AuNRs.
By comparison, monocrystalline AuNRs are grown from seeds that are typically cuboctahedral, these
present {100} and {111} facets in all directions, meaning there is no preferential direction of growth. Hence
additional components must be added to growth solution in order to induce anisotropic growth, in the form
of silver ions [362]. This is true for seedless growths also.
The Role of Silver in the Growth of Monocrystalline AuNRs
The advantages of adding silver ions to the growth solution was realised fairly quickly after the 2001 Jana
publication [147], although there was little elucidation the role played by silver in the synthesis (i.e. at this
point it was still being used in conjunction with citrate–capped seeds). The most commonly excepted model
is that AgNO3 is deposited on to the AuNRs through a process known as underpotential deposition (UPD).
UPD is an electrochemical technique whereby a monolayer of a metal is deposited on another metal at a
redox potential more positive than the Nernst potential [28]. Above this potential a metal will no longer
be readily deposited onto itself, but can be deposited on by a metal higher in the reactivity series. The net
result of this in this system is that silver will be reduced onto the nanorod surface, but no other metals ions in
solution can will be reduced on top of this, hence a silver monolayer forms. Hence the reduction potential
must be finely tuned to achieve this, too higher pH and no UPD will occur. UPD is sensitive to the surface
free energy of individual facets, and hence the reduction potential can be set such that silver is only deposited
on the {110} facets along the sides of the AuNR [362].
The importance of this is twofold, firstly, the deposition of Ag early in the growth appears to be key to
providing the initial symmetry breaking. Attempting the synthesis of monocrystalline AuNRs without Ag (in
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Figure 1.16: Schematic: The role of silver in stabilising a nascent truncating {110} surface during AuNR
synthesis and subsequent stabilisation of that surface by UPD. Figure taken from [362].
both seeded and seedless reactions) will result in the formation of no AuNRs. Instead only spherical particles
will grow from the seeds. The seeds are effectively isotropic, with no preferential growth direction, as these
seeds grow at the start of the reaction {110} truncations will intermittently appear along the intersections of
facets, before further reduction of Au destroys them. However in the presence of Ag will disproportionately
reduce on to these embryonic {110} surfaces, resulting in them being stabilised. It is speculated that strong
internal mechanical forces encourage the formation of ‘paired’ {110} truncations in a single plane [362]. The
growth of these facets then leads to preferential growth along a single axis. This mechanism is shown in
fig. 1.16(a).
Secondly, the presence of Ag plays an important role in regulating anisotropic, beyond this initial
symmetry breaking role. The epitaxial layer of Ag on the {110} facets serves an important role in slowing
Au reduction along the sides of the AuNR. Silver on these surfaces can be redissolved into solution via a
galvanic replacement reaction1, hence the capping is not permanent. Instead what is occurs is a continuous
parallel process of UPD and galvanic replacement, the net result of which is that growth in these directions is
inhibited, rather than completely prevented. Thus the AuNRs growth in both length and diameter during
the synthesis. The mechanism which drives the growth of the {110} facets is shown in fig. 1.16(b), whereby
disproportionate growth at the {111} and {100} facets at the tips leads to progressive expansion of the {110}
facets along the major axis of the AuNR [362].
Experimental evidence seems to support this model, energy dispersive X–ray spectroscopy suggests that
silver is located only on the surface of the AuNR and not in the bulk interior [143]. Attempts at overgrowing
monocrystalline AuNRs without the the presence of Ag also results in isotropic growth of the particles
ultimately resulting in their conversion to spheres, demonstrating the important role Ag plays in controlling
anisotropic growth beyond the initial symmetry breaking [307]. X–ray photoelectron spectroscopy has also
been used to demonstrate that alternative explanations for the role of Ag, such as surface passivation by
AgBr species is unlikely to be true, as the observed concentrations of Br− were independent of the [Au]:[Ag]
ratio of a given set of AuNRs [405].
It has also been observed that commonly reported problems resulting for iodide impurities in CTAB can
be mitigated by increasing the concentration of Ag ions during the growth [152]
1Probably via Ag + AuCl –2 −−−→ AgCl + Au + Cl
– , rather than 3 Ag + AuCl –4 −−−→ AgCl3 + Au + Cl
– , due to the large excess
of reducing agent present.
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Other Additives
The roles of additional additives in monocrystalline AuNR syntheses is still not fully understood, but seems
to stem from manipulating the packing density of CTAB monomers on the surface of the forming AuNR.
The most obvious example of this is the inclusion of oleate in the synthesis, a negatively charged surfactant
that will intercalate into the bilayer, adding additional screening between CTAB headgroups and encouraging
higher packing on the AuNR surface [396]. The inclusion of aromatic additives seems to similarly result
in intercalation into the bilayer, and providing a similar screening effect [395]. The same dynamics have
been demonstrated by varying the concentrations of Hofmeister salts in the growth solution which will
similarly provide screening of the positively–charged CTAB headgroups enabling tight packing of the CTAB
monomers [269]. This higher packing density will help lower the access of Au ions to AuNR surface along
the sides of the AuNRs slowing lateral growth, encouraging the formation of anisotropic particles and hence
resulting higher shape yields. These additives also result in higher monodispersity in the synthesised AuNRs
which probably results from the impact of the effect of increased surfactant packing on the growth kinetics.
1.6 Surface Functionalisation of Gold Nanorods
The surface coating of AuNPs are highly important to their applications, as they imbue particles with a wide
range of properties such as hydro–phobicity/–philicity, surface charge, steric stability, specific targeting and
biocompatibility. Hence an active area of research is the development of novel surface coatings with which
to prepare AuNPs for the wide variety of applications in which they are now used. This section will focus
primarily on the functionalisation of AuNRs, but the majority of techniques can be more widely applied to
all AuNPs.
Thiol Displacement
These are a general strategy by which any simple thiol containing molecule can be bound onto the surface
of a particle. Thiols have a particularly high affinity for binding with the noble metals, as such in theory
can easily displace more weakly bound molecules such as CTAB. Typically the molecules used for this are
alkanethiols [48] or PEG–thiols [310, 407], these can be decorated by large number of functional groups to
provide additional desired properties. The efficiency of ligand transfer is can be very low in some of these
protocols, and hence additional strategies have been developed recently to optimise this exchange [310].
Passivation
These are a set of protocols grouped together because they do not actually remove CTAB from the surface of
the AuNRs. Instead they passivate the CTAB bilayer by coating it with a layer of silica or organic materials
which prevents release of free CTAB from the particle surface.
The first of these is silica coating. A layer of silica can be grown directly on the CTAB bilayer coating
the AuNR surface [112]. This has been shown to be an effective strategy for increasing the biocompatibility
of CTAB–capped AuNRs [140]. It also has a number of other advantages in that it can prevent thermal
reshaping [31, 53, 59, 60, 157, 216, 382] and plasmonic coupling [62].
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Other passivation strategies include coating the CTAB layer with polymers. This is normally achieved
based on simple charge interactions with a negatively charged polymer, which will readily bind to the
positively charged AuNR surface. Popular materials for this include poly(styrene sulphonate) [109, 196] and
poly(acrylic acid) [129, 130]. Such protocols can easily allow thick coatings to be created through building
up multiple alternating layers of negatively and positively charged polymers [109].
Both the polymeric and silica coating strategies offer the opportunity for drug–loading enabling the
inclusion of small molecules in the passivating layer, for slow or thermally–triggered released [109, 328].
Direct Exchange
Because of the manner in which CTAB actively exchanges with with molecules in solution, it is possible to
directly exchange the CTAB bilayer with other molecules if a sufficiently large excess is placed in the bulk
solution. Hence CTAB–coated particles can be resuspended in a strong solution of the desired molecule and
additional agitation provided to encourage exchange (by heating or sonicating). These techniques have been
reported for a number of molecules including phospholipids [222, 266, 304, 339, 398], oleic acid [204, 364]
and bovine serum albumin [342]
Conjugation of Targeting Ligands
Finally, in a wide number of applications additional functionalisation with targeting ligands (or other
molecules, such as fluorophores) is desirable, hence conjugation of these molecules to the surface is desirable.
A wide number of routes to conjugate such molecules to surface ligands are available such as ‘click chemistry’
[37, 40], NHS–EDC linker chemistry [30, 286], biotin – streptavidin coupling [277] and thiol – maleimide
coupling [365].
1.7 Gold Nanoparticles and Biology
1.7.1 In Vitro Toxicology
Nanotoxicology, study of the toxic effects of nanoparticles, has grown substantially in the last 20 years with
from 1,100 publications in 1998 to over 75,000 last year. A large amount of concern has been expressed
about the potential toxic effects of nanomaterials. These are not limited to manufactured nanoparticles, but
include the wide array of nanoparticles generated as a result of combustion and industrial processes as well
naturally occurring particles from events such as volcanic eruptions. Here we discuss very briefly the current
questions surrounding the human toxicology of AuNPs, with specific emphasis on AuNRs.
A lot of the results in the literature are contradictory, as is attested by a recent major review by Krug
which laments the current state of nanotoxicology [186]. In particular the problems arising from the large
number of studies that are now being contributed by non–toxicologists, highlighting the large number of
studies that lack careful analysis of the dose–response relationship of nanoparticles without identifying a
safe, intermediate or lethal dose of nanoparticles. A number of studies reporting toxic effects were based on
exposure of cells to very high in vitro concentrations of AuNPs unrepresentative of the exposures expected
during actual treatments [186]. Hence an important aspect of taking this research forward in a sensible
direction will that of collaboration between material scientists and biomedical researchers.
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In a similar vein, the toxicological properties of gold nanoparticles remain improperly understood, as the
large number of inconclusive reviews can attest (e.g. [47, 96, 166]). Whilst gold in bulk remains one of the
least reactive elements, when reduced to the nanoscale this can no longer be taken for granted. The high
surface area of AuNPs makes them significantly more reactive than the bulk state and their plasmonic activity
makes it possible catalyse chemical reactions. Toxicology studies on AuNPs present a particular problem
due to significant range of sizes, morphologies, and surface functionalisations which have to be considered,
making broad general statements about to toxicity of AuNPs difficult to conclusively argue. In the case of
‘bare’ AuNPs (i.e. citrate–capped), the primary concern is largely that of oxidative stress, resulting from the
generation of reactive oxygen species at the surface of the particle [185, 218]. This is an inherent property of
all AuNPs and means they will always present a low level toxicity, although this is a relatively minor effect
with citrate–capped AuNRs presenting an IC50 > 150 µg·ml−1 [356]. However different surface coatings and
morphologies radically change this how AuNPs will interact with biological systems.
In the case of AuNRs the most commonly used methods for synthesis require the use of CTAB. This is
extremely problematic, CTAB is highly cytotoxic, presenting an IC50 of ∼ 4 µM [232, 296], whereas the
typical background concentrations of CTAB required to maintain colloidal stability are typically >100 µM
[13, 296]. Hence CTAB coated particles are completely unsuited for use in biological application. Free
CTAB is a positively charged surfactant and will disrupt cellular membranes and simultaneously quench the
enzyme ATPsynthase preventing metabolisation of energy by cells [309]. Hence, there is a large amount of
work seeking to detoxify CTAB–capped AuNPs, such as AuNRs, by replacing or passivating CTAB on the
surface of such NPs. These strategies are discussed in section 1.6, but generally speaking the most common
strategies are PEGylation and silica–coating resulting in IC50 values around or higher than that seen for
citrate capped particles [134, 297] with charged polyelectrolyte coated AuNRs showing IC50 values around
∼150 µg·ml−1 [196], although these numbers vary considerably in the literature and are cell–line dependent.
These IC50 values are well above the local concentrations likely to achievable in vivo when administered
intravenously, and inform the suitable dose for in vivo experiments.
1.7.2 In Vivo Toxicology
The fate of nanoparticles after in vivo administration is also an open question. The broad mechanisms by
which particles are cleared are relatively well understood, smaller particles (< 5 nm) are at least partially
captured by the kidneys and disposed via the urinary tract [73]. However this clearance is not based only
simplistic size filtration, and is charge dependent, preferentially allowing the passage of positively–charged
particles [41]. Larger particles are typically collected by the mononuclear phagocyte system (MPS), and
then accumulate in the liver and spleen, before being eliminated via the digestive tract. Accumulation in the
liver is the most commonly observed result in the administration of nanoparticles [352]
The rate at which the MPS can collect particles is highly dependent on the surface charge, with charged
particles being collected and more rapidly delivered to the liver [352]. This has been attributed to increased
interaction between the particle surface and charged biomolecules in the blood identifying these cells to
macrophages for clearance. This rate seems to also be size–dependent, where larger particles are much more
rapidly collected by the MPS than smaller ones [326].
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The clearance of particles from the liver to the digestive tract is also problematic. With a number of
papers reporting very slow clearance from the liver for a variety of surface functionalisations, with typically
<20% reduction in Au concentration of the liver for citrate (6 months later [300]), silica (3 days [363])
and PEG (3 months) [282] and 15 months [11]) capped AuNRs [5]. This persistence in the liver could be
very problematic, since the long term impact of these on organ function remains unclear, with potential
side–effects including drug– or nanoparticle–related toxicity [352].
PEGylation is the most commonly strategy to increase blood circulation time. PEGylated particles
display low surface charge and non-specific binding and are hence are much more slowly uptaken by the
MPS [251]. Once cleared to the liver or spleen, the particles tend to accumulate there, only very slowly
clearing thereafter, with particles still being detectable months after administration. Although the benefits of
this increased blood circulation are open to question, with some papers suggesting that there is very little
evidence to demonstrate increased blood circulation time necessarily leads to with increased tumour uptake
[352].
1.7.3 Interactions of Particles with Physiological Media – Formation of Protein
Corona
Nanoparticles in media containing charged biomolecules, such as proteins, peptides and lipids, will rapidly
undergo the formation of what are known as protein corona. That is non–specific binding of such molecules
to the particle surface, which radically alters the surface functionalisation of such particles. The nature
of the formed corona is dependent not only particle properties such as size, curvature, surface charge
and functionalisation, but also on factors such as exposure time (corona biomolecule populations change
dynamically) and temperature [78]. These have been observed for a wide range of surface functionalisations
[13, 313], and seem to be largely unavoidable, with even PEGylated particles so far showing the formation
of coronae [352]. Zwitterionic coatings have, to a limited extent, been shown to display some resistance to
non–specific binding [126].
These are potentially a major problem, as the unknown surface chemistry of these corona make prediction
of NP behaviour difficult to predict. It also has the potential to completely undermine targeting strategies,
given that corona can often be as much as 100 nm thick [178], obscuring any small surface bound targeting
ligand. Hence there is a need for an understanding of the nature of such corona, the effects it has on NP
interactions in vivo and in vitro and potential methods for mitigating the effects of them or utilising them as
part of a therapeutic strategy. There are a large number of studies attempting to characterise and understand
the nature of corona on nanoparticles using techniques such as differential centrifugal sedimentation [69, 70],
isothermal titration calorimetry [24], liquid chromatography – mass spectroscopy [343], as well as molecular
spectroscopy techniques (i.e. FTIR, Raman or NMR).
1.7.4 Uptake of Nanoparticles by Cells
Humans have been exposed to naturally occurring nanomaterials throughout their evolutionary history and
as such have evolved defenses to deal with the potential negative health consequences. This is as true
at a cellular level, as it is at the level of the whole organism. Cells interact with NPs primarily through
endocytosis, a process in which foreign material is brought into the interior of cell contained within a
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vesicle [181]. The rate at which this occurs is dependent on both the cell type and the characteristics of the
nanoparticle itself (i.e. size, shape, surface charge, protein corona...) [4, 408]. Charged particles are typically
endocytosised at a higher rate than non–charged particles, due charge interactions between the phospholipid
headgroups in cellular membrane and the particle surface [243]. Particle size also plays an important role
with smaller NPs (<50 nm) being taken up by cells much more rapidly than larger ones [188].
Endocytosis is a potential problem when using plasmonic NPs, as multiple particles are typically enclosed
in each endosome. The small volume combined with the a relatively high concentration of NPs makes
aggregation inevitable. In the case of plasmonic AuNPs this means that plasmonic coupling will occur and
the desired optical properties will be lost, this is a widely recognized problem [8, 115, 280]. Some solutions
have been demonstrated such as thick silica–coating which prevents coupling between particles, even during





2.1 Synthesis of AuNRs
All glassware used in the synthesis were cleaned by sonication in a 10% Decon90 solution for 10 minutes,
followed by through rinsing using Milli-Q water and further sonication in Milli-Q. The glassware was then
by soaking in freshly prepared aqua regia for 30 minutes. Aqua regia is a 1:3 mixture of concentrated HNO3
and HCl, a mixture of a strong oxidiser and source of Cl− ions which will readily dissolve gold, removing
any potential nucleation sites for the reduction of gold during the synthesis reaction. All glassware was then
throughly rinsed with Milli-Q water and dried overnight in an oven at 70°C. All glassware was cooled to
room temperature before use.
Small Batch Syntheses
To prepare 10 mL of AuNR colloidal solution the following steps were performed. Solutions of CTAB
and NaOL (200 mM) were prepared in advance of the synthesis and heated to 70°C until all solute was
dissolved. These were then added in the desired ratio and topped up to 5 mL with Milli–Q (total surfactant
concentration between 20 mM and 180 mM). This was followed by adding sequentially 5 mL HAuCl4 (1
mM), 240 µL AgNO3 (4 mM), 50 µL HCl (11.8 M), and 75 µL ascorbic acid (85.8 mM). To this 7.5 µL
freshly prepared, ice–cold NaBH4 (10 mM) was rapidly injected into the mixture. The mixture was then
kept at 30°C for 4 hours. The AuNRs were then isolated by centrifugation at 9000 g for 30 minutes. The
supernatant was discarded and the precipitate resuspended in Milli–Q. AuNR solutions were stored in the
dark at room temperature.
Large Batch Syntheses
For the production of larger batch sizes of ∼0.5 L, some modification to this recipe is required. The initial
CTAB–NaOL surfactant mix was prepared by heating 250 ml Milli–Q water to 70°C in a water bath, under
constant stirring. The desired quantity of powdered CTAB and NaOL were then added directly to the heated
water and stirred until completely dissolved. The stirred solution was then cooled to 30°C. 250 ml HAuCl4 (1
mM), 12 ml AgNO3 (4 mM), 2.5 ml HCl (11.8 M), 3.75 ml ascorbic acid (85.8 mM) were added in sequence
under constant stirring, the mixture was allowed to stir for ∼5 minutes between addition of each solution.
Finally, the stirring of the solution was increased to 1200 rpm and 0.375 ml ice–cold freshly–prepared
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NaBH4 (10 mM) was rapidly injected. Stirring was immediately ceased and the solution kept at 30°C for 4
hours. The resulting AuNRs were cleaned by centrifugation at 9000g for 30 min as above.
2.2 Surface Modification of AuNRs
2.2.1 Preparation of PSS–Functionalised AuNRs
1 ml of as–synthesised 75 µg·mL−1 AuNR solution was washed twice by centrifugation and was then placed
under magnetic stirring. To this was added dropwise a solution containing 10 mg·mL−1 PSS and 5 mM NaCl.
The mixture was left stirring for 24 hours, followed by cleaning by centrifugation (9000g, 30 min) and the
pellet was redispersed in a 1 mg·mL−1 PSS solution. This cleaning process was repeated twice more, before
redispersal in Milli–Q grade water. This process was scaled up as required.
2.2.2 Preparation of Phospholipid SUV Solutions
Upon receipt from Avanti and Lipoid, phospholipids were dissolved in a 2:1 chloroform–methanol mixture
by volume to a known concentration of 10–20 mg·mL−1 using the method originally described by Folch et al.
[92]. Stock lipid–solvent solutions were stored at -20°C. In order to prepare SUV solutions, the solvent was
evaporated using a rotary evaporator (40 mbar, 100 rpm and 30°C), until the lipids formed a visible film on
the inside surface of the flask and no solvent was apparent. Residual solvent was removed by dessicating the
lipid film overnight. The films were then hydrated using to a desired concentration and then bath–sonicated
for a further 24–hours in a refridgerated sonicating bath. The peak size of the vesicles were then measured
using a Malvern Zetasizer Nano ZSP and used if the size peak of the vesicles was . 50 nm.
2.2.3 Preparation of Phospholipid–Functionalised AuNRs
1 mL of as–synthesised 75 µg·mL−1 AuNR solution was washed twice by centrifugation and was resuspended
in 300 µl 10 mg·mL−1 phospholipid SUV solution. The mixture was placed in a refrigerated sonicating bath
for 24 hours. The AuNRs were cleaned by centrifugation (2000g, 15 min) and redispersal in 300 µL 10
mg·mL−1 phospholipid SUV solution. This process was repeated threefold (i.e three rounds of redispersal,
sonication, centrifugation, and removal of the supernatant). After the third round, the pellet was redispersed
in Milli–Q grade water. To reduce the background concentration of free lipid the AuNRs were cleaned
further by centrifugation. This process was scaled up as required.
2.2.4 Conjugation of Targetting Affimer
A portion of the lipids can be replaced with DSPE-mPEG-Maleimide enabling conjugation of thiolated
molecules to the surface. For the purposes of targetting our AuNRs, a CEA–specific affimer was selected.
After preparation of the phospholipid–functionalised particles (with for instance 5% mol. DSPE-mPEG-Mal).
A solution containing 23 mM TCEP, 0.2 M MOPS and 1 mM EDTA (pH 8.2) was prepared and added to a
stock of the affirmer (55 µM) at a ratio of 1:2 TCEP solution to adhiron suspension (210× molar excess of
TCEP). The solution was kept at room temperature for 90 minutes. AuNRs were centrifuged at 3000g for
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10 minutes, the supernatant discarded and the pellet resuspended in the prepared affimer–TCEP mixture,
such there was a 3.3× molar excess of adhiron per maleimide site. The number of maleimide sites availible
was calculated based on assuming that each lipid headgroup occupied a 1 nm2 space on the surface on
the AuNR and the molar composition of lipids on the surface was the same as that in the SUV solution.
Post–conjugation particles were cleaned by centrifugation and sterile–filtered.
2.3 Characterisation
Lower manification TEM images were obtained using a Tecnai G2 Spirit TWIN/BioTWIN with an ac-
celeration voltage of 120 kV. A field emission gun TEM microscope (Philips CM200 FEGTEM; 200kV)
equipped with a Gatan GIF200 imaging filter running Digital-Micrograph software was used to take higher
magnification TEM images and selected area of diffraction. TEM samples were prepared by drying ∼5 µL of
10× concentrated nanoparticle dispersion (in Milli–Q) on an amorphous carbon–coated 400–mesh copper
grid (Electron Microscopy Services, CF400–Cu). Sizes of AuNRs were measured manually using ImageJ.
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Figure 2.1: Measured Au0 concentrations as a function of A400nm. The red line is a linear fit, whereas the
green line is the published value of ∼0.416 mM.
Concentrations were determined by using either a Varian 240fs atomic absorbance spectrometer (AAS)
or from by measurements of the absorbance of AuNP solutions at 400 nm. The latter method was prefered,
due to the increased convenience, and seems to provide similar levels of accuracy to AAS itself. It relies
on using the change in absorbance in the section of the AuNP spectrum dominated by interband transitions
(see section 1.2.2), rather than the higher wavelengths dominated by plasmonics which are sensitive to other
factors other than cocentration, such as polydispersity. This technique is only viable for small particles,
around or below the skin depth, where absorbance is the still the dominant optical effect. In fig. 2.1 a
comparison of A400nm and the AAS determined C[Au0] values is shown, demonstrating the strong linear
correlation between the two measurements for a set of four samples. The measured gradient is in close
agreement with the values published in the literature [167, 308, 315]. This was used in conjunction with the
TEM determined geometries to ascertain the particle concentrations in solution.
UV–vis spectroscopy
UV–vis spectra were taken with a Agilent Cary 5000 UV–vis-NIR using quartz crystal cuvettes (path length
= 1 cm). Samples were typically diluted by a factor of 10 before spectra acquisition. Where spectra are
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presented unnormalised, they have been multiplied through by the dilution factor to account for this spectra
are multiplied through by a factor of 10 to account for this (in accordance with the Beer–Lambert law).
For kinetic spectra, AuNR growth solutions were prepared in a 20 mL vial, after addition of the NaBH4,
the solution was mixed quickly and 700 µl was pipetted into a cuvette and spectra capture immediately started.
During the first 5 hours of a synthesis kinetic spectra were taken at 2 minute intervals at the 1800 nm·min−1,
this was then followed by 10 minute intervals at 900 nm·min−1 for the following 24 hours. Solutions were
heated to 30°C throughout. Samples monitored during the kinetic spectra were undiluted, instead a quartz
cuvette with a path length of 0.1 cm was used in order to prevent the LSPR peak exceeding the detection
threshold of the instrument. Spectra from these measurements are multiplied through by a factor of 10 in
order to retrieve the true extinction value (again in accordance with the Beer–Lambert law).
2.4 Optical Microscopy
Figure 2.2: Left: Simplified diagram of key optical components in the DIC–darkfield microscope. The
assembly shown above is for use as a DIC microscope. The condenser turret assembly (highlighted in green)
containing aperture #2 and Wollaston prism #1 can be replaced with a darkfield condenser (highlighted in
pink) to allow the system to be used as a darkfield microscope. Right: Diagram demonstrating the principle
behind transmission darkfield microscopy. Collimated light travels through a condenser lens and with a
central patch stop, creating a hollow cone of illumination which is focussed onto the sample. Directly
scattered light is collected by the objective. For high numerical aperture objectives, an internal iris is used to
further eliminate indirectly scattered light. The image then directed to a digital camera, and the eye–piece or
a 10 µm multimode optical fibre centred on the image. This fibre carries scattered light to a high sensitivity
spectrometer allowing measurement of the scattered light spectrum from a sample.
2.4.1 Darkfield Microscopy and Single Particle Spectroscopy
Darkfield microscopy images only the light scattered by the sample to produce an image. It is particularly
useful for imaging plasmonic metal nanostructures due to their high scattering cross sections. The first use
of such techniques to image plasmonic nanoparticles was by Zsigmondy et al. in 1902 [321], who pioneered
the development of optical darkfield techniques in the study of colloids [402, 403]. The core components of
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such systems include a collimiated bright light source with a broad emission spectrum, which is focused
through a darkfield condenser (consisting of a condensing lens and annulus shaped aperture) onto the sample.
This produces an inverted hollow cone with the sample at the apex. The angle of incidence of this cone is
such that only light scattered by the sample is collected by the objective, whilst transmitted light is discarded.
For higher numerical aperture objectives, some of this light may also be collected and an internal iris must
be used to shutter it from reaching the camera/eye–piece.
Individual scatter spectra can be collected by using a fibre optic to sample the emitted light across a
circular spot. The fibre will a combined spectrum resulting from the background and any particles within
this region. We can thus express the measured spectrum from the sampled area as:
Imeas(λ) = Ibulb(λ) ·
[
S NP(λ) + S bkgd(λ)
]
(2.1)
where Imeas(λ), and Ibulb(λ) are the measured and illumination spectra, and S NP(λ), and S bkgd(λ) are the
scattering functions of the nanoparticle and surrounding substrate. The angular dependence of the scattering
functions are ignored, as the numerical aperture of the condenser is fixed at ∼0.875, resulting in a angle
of incidence of 61°. This fortunately means the unpolarised light focussed on the sample closely excites
the LSPR and TSPR of particles roughly correct proportions for a random orientation in space. Hence
from eq. (2.1), measured signals must be corrected by dividing through by the normalised spectrum of the
illumination source and then subtracting the corrected background spectrum. The background spectrum is
taken to be equal that of a region of the substrate free from particles.
Experimental Set–up
Darkfield microscopy images were taken on a Nikon Ti–S microscope using a TI–DF dry darkfield condenser
and a CFI Plan Fluor 100× oil–coupled objective. Images were captured using an Olympus UC90 camera
and spectra collected via Ocean Optics QE–Pro fibre–coupled to the microscope with a 1000 µm fibre optic
(Ocean Optics, QP1000–2–VIS–BX). The fibre optic collected light from a 10 µm spot. In order to obtain
a scatter spectrum, background spectra were collected from regions without particles. A particle was then
moved into the central focus and a spectrum collected. The background spectrum was then subtracted from
this and then divided through by the normalized illumination spectrum, to correct for the non–uniform power
spectrum density of the bulb. Particles with a LSPR outside of the human visual spectrum (>750 nm) were
beyond the spectral range of the camera. The following steps during sample preparation were found to
minimize background scatter during spectra collection. Samples were prepared on (24 × 50) mm coverslips
(Menzel Gläser, CS2450100). To minimize background scatter these cleaned by washing sequentially in
10% Decon90 solution, acetone, isopropanol and finally Milli–Q water. These were then placed in piranha
solution heated to 80°C for 30 minutes, rinsed using Milli–Q water and then stored under ethanol until use.
After drying, the coverslip was placed in a spin–coater and 100 µl of AuNR solution diluted to ∼5 fM was
placed onto the centre of it. The coverslip was spun at 1000 rpm for 1 minute ensuring all particles which
adhered to the surface were well separated during imaging and spectra collection.
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2.5 Measurements of Colloidal Stability
Figure 2.3: Comparison of the effective buffering ranges of commonly used buffers. Buffers used in this
thesis for ζ–potential measurments are outlined with bold text.
Buffer pH Solution #1 Solution #2(100 mM) (100mM)







4 30.7 ml 19.3 ml
5 24.3 ml 25.7 ml
6 17.9 ml 32.1 ml
7 6.5 ml 43.6 ml
8 3.5 ml 46.5 ml
Tris 9 HCl 4.5 ml C4H11NO3 45.5 ml
Carbonate–Bicarbonate 10 NaHCO3 22.5 ml Na2CO3 27.5 ml
Hydroxide–Phosphate 11 NaH2PO4 7.2 ml NaOH 42.8 ml
KCl – Hydroxide 12 KCl 9.7 ml NaOH 40.3 ml13 13.8 ml 36.2 ml
Table 2.1: Recipes used for preparing 50 ml 100 mM buffer between pH 1 and pH 13. Small adjustments to
in the pH were acheived by adding dropwise 100 mM NaOH or 100 mM HCl
2.5.1 Zeta Potential Measurements
In order to monitor the surface charge of nanoparticles, measurements were taken of the ζ–potential of
solutions using a Malvern Zetasizer Nano ZSP. ζ–potential is measured by monitoring the response of
particles in solution to an applied DC voltage. Specifically the electrophoretic mobility is directly measured





where UE is the electrophoretic mobility, ε is the dielectric constant of the dispersant, ζ is the zeta potential,
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η is the dispersant viscosity and f (ka) is Henry’s function 1, k is the debye length and a is the paticle radius.
For the measurements here f (ka) is taken to be 1 under the Debye–Hückel approximation (a < 100 nm and
celectrolyte << 10 M) [74].
The Malvern Zetasizer uses laser doppler velocimetry to measure the particle velocity distribution.
Briefly, a monochromatic light beam illuminating the sample is modulated by an oscillating mirror, the
intensity of the light scattered by the particles in solution is recorded and then analysed by a digital signal
processor to extract the characteristic frequencies in the scattered light. the frequency of the fluctuating scatter
intensity signal is directly proportional to the electrophoretic mobility and measurement of the Doppler shifts
of the incident light gives an a direct measure of the direction of motion.
Colloidal solutions are often quoted to display stability, if |ζ | > 30 mV, based on the qualititative
definitions outlined by Riddick in his 1968 book [291], although this threshold is somewhat arbitrarily
selected. Optimisation of the ζ–potential of solution through proper surface modification and buffer pH is
key to maintaining the long–term stability of charged stabilised samples.
Stability characteristics ζ–potential (mV)
Extreme to very good stability -100 < ζ ≤ -60
Reasonable stability -60 < ζ ≤ -40
Moderate stability -40 < ζ ≤ -15
Threshold of light dispersion -15 < ζ ≤ -10
Threshold of agglomeration -10 < ζ ≤ -5
Strong agglomeration and precipitation -5 < ζ ≤ 5
Table 2.2: Stability of colloidal solutions from their ζ-potential. Taken from ref. [291]
Two key parameters to consider during these measurement are the ζ–potential are pH and electrolyte–
concentration, which will radically change the measured ζ–potential. Hence because of the low buffering
capacity of DI water, the pH is very poorly defined, meaning all measured values of ζ in this medium are
pratically meaningless. Beyond this, the poor conductivity of DI water leads to electrode polarisation, making
it impossible to reliably produce a uniform electric field with in the typical folded capilliary cuvettes used
for ζ–potential measurements. Hence all measurements must be performed in buffer at known pH and ion
concentration. Hence the following buffers were used to control the pH during ζ–potential measurements:
ζ–potential measurements are taken in disposable folded capilliary cells purchased directly from Malvern.
In a standard measurement the folded capillary is filled throughout with the colloidal dispersion, however
a number of issues arise from this technique when applied to highly conductive colloidal samples. For
instance, Joule heating and electrode polarization, which can be minimised by reducing measurement time
and voltage. But more concerningly electrode blackening and sample degradation, due the denaturation
of many organic materials, including surface–stabilising ligands, in response to the high electric field in
close proximity to electrodes. The only route to avoid this is to avoid direct contact of the colloid with the
electrode. Either through the use of a semi–permeable membrane or through a diffusion–limited barrier
methodology [18, 19, 236, 237, 347].
All work here was performed using the diffusion barrier method. The folded capillary was loaded with
buffer at known pH and concentration (typically 10–100 mM). A small volume (∼50 µl) of colloidal solution
1Henry’s function: f (ka) = 1 + 116 (ka)




12 (1 − ka) −
(





from refs [124] and [335]. E1(ka) is
the exponential integral.
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Figure 2.4: Different configurations for ζ–potential measurement. The “standard” measurement with colloid
in close proximity to the electrodes and the difusion–limited measured with the colloidal solution isolated at
the bottom of the folded capillary.
suspended in the buffer was injected into the base of the cuvette using a 200 µl gel–loading tip. This creates
a high concentration of colloid in the measurement region of the cuvette with minimal osmotic pressure
(i.e diffusion–limited). Further to prevent material from reaching the electrode, the measurement voltage in
reduced with increasing buffer concentration1. Measuring via this technique is in full compliance with the
current standard for measuring the colloidal stability of biological nanomaterials (ASTM E2865-12(2018)
[21]).
2.5.2 Surface Enhanced Raman Spectrscopy
Quartz slides were sonicated with acetone, 1% Decon 90 and rinsed with Milli–Q prior to piranha etching
using 30% Hydrogen Peroxide and Sulfuric Acid ( >95%) at 3:7 (v/v) ratio. Slides were cleaned for 20 m
and rinsed and stored in Milli–Q and dried with nitrogen gas prior to use.
Concentrated AuNR sample was dried onto the quartz slide using hydrophobic chambers. A Raman
confocal microscope system (inVia Raman, Renishaw) was used with a 785 nm laser line, 1800 mm−1 grating
and a near infrared enhanced CCD array detection. Before each experiment, the system was calibrated by
collecting spectra of a silicon sample using a 10× objective and peak calibrated to 520.5 cm−1. For AuNR
measurements, a 40× objective was used and focused on the dried surface. For each sample, a Raman spectra
map was acquired over a 200 × 200 µm area with 25 measurement points with a spot size of ∼10 µm and
laser power of 10 %, to prevent sample degradation. Raw spectra were background corrected using the
f baseline corr MATLAB function with a smoothing width of 30 and bandwidth of 350 for 75 iterations
[175]. After background subtraction, each spectra was summed and normalised to the maximum peak value.
2.5.3 NMR
All NMR spectra were taken on a Bruker Avance500 instrument at 500 MHz at 295 K using a 5 mm
broadband solution probe. For CTAB, Oleate, DOPC and DSPE–mPEG-2000 an acquisition time of 3.6
1The measurement voltage was approximately set using the following relationship: Vmeas = 18 + 162·exp{−0.02 ·C}, where Vmeas
is the measurement voltage in mV and C is the buffer concentration in mM.
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s and 16 scans were used. For AuNR spectra an acquisition time of 3.6 s and 128 scans were used. All
spectra were taken using D2O as the solvent. Spectra were corrected according to the expected position of
the chemical shift resulting from residual HDO.
Preparation of solutions for NMR
Solutions of 10 mM CTAB and sodium oleate were prepared by hydration of the powder in D2O.
Phospholipid solutions were prepared by first drying the lipid stock (in CHCl3 – CH3OH (1:1)) under a
nitrogen stream for 30 minutes. Residual solvent was removed by overnight dessication. The lipids were
rehydrated using D2O and tip–sonicated for 30 minutes. The solutions were then repeatedly passed through
a 50 nm track–etched membrane to further reduced the size of formed vesicles. Without extrusion only
poor quality NMR spectra were recovered for phospholipid solutions. AuNR solutions were cleaned by
centrifugation and resuspending the pellet in D2O, this was repeated threefold to remove as much residual
H2O as possible.
2.5.4 Stability in Biorelevant Media
In order to test the long–term stability of AuNRs, AuNRs were resuspended in various biorelevant media
at 75 µg·ml−1 including a number of buffers, media, serum and mouse plasma. The resuspended AuNRs
were placed in a 96–well plate and the longitudinal surface plasmon monitored at various timepoints across a
2–week period using a well plate reader. The solutions were stored at room temperature during this period.
The following buffers were prepared as biorelevant surrogates for blood plasma, due to their similar ionic
compositions in addition to DPBS.
Compound
Plasma-lyte 148 Pseudo-plasma Buffer
Conc. Mass in 100 ml Conc. Mass in 100 ml
(mM) (mg) (mM) (mg)
Sodium Chloride 90.00 526.0 89.70 523.8
Potassium Chloride 5.00 37.0 4.25 31.7
Sodium Lactate 1.50 30.0 2.00 22.4
Trisodium Phosphate – – 1.15 18.9
Calcium Chloride – – 1.15 12.8
Magnesium Chloride – – 0.88 8.4
Sodium Persuphate – – 1.00 23.8
Sodium Acetate 27.00 368.0 – –
Sodium Gluconate 23.00 502.0 – –
Sodium Bicarbonate – – 20.00 168.0
Sodium Carbonate – – 11.90 126.1
Table 2.3: Recipes used in buffers prepared for measuring the stability of various nanoparticle functionalisa-
tions.
2.6 Photothermal Experiments
A bespoke system was assembled to allow the automated photothermal heating of cells a tunable laser source
in a controlled environment. The rig allowed a well–plate to be precisely moved above the laser source
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Figure 2.5: Optical Schematic showing the components used to shape and monitor the beam used in
photothermal heating experiments.
Figure 2.6: Optical Schematic showing relative positives of the XY–stage, well–plate, and beam dump
relative to the final mirror in the optics path. Right: Beam intensity profile after passing through the aperture.
Red dashed lines indicate the lost beam intensity at the periphery of the beam.
within an environment maintained at 37°C. Additionally the resultant temperature change could be monitored
through an 8–channel thermocouple logger.
A Coherent Mira 900–F was selected as the light–source. This is a tunable femtosecond–pulsed Ti:Sapp-
hire laser, however it was utilised as a CW source. The Mira 900–F provides a 0.8 mm diameter horizontally
polarised Gaussian beam, tunable between 700 and 980 nm, at up to 2.2 W in CW mode. ∼1% of this beam
was sampled using a polarised beam splitter and the power measured using a Thorlabs PM100D power meter
fitted with a S120C sensor–head, and the wavelength monitored using a fibre–coupled Ocean Optics Flame
spectrometer.
The main beam was expanded 7.5 times to achieve a FWHM of 6 mm (the diameter of a well on a
96–well plate). The low intensity region outside the FWHM were removed by passings the beam through a 6
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mm aperture, the effect of this on the beam profile is shown in fig. 2.6. The beam was then passed through
an interlocked bespoke shutter (which simultaneously acted as a beam dump when closed), allow remote
control when the sample was exposed to the beam. Finally the beam was reflected vertically by a 45° prism
mirror into the main chamber (fig. 2.6).
The main chamber contained a Prior H128 motorised XY–stage, fitted with a mount for standard well
plates, allowing them to be moved directly above the beam. Directly above this was a beam dump terminating
the path of the beam. The chamber could be maintained at a setpoint temperature, typically 37°C, using an
IncuKit cabinet incubator heater. Finally, an 8–channel Pico Technology data logger could be mounted to the
stage allowing direct monitoring of the temperature inside well using thermocouples. The entire chamber
and beam path were self contained and interlocked to prevent exposure to the beam. After the beam had
passed through all components beam intensities upto 2.7 W·cm−2 could be acheived across a 6 mm diameter
circle, dependent on wavelength.
The spectrometer, thermocouple datalogger, XY–stage and shutter were all connected to a PC via USB.
A python script was written to allow a sequence of wells and exposure times to be directly input through a
graphical user interface and allow experiments to proceed without the need for constant monitoring.
2.7 Tissue Culture
All tissue culture was performed under sterile conditions in a class II A1 biosafety cabinet. All consumables
were either purchased sterile or autoclaved at 131°C for 30 mins. Cells were incubated at 37°C in 5% CO2
and passaged at a 1:10 ratio upon reaching ∼70% confluency. Cells were disgarded as the passage number
approached 100. The following cell lines were used during the course of this thesis:
2.7.1 Cell Viability Assays
The cytotoxity of AuNPs to the various cell lines were assessed using the CCK-8 cell viability assay. In brief,
CCK-8 consists of a water soluble tetrazolium salt, WST–8 which is reduced by dehydrogenase inside living
cells leading to the formation of WST-8 formazan an orange dye which a strong absorbance peak at 450 nm.
The absorbance at this wavelength is linearly proportional to the number of viable cells and hence can be
used to ascertain the relative viabilities of cells under different conditions.
Cells were seeded in 96 well plates at a density of 5000 cells per well in 100 µl media. The plates
were then incubated at 37°C in 5% CO2 for 24 hours. Post–incubation the media was exchanged with
media containing a known concentration of AuNRs and the plate incubated for the required exposure time.
Following this the media was replaced with media containing 10% CCK-8 solution and incubated for a
further 4 hours. The absorbance at 450 nm was then measured using a a microplate reader (Mithras LB 940).
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Cell viabilities were then expressed as a fraction of the untreated control viability. The measurement was
background corrected through subtraction of the absorbance of wells treated with AuNRs and media, but
containing no cells. All absorbances were calculated from the average of at least six wells and the experiment
performed in triplicate on different cell passages. The expression for the cell viability, θ, is as follows:
θviability =
A(sample)450 nm − A
(bkgd)
450 nm





Cell viability was assessed using the CCK-8 cell viability assay as above. Cells were seeded in 96 well plates
at a density of 5000 cells per well in 100 µl media. The plates were then incubated at 37°C in 5% CO2 for 24
hours. Post–incubation the media was exchanged with media containing a known concentration of AuNRs
and the plate incubated for the required exposure time. Cells kept at 37°C were then illuminated using a
continuous wave tunable laser at a known light intensity and wavelength, before a further incubation of 24
hours. Following this the media was replaced with media containing 10% CCK-8 solution and incubated
for a further 4 hours. The absorbance at 450 nm was then measured using a a microplate reader (Mithras
LB 940). Cell viabilities then calculated as a fraction of the untreated control viability (eq. 2.3, as above).
All absorbances were calculated from the average of at least three wells and the experiment performed in
triplicate on different cell passages.
2.7.3 Preparation of Cells for Optical Microscopy
Cells were seeded on to a 20 × 20 mm glass coverslip in a six-well plate at density of 2 · 105 cells per well
and incubated at 37°C in 5% CO2 for 48 hours. The media was then exchanged with media containing
known concentrations of AuNRs. The cells were then incubated for the desired exposure time. Following
this the cells were washed twofold with DPBS, before being placed in a 4% paraformaldehyde solution in
DPBS for 10 minutes, fixing the cells. The cells were then rinsed with DPBS a further two times before
removing excess fluid and adhering the coverslips to clean glass slides using an aqueous mounting medium.
2.7.4 Preparation of Cell Sections for Electron Microscopy
The method followed here is adapted from J.H. Luft 1961. ‘Improvements in epoxy resign embedding
methods’ [214].
SW620 and LS174T were seeded in 6-well plates at densities of 6 · 105 and 6.9 · 105 cells per well
respectively. Cells were incubated at 37°C in 5% CO2 for 24 hours before the media was exchanged with
media containing 15 µg·ml−1 AuNRs. After a set amount of time had occured, cells were washed three times
with 150 mM PBS, before being trypsinised and washed once more with PBS. The cells were fixed using
2.5% glutaraldehyde in 150 mM PBS for 2.5 hours. The cells were then centrifuged again and washed twice
in 150 mM PBS. The supernatant was disgarded and replaced by 1% osmium tetroxide in 150 mM PBS
overnight. The cells were then washed twice in in 150 mM PBS. The pellet was then dehydrated by washing
in an ascending alcohol (in water) series at 20%, 40%, 60%, 80%, 100% (twice) for 20 min per step. The
pellet was then washed in propylene oxide twice for 20 min to remove residual alcohol, before resuspension
in 50% propylene oxide – 50% araldite mixture and being left overnight. Araldyte mixture is comprised of
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52.9% Araldite CY212, 45.1% DDSA, 1.9% DMP 30. The pellet was then transferred to 25% propylene
oxide – 75% araldite mixture and left for 6 hours. Finally the pellet was transfered to 100% araldite mixture
and left in an oven overnight to cure at 60°C.
Sections were then prepared by taking ∼90 nm sections using a ultramicrotome (Reichert-Jung Ultracut
E) fitted with a 45° glass knife. Sections were collected in an aqueous bath, and prepared on 300 mesh
copper grids and then post-section stained with uranyl acetate.
2.7.5 Protein Expression
The CEA–expression of the following cell–lines was measured by immunofluorescence and flow cytom-
etry; LS174T, HEK293, SW620, SW480, LoVo, HCT116, and DLD–1. The primary antibody used was
CEA/CD66e (mouse) and the secondary was anti–Alexa488.
Immunofluorescence Measurements on Fixed Cells
Cells were plated on coverslips in 6–well plates at densities of 105 cells per well and incubated for 72 h.
Cells were then fixed with ice–cold methanol or 4% PFA, cell were then washed threefold with DPBS. 100
µL 1% BSA in DPBS was then added to each well for 1 h at room temp to block non–specific binding. This
was replaced by the primary antibody at the appropriate concentration in 1% BSA in PBS and incubated for
a further 1 h. The cells were washed threefold with DPBS. The secondary antibody (with fluorophore) at the
appropriate concentration in PBS was added to each well and incubated for 1 h in the dark. The cells were
washed threefold in DPBS and mounted using 20 µL of Prolong Gold Antifade Mountant. This was allowed
to set in the dark overnight at room temperature.
Flow Cytometry for the Titration of Antibodies
Cells were washed in DPBS and 1 mM sterile–filtered EDTA added, a minimal amount was left on the cell
monolayer for 10 m at room temperature. Cells were then trypsinised until individual cells were suspended
in solution. The trypsin was then inactivated by the addition of media and then the cells then spun down into
a pellet at 400g, before being resuspended in FACS buffer (5% FBS + 0.05% NaN3 in PBS). 107 cells were
placed into FACS tubes and increasingly dilute concentrations of antibodies (1:200 – 1:1600) added to each
tube (100 µL). The cells were then incubated for 30 m in the dark on ice. 2 mL FACS buffer was added and
the cells spun down to a pellet before the addition of 50 µL of the secondary antibody (1:300). Cells were
then incubated for 30 m in the dark on ice. 2 mL FACs buffers was then added and the cells pelleted. The
buffer was removed and 5 µL of 10 µg·mL PBS added before reading on a flow cytometer.
2.8 Murine Models
All mice used were BALB/c nude mice (originally obtained from Charles River Laboratories, Kent) and
maintained in house. All mice were maintained under high health status and are specific pathogen free (SPF)
status. Mice were housed in individually vented cages (IVCs) with access to food and water ad libitum.
All procedures were approved by the UK Home Office and carried out according to the Animals (Scientific
53
2. Methods and Materials
Procedures) Act 1986 and under the project licence of Dr Louise Coletta (70/7965) with the technical work
carried out by Dr Nicola Ingram under PIL IDD6965FF.
2.8.1 Administration of Gold Nanomaterials in vivo
BALB/c mice were injected substaneously with 1×109 of LS174T cells in 100 µL 289 mOsm·L−1 DPBS
(culture protocols given in section 2.7). Tumour volumes were measured by calliper until a desired tumour
volume of ∼200 mm3 was reached. Gold nanomaterials were concentrated to 200 µg·mL−1 suspended in 289
mOsm·L−1 DPBS. 200 µL of this preparation was then administered to the mice via tail vein injection. Mice
were then monitored to determine if any adverse effects on the health of the animals. Mice were sacrificed at
predetermined time–points and tissue harvested for ex vivo analysis.
2.8.2 Tissue collection and ex vivo Biodistribution Analysis
Organs were extracted immediately post–sacrifice. Individual organs were measured for their mass and then
placed in cryo–vials. These were then flash–frozen in liquid nitrogen before transfer to a freezer at -80°C.
Preparation of the samples for elemental analysis requires digestion in aqua regia to liberate metal ions
into solution. Hence water must be removed from the samples prior to digestion, this was acheived by
placing samples in a lyophyliser for at least three days. Each organs was then measured for its mass again
and transferred to an acid–resistant 15 mL centrifuge tube. Larger samples were homogenised prior to
digestion. 1 mL aqua regia was then placed in each tube and left overnight to digest. Occasionally samples
were agitated by vortexing if required. After digestion an additional 10 mL Milli–Q grade water was added
to each tube and the samples centrifuged at 4000 g for 30 minutes and the supernatant collected, this was
repeated twice, ensuring the removal any non-digested particulate matter.
In order to demonstrate the efficacy of the extraction process, a liver from a mouse untreated with AuNPs
was dissected into five and doped with a known quantities of Au prior to lyophilisation. The samples were
then processed by the same digestion process described above.
2.8.3 Blood Collection and Haemolysis Assays
Blood was collected post–sacrifice by terminal cardiac puncture into an EDTA-coated paediatric blood
collection tube (Greiner). Tubes were centrifuged at 500 g for 5 min at 4°C. The plasma and red blood cells
and were then separated.
Haemolysis Assays
Red blood cells were then gently resuspended in 150 mM NaCl. The red blood cells were washed a
further two times with 150 mM NaCl. Finally the red blood cells were resuspended in PBS. This was then
diluted 1:50 with PBS. 10 µl of particles at 2000 µg·mL−1 and 400 µg·mL−1 were added to 190 µL of diluted
red blood cells in a 96–well plate in triplicate alongside a positive control (1% (v/v) Triton x-100) and
negative control (PBS). The final concentrations of AuNRs were 100 µg·mL−1 and 20 µg·mL−1. The cells
were incubated at 37°C for one hour at 100 rpm on an orbital shaker. The plate was then centrifuged at 500 g
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for 5 minutes to pellet the intact red blood cells. 100 µl of the supernatant was placed in a fresh 96 well plate
and the absorbance at 420 nm was read 1. The lysed fraction, θlysed, was then expressed as:
θlysed =
A(sample)420 nm − A
(negative)
420 nm




where A(sample)420 nm , A
(negative)
420 nm , and A
(positive)
420 nm are the absorbances at 420 nm for the sample, negative control, and
positive control respectively.
CTAB AuNRs for this assay, were cleaned twice by centrifugation after synthesis, reducing the back-
ground CTAB concentration to approximately 40 µM. The particles were then centrifuged a third time and
∼96% of the supernatant removed, concentrating the sample to 2000 µg·mL−1. Cleaning the particles further
than this this resulted in loss of colloidal stability, hence it was decided that this represented the best case
lowest acheivable cytotoxicity without comprising the properties of the CTAB–functionalised AuNRs.
2.9 Photoacoustic Imaging
All photoacoustic (PA) measurements were taken in a real–time preclinical multi spectral optoacoustic
tomography (MSOT) scanner (MSOT inVision 128, iThera Medical Germany). All photoacoustic spectra
were calculated from ‘raw’ PA intensity maps, any other images are multispectral projections, based on the
provided absorbance spectra of the administered particles.
2.9.1 Phantoms & Photoacoustic Spectra
For assessment of the spectral response of AuNRs, solutions were placed in an agar phantom (fig. 2.7). The
solutions were contained within 4 mm plastic straws and capped with glue. Agar phantoms were prepared
according to published protocols [66]. 0.75 g Agar was added to 50 mL of Milli–Q grade water and brought
to boil. To this was added 1.5 mL Intralipid and a drop of Germall Plus. The mixture was then poured into
moulds and allowed to set. The Intralipid served to give similar attentuation due scattering as observed in
human tissue and the Germall Plus prolonged the life span of the phantoms by preventing mould growth. A
multispectral reconstruction of the AuNR solution distribibution is given in (fig. 2.7).
Photoacoustic spectra could then be measured by sweeping the illumination wavelength and recorded the
PA intensity through a single plane inside the phantom. A second sample containing only H2O was also
inserted in the agar phantom, allowing the spectrum of the supernatant to be recorded. The PA signal was
recorded by placing measuring the average intensity of the top 5% most intense pixels. The PA response of
the H2O control was subtracted from the PA response of the AuNR solution, to give the PA reponse of the
AuNRs.
2.9.2 In Vivo Imaging
All mice were prepared with subcutaneous tumours and administered according to the protocol given in
section 2.8.1. During imaging mice with anesthetized with isofluorane and placed in supine position inside
1Normally 540 nm is used for haemoglobin, the transverse band of the AuNRs interfered too much at this wavelength, 420 nm
(Soret band) was used instead.
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Figure 2.7: Left: Diagram of agar phantom, showing the relative positions of the sample and water control.
Not shown are the plastic straws used to contain the samples when submerged in the water bath. Right:
MSOT image of phantom containing H2O (left circle) and 37 µg·mL−1 AuNR solution (λLSPR = 811 nm),
right circle). The MSOT signal was reconstructed using a linear regression algorithm which calculated
the spatial distribution of the AuNR solution based on an extinction spectrum measured using a UV-vis
spectrometer. The background signal is the response seen at 680 nm.
the imaging chamber. Imaging was taken during AuNP administration, although only the 24 h time point is
presented here. Transverse slices through the mouse were taken at 1 mm intervals throughout the abdomen
of the mouse. Laser excitation wavelengths of 715, 730, 760, 800, 830, 850, and 900 nm were selected
corresponding to the absorption maxima and minima in the spectra of the PSS–AuNRs, oxyhaemoglobin
and haemoglobin. Each frame was construction from an averages of 10 pulses per transverse slice. Images
were reconstucted and individual spectral components were decovoluted using a using a linear regression
model. No background correction was performed after the initial scan due to the mouse being repositioned
between scans.
2.10 Finite Element Simulation of Gold Nanoparticles
For the purposes of the simulations in this work finite element analysis was utilised via the COMSOL
Multiphysics package. COMSOL was used since it offers a user-friendly interface with no requirement
for significant prior knowledge of the underlying modelling technique to generate accurate solutions to
the physical problem (only a knowledge of the relevant physics to be solved). Secondly, as a multiphysics
package it offers the ability to solve complex problems that involve multiple physical phenomena, such as
the thermal response of a nanoparticle to an incident light field.
2.10.1 Absorption and Scattering Cross Sections
For the simulation of the optical response of AuNPs, COMSOL’s radio frequency module was used. This
is a module designed for solving general physics problems involving electromagnetic waves. To reduce
computation time simulations were performed in the frequency domain under the assumption that all
electronic responses would show a sinusoidal time dependence. For excitation of a simple plasmonic
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nanostructure by an electro-magnetic plane wave of the form ~Eb(~r, t) = ~E0exp{i~k · ~r − iωt}, this is a
reasonable assumption.
Each AuNP was simulated in a centrally located position embedded within an ambient medium, typically
water, with a width several times larger than the length of the largest wavelength of light used. Values for
the refractive index of gold were taken from Johnston and Christy [156], and the values for the medium
were taken from the COMSOL Multiphysics Material Library. The surrounding medium was encased by a
perfectly matched layer, a region which perfectly absorbs incident radiation without reflection or scattering.
This is used to prevent the external boundaries of the model creating radiation patterns which overlap with
the calculated solution of interest.
To further improve accuracy all calculations were computed in the scattered field formulation, the benefits
of this are two fold. Firstly, the incident field is usually significantly larger than the scattered field (the
quantity of interest), leading to it being inaccurately resolved in the full–field formulation. By solving only
for the scattered field this problem it is thus possibe to significantly boost the accuracy of solutions. Secondly,
it allows for a global plane–wave excitation to be used without any need to account for the damping inside
the PML, which is otherwise required in the full–field approximation.













k20~Erel = 0 (2.5)
where k0 is the free space wavenumber, σ is the conductivity of the particle and ~Erel is the relative field
defined by ~Erel = ~E− ~Eb, where ~E is the total field at any point and ~Eb is the background field. Typically this
is solved using the PARDISO direct solver included with COMSOL, which is particularly memory-intensive,
but is significantly faster than other provided solvers.
σabs(λ) can be obtained on the assumption that all energy dissipation from the particle occurs through
resistive heating (no photoluminescence), and hence can be calculated from the volume integral of the
resistive heat losses through the particle, Qrh. Conversely, and σscat(λ) can be calculated through a surface













σext(λ) = σabs(λ) + σscat(λ)
(2.6)
Considerations of the symmetry in the system allows for the averaged angular crosssection to be
calculated. For a AuNR with its long axis in the z-direction, the longitudinal excitation can be driven by light
polarised in the z-direction propagating in the x–y plane, (notated here as Ex,z and Ex,z). Two methods to
then excite the transverse mode; firstly light both polarised and propagating in the x–y plane (Ex,y and Ey,x)
can excite it across the waist of the particle, and secondly, light propagating in the z direction (Ez,x and Ez,y)
will similarly excite the transverse mode but with a different particle orientation relative to the plane wave.
Due to the symmetries of rods, all three cases are doubly degenerate and only need to be simulated in a
single case to calculate the averaged crosssection i.e only using Ex,z, Ex,y and Ez,x (fig. 2.8 (a)).
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Figure 2.8: (a) Different plasmonic excitations of AuNRs. Longitudinal excitations in blue, Transverse
excitations in the x − y plane in purple and transverse excitations perpendicular to the zaxis in green. (b)
COMSOL simulated absorbance crosssections for a (60 × 16)nm AuNR, with a tip eccentricity of 0.5,
alongside the averaged crosssection and crosssection for a aingle simulation calculated to reflect the averaged
angular crosssection. Good correlation can be seen between this model and the average from the three
individual excitations. Inset: Closeup of the crosssections around the transverse excitation.
Further consideration allows the averaged angular crosssection to calculated in a single simulation,
exciting the particle with light propagating the x direction with the polarisation axis at 45 from the y-axis
(Ex,yz) allows excitation of both the longitudinal and transverse axis across the side of the AuNR. Furthermore
in addition to this a rotation of the AuNR about the y-axis of sin−1( 1√
3
) ∼35.26° allows excitation of the
transverse mode from the end of the AuNR in the correct proportion to produce a value equal to the average
angular excitation. Fig. 2.8 (b) shows the all three calculated crosssections, the averaged crosssection and the
crosssection from the arrangement just described, showing near perfect agreement
The end–caps of AuNRs were paramerised as hemispheres of an ellipsoid, with an eccentricity defined
by, e = 2a/D, where a is the semi–minor axis of the ellipsoid and D is the diameter of the AuNR [384].
Eccentricities were considered between the two theoretical extremes, a cylinder (e = 0) and a prolate ellipsoid
(e = R).
2.10.2 Particle–on–a–substrate
In order to simulate the expected scatter spectra for AuNRs at a glass–air interface, such as is the case with
the darkfield–single particle scatter spectroscopy system, a different approach was required. Simulations
were still performed using the RF module in the frequency domain. Due to the presence of the interface the
background field can no longer be assumed to be the same as the excitation field. Hence a travelling–wave
incident at 61° from normal to the surface (average angle of incident for the darkfield condenser) was used
with port conditions above and below the interface. All side boundaries were set up with Floquet boundary
counditions, effectively extending the geometry infinitely in the plane of the interface.
The simulation was initially run without the AuNP present, allowing the background field to be calculated.
A second RF frequency interface was then set up to introduce the AuNP and solve for the scattered field.
This particle was typically a single hemispherically–capped AuNR in contact with the glass surface. As
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above an angle of polarisation and incidence was selected such a single simulation provided the averaged
excitation expected from darkfield excitation. The effect of surface coating was not considered, real–world
spectra are expected to be red–shifted relative to those simulated due to the presence of CTAB on the surface
of the AuNRs.
2.10.3 Heat Generation
The results of section 2.10.1 can be used to calculate the expected heat generation from pulsed light sources.
This is conditional on the region being simulated being large enough to contain the generated temperature
gradient within the simulated timescale. The Heat Transfer in Solids module in the time domain was used as
second-simulation step. This simulation is restricted to using a single wavelength, this is not a significant
issue, since most lasers used for photothermal heating have spectral bandwidths significantly narrower than
the typical longitudinal SPR peak. A single wavelength simulation at the LSPR and expected peak intensity
of a nanosecond pulse of was run to determine σabs(λLSPR). From this simulation the corresponding heat
generation function, Q(λ,~r, t) inside the domains constituting the AuNP was obtained. This can then be














where w is the pulse width and t0 is the pulse centre. Providing a heating pulse which is Gaussian in time
and the correct peak intensity. Temperature distributions can then be recovered from point probes along a
single axis. At the time of writing there are no boundary condition availible which allow heat to flow out of
the simulated region, hence the upper time limit over which these temperature distributions will be physical
is given by the thermal diffusion time, τth = L2/α, where L is the shortest distance between the particle and
the boundary of the simulation and α is the thermal diffusivity (1.43 × 10−7 m2s−1 for water). However for
nanosecond pulses in sufficiently large volumes the bulk temperature rise is sufficiently low relative to the
localised heating in the vicinity of the AuNP that is not a major concern.
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2.11 Materials
Milli–Q water (18 MΩ·cm) was used in the preparation of all solutions. All chemicals were used without
further purification.
2.11.1 Synthesis
Reagent Name Product No. Supplier
l–(+)–ascorbic acid A15613 Alfa Aesar
Hydrochloric acid (12.1 M) UN1789 Fisher Scientific
Silver nitrate 11414 Fisher Scientific
Sodium borohydride 10599010 Fisher Scientific
Gold (III) chloride trihydrate 520918 Sigma–Aldrich
Hexadecylammonium bromide H6269 Sigma–Aldrich
Sodium oleate O0057 TCI
2.11.2 Phospholipids










Reagent Name Product No. Supplier
DMEM + GlutaMAX media 31966 Gibco Life Sciences
Dulbecco’s phosphate–buffered saline 14190-144 Gibco Life Sciences
Foetal bovine serum A3160401 Gibco Life Sciences
RPMI 1640 + GlutaMAX media 11875-093 Gibco Life Sciences
TrypLE express 12604054 Gibco Life Sciences
CCK-8 cytotoxicity assay reagent 96992 Sigma–Aldrich
Paraformaldehyde 158127 Sigma–Aldrich
Poly–l–lysine P4707 Sigma–Aldrich
Trypan blue T8154 Sigma–Aldrich
Consumable Product No. Supplier
0.22 µm–pore syringe filters SLGP033RS Millipore
T75 culture flasks 3290 Corning
96 well plates, clear 3599 Corning
12 well plates, clear 3513 Corning
6 well plates, clear 3516 Corning
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2.11.4 Preparation of Tissue Samples for Electron Microscopy
Reagent Name Product No. Supplier
DDSA – dodecenyl succinic anhydride R1053 Agar Scientific
DMP-30 – 2,4,6-tris(dimethylaminolmethyl)phenol R1042 Agar Scientific
Osmium tetroxide R1016 Agar Scientific
Propylene oxide R1080 Agar Scientific
Uranyl acetate R1260A Agar Scientific
Glutaraldehyde G-5882 Sigma
2.11.5 Surface Coating, Conjugation and Targetting Experiments
Chemical Name Product No. Supplier
MOPS 327661000 Acros
Poly(sodium-p-styrenesulfonate) M.W. 70000 222271000 Acros
CEA protein 30-AC25 Fitzgerald
Tris(hydroxymethyl)aminomethane B2005 Melford
Ethyldiaminetetraacetic acid (EDTA) EDS Sigma–Aldrich
Sun Fluor 488 Thiol SF488-TH-1 Sunlights
2.11.6 Buffer Solutions
Chemical Name Product No. Supplier
Tris(2-carboxyethyl)phosphine hydrochloride C4706 Aldrich
Sodium acetate A16230 Alfa Aesar
Trisodium citrate 45556 Alfa Aesar
Sodium lactate solution 60% w/w S/5161/08 Fisher Scientific
Potassium chloride P/4240/53 Fisher Scientific
Sodium bicarbonate S6014 Fluka
Sodium chloride 71376 Fluka
Sodium phosphate dibasic 30435 Honeywell Fluka
Sodium phosphate monobasic S9638 Honeywell Fluka
Magnesium chloride 8.14722 Merck
Gluconic acid 8.22058 Merck
Citric acid 27847 Sigma
Calcium chloride C1016 Sigma–Aldrich
Sodium carbonate S77795 Sigma–Aldrich
Sodium hydroxide S5881 Sigma–Aldrich
Sodium persuphate 13457 Sigma–Aldrich
Trisodium phosphate 342483 Sigma–Aldrich
2.11.7 Other Acids, Oxidisers, Solvents... etc
Chemical Name Product No. Supplier
Nitric acid (15.6 M) A15613 Fisher Scientific
Hydrogen peroxide (30%) H/1750/17 Fisher Scientific





Sodium dodecyl sulphate LS750 Sigma–Aldrich
Sulphuric acid (18.4 M) 07208 Sigma–Aldrich
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Chapter 3
Synthesis and Morphological Control of
Gold Nanorods
Some of the content discussed in this chapter forms the basis of the following publication:
L. Roach et al. 2018. ‘’Morphological control of the seedless synthesis of gold nanorods using binary
surfactants’ in Nanotechnology 29:359501 [292].
The dataset associated with this paper is available from the University of Leeds: doi.org/10.5518/273.
3.0.1 Motivation
Gold nanorods (AuNRs) offer the highest absorbance cross section per unit mass of any AuNP1. They offer
easily tunable optical properties with high photothermal conversion efficiency in the NIR. Hence AuNRs
were chosen as the candidate nanomaterial for our theranostic applications. As detailed in section 1.5, two
key approaches exist for the aqueous synthesis of single crystalline AuNRs, seeded and seedless methods,
both present challenges. As the literature currently stands, seeded protocols currently offer the method for
producing AuNRs with the highest monodispersity and shape yield, but they suffer from being a two–step
process, seeds must synthesised in advance of the main growth, and used in relatively narrow time window.
Seedless protocols are a single–step protocol, avoiding the seed synthesis step, but historically have suffered
from high polydispersity and low shape yield. One–step protocols are desirable, in that they are simpler to
perform and should be easier to translate into industrial syntheses or allowing the synthesis of AuNRs under
continuous–flow.
Hence, the approach decided upon here was to pursue improvements in the seedless synthesis of AuNRs,
thus making it a viable method for synthesising good quality AuNRs. Recent approaches in improving
the yield of seeded AuNRs has been to include additional additives in the growth solution. Of particular
interest was inclusion of oleate as a co–surfactant, which demonstrated significant improvements in the
morphological control and monodispersity [396]. Here we present an investigation of the effects of including
oleate in the seedless synthesis of AuNRs and have sought to further understand the underlying formation
process of gold nanorods formed during this process.
1A possible exception to this are bipyramids, which are fairly similar in shape in that they can be approximated by an ellipse
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Figure 3.1: (a): Wide–field TEM image of sample showing good monodispersity and high shape yield.
(b): High resolution TEM showing the crystalline structure of a AuNR synthesised using a 48 mM CTAB –
CTAB 15 mM oleate growth solution. Annotated on the image is the measured lattice spacing of 2.04 Å
(calculated from 100 lattice rows), corresponding to a (200) lattice spacing. Inset is a (4 × 4) nm region
showing the visible lattice structure. (c): Selected area electron diffraction image of the same AuNR. The
corresponding Miller indices for each spot have been labeled on the figure. These are consistent with a
monocrystalline FCC metal. (e): Photo of a 500 mL as-synthesised AuNR batch synthesised using a 60 mM
CTAB – 12.5 mM oleate growth solution (e) UV–vis spectrum of the same 500 mL solution.
3.1 Gold Nanorod Synthesis Protocol
The full protocol followed is detailed in sec. 2.1.
AuNRs were synthesised using a binary–surfactant seedless protocol similar to that published by Lai
et al. [189], however the range of surfactant concentrations used to control the morphology has been
expanded substantially. The particles were synthesised in a growth solution containing a mixture of
cetyltrimethylammonium bromide (CTAB) and sodium oleate in the presence of a weak reducing agent,
ascorbic acid (AA), and silver nitrate. Initially, HAuCl4 was added, to a CTAB–oleate mixture, which
was observed to turn a dark orange–yellow as CTA+–[AuCl4]− ion complexes were formed [308]. The
unsaturated double–bond of sodium oleate is capable of the slow reduction of Au3+ to Au1+, hence the
mixture was observed to clear if left undisturbed after this point [189, 396]. To this mixture, AgNO3, HCl
and AA were added sequentially, any remaining yellow hue in the solution cleared following the addition of
AA due to the reduction of all Au3+ to Au1+. Finally, nucleation of the particles was initiated by the rapid
injection of freshly prepared ice–cold NaBH4. The solution was then left unstirred for 4 hours, at 30 °C.
Particles were then cleaned by centrifugation at 9000 g for 30 min. The supernatant was discarded and the
precipitate resuspended in Milli–Q grade water.
This protocol showed good reproducibility, with little variation in optical properties between different
batches grown to the same recipe (fig. 3.3(d)) and can be scaled up substantially1, with only a minor reduction
in the quality of the end product (3.1(d)&(e). The samples synthesised by this protocol showed very high
shape yields, normally in excess of 98% as shown in figure 3.1(a). For several batches it was not possible
1The highest volume synthesised to date is 2 L.
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Figure 3.2: (a): Effect of surfactant concentration on LSPR wavelength as function of both CTAB and oleate
concentration, with all other components held constant. The shape of the each point indicative of shape
yield, with: ut >98% AuNRs; ◦ >90% AuNRs; – low shape yield. The LSPR wavelength is interpolated
between points, the colour scale for this is given in the right of the figure. (b): Effect of CTAB concentration
on length (black) and diameter (red) of AuNRs at a constant oleate concentration of 17.5 mM (horizontal
line in (a)). (c): Effect of oleate concentration on length (black) and diameter (red) of AuNRs at a constant
CTAB concentration of 48 mM (vertical line in (a)). Error bars indicate the standard deviation of the AuNRs
in each batch.
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Figure 3.3: (a): Photograph of particle solutions exhibiting LSPR from 520 to 900 nm, coloured circles on
lid indicate the associated UV–vis spectrum shown in (b). (b): UV–vis spectra of solutions with resonances
over same range. Spectra have been normalised to unity at 400 nm [308]. (c) Experimentally observed
AuNR vs FEM predicted LSPRs for different end–cap geometries. Coloured lines are λLS PR by a linear fit
to FEM simulated spectra for various tip eccentricities (e = 0, 0.1, 0.5, 1,R) as a function of aspect ratio.
Experimental data collected via UV-vis and TEM measurements. Point colours represent the cap geometry
most closely matched by those simulated (0 ≥ e ≥ 1). All samples fall within the theoretically expected
ranges. There is some deviation from the simulations for the hemispherically–capped particles. (d) 11
batches grown to the same recipe, showing high reproducibility in position of the LSPR peak. All spectra
were normalised to the peak absorbance of the LSPR band of each batch.
65
3. Synthesis and Morphological Control of Gold Nanorods



























Figure 3.4: TEM of (150 × 150) nm areas of particles synthesised at different surfactant concentrations,
demonstrating the change in morphology.
to locate any non–rodlike AuNPs, suggesting yields approaching 100%. Consistent with other seedless
protocols the synthesised AuNRs are monocrystalline, as indicated by the strong diffraction pattern seen
using SAED (figure 3.1(b)&(c)).
3.2 Morphological Control using Binary Surfactants
The effects on the morphology of synthesised AuNRs from variation of the concentrations of each surfactant
in the growth solution were explored. The initial concentrations of HAuCl4, NaBH4, AgNO3, and AA
explored were decided upon based on values commonly seen in the literature, the range of surfactants
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explored could probably be expanded further by synergistically varying these other parameters with the
surfactant concentration. The variation of the two surfactants in tandem allows us to define a bivariate space
in which the changes to the morphology can be studied.
It was found that the presence of sodium oleate in the growth solution and the reduced concentration
of CTAB, increased the pH to such an extent that the growth of AuNRs became extremely rapid. This
uncontrolled growth led to low rod yields and a high population of spheres. Hence the amount of HCl had to
be increased from 12 µL to 50 µL compared with CTAB–only synthesis protocols, achieving a pH of ∼1.5
in the growth solution. The effect of varying the amount of HCl added to the growth solution is discussed
further in section 3.3.1.
Concentrations of oleate between 5 and 25 mM, and CTAB concentrations between 22 and 78 mM were
added to the growth solution. Over these ranges a region of viable surfactant concentrations which produced
high nanorod yields. Figure 3.2(a) plots the variation in LSPR as function of the two concentrations; it can be
seen from this that a roughly ellipsoidal region centred on 45 mM CTAB – 16.5 mM oleate (with boundaries
±22 mM CTAB and ±7.5 mM oleate) exists where AuNR yields in excess of 98 % can be achieved. Shape
yield drops off rapidly beyond this region, which is apparent in the UV–vis spectra through noticeable
through the appearance of a third peak at ∼550 nm due to the presence of spherical inclusions.
Within this region batches were synthesised with LSPR values between 620 and 900 nm (fig. 3.3). The
LSPR wavelength was seen to decrease with an increase in the oleate concentrations. Conversely a small
increase was observed with an increase in CTAB concentration. However this change in LSPR (and hence
aspect ratio) is significantly more sensitive to changes in oleate concentration than CTAB. Analysis of this
via TEM (see (fig. 3.2(b)&(c)) and fig. 3.4) showed that this reductions in aspect ratio occurred through
an increase in the diameter of the synthesised AuNRs whilst yielding a proportionally smaller increase
in the length, blue–shifting the LSPR. By contrast, a much greater change in the concentration of CTAB
was required to have similar effects on the geometry of particles. Potentially the increased range of sizes
made available here could be extended further through direct overgrowth in a two–step process [165]. Size
distributions from analysis of TEM images are given in appendix A).
There is also a noticeable difference in the end–cap morphology of the AuNRs alongside the overall
changes in morphology. Some batches showing end–caps varying between hemispheres whilst others have
flat near–cylindrical tips (fig. 3.4). Tip geometry is known to change the optical properties of AuNRs,
red–shifting the LSPR with decreasing tip eccentricity [281, 384], hence control of this represents a route for
further modifying the optical properties of synthesised AuNRs. It is also expected to be of importance in
the packing of AuNR assemblies, with flatter caps exhibiting higher capillary forces due to the increased
available contact surface [386], making tip–to–tip arrangements more energetically favorable. Comparison
with simulated spectra of AuNRs of varying tip morphology show that the measured resonances fall within
the ranges expected from theoretical predictions (fig. 3.3(c)). However, there is some deviation between the
simulations and the experimental data, especially for the hemispherically–capped samples, which showed
generally higher resonances than expected. Hence the end–cap geometry seems to be sensitive to the changes
in surfactant concentration in the growth solution and may offer a potential route to achieve control over this.
For surfactant concentrations which demonstrated a low shape yield, it was found that decreasing the
pH further significantly improved the shape yield [12], although this was accompanied by a corresponding
red–shift of the LSPR [374]. It seems highly probable that proper optimisation of the concentrations of
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other components in the system at these surfactant concentrations would extend range of viable recipes and
potentially extend the range of achievable LSPR wavelengths.
The samples synthesised by this protocol displayed good monodispersity, as indicated by the well–defined
LSPR mode in the UV–vis spectra and confirmed by TEM images for a number of samples. Typically
the standard deviation of a sample amounted to approximately ∼15 % of both the diameter and length
(appendix A). The narrow NIR absorbance peaks resulting from this low polydispersity will make them
well–suited for use as photothermal agents in photoacoustic imaging [372] and plasmonic photothermal
therapies [283].
3.3 Other Parameters
In addition to the effect of the surfactants on the particle morphology, the effect of the other components
such as HCl, AgNO3, AA and NaBH4 in the growth solution were explored. The effects of each of the
components are interrelated, making it difficult to categorically identify changes as the result of a single
variable. However the impact of the introduction of new component, oleate, on the others was not well
understood so studies were undertaken on each of these.
3.3.1 Hydrochloric Acid
The addition of sodium oleate to the growth mixture alters the reaction pH significantly which has important
implications for the reaction kinetics. Solutions of sodium oleate above its CMC typically have pH values of
∼pH 9. Increased concentrations of oleate will thus make the growth solution more basic and hence decrease
the reduction potential increasing the formation rate of particles (see eq. (1.27)). If the pH is increased too
far, this will result in the rapid formation of spherical particles.
This is already an issue in CTAB–only growth protocols where typically a concentration of 14 µM HCl
is added to the growth solution to slow down the reaction kinetics, achieving a pH of ∼1.5 [12]. If this HCl
is not added to the reaction mostly spherical AuNPs are created. In the case of a oleate–CTAB mixture,
initially an increase to 59 µM was used to reliably synthesise AuNRs.
Hence it was decided to explore the effect of changing the concentration of HCl in the growth solution.
A single 48 mM CTAB, 12.5 mM oleate growth solution was prepared and aliquoted in 11 separate 10 mL
aliquots, to this was added between 23 and 74 µM HCl, followed by the two reducing agents. The spectra of
the synthesised AuNRs and the respective LSPR positions can be seen in fig. 3.5.
Based on the changes in the UV-vis spectra it can be seen that increases in the HCl volume above 18
µM leads to high yields of AuNRs evident from the decreased width of TSPR peak. Above this increasing
the concentration leads to a redshift in the position of the LSPR, the changes in the height of the peak is
broadly in line in what is expected from Gans theory, due to increasing plasmonic damping below 700 nm
(see figs. 1.2 and 1.5), suggesting that the rod yield is quite high. The red–shift in this peak appears to stop
once the the HCl volume is increased above 45 µL. HCl thus offers a potential method to fine–tune the LSPR
resonance position of synthesised AuNRs.
A concentration of 59 µM HCl was used for all further syntheses, unless otherwise specified. It is
worth noting that variations in pH will still occur for other syntheses as a result of changing the surfactant
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Figure 3.5: Effect of varying HCl concentration on synthesised AuNRs in a 48 mM CTAB, 12.5 mM oleate
growth solution. Left: UV-vis spectra normalised to 400 nm. Low volumes of HCl (. 25 µL) lead to high
populations of AuNSs, increasing the HCl content further leads to a red–shift in the LSPR peak up to around
58.5 µM. Right: LSPR as a function of HCl volume, demonstrating the increase in LSPR peak position
with increasing HCl concentration. This behaviour begins to plateau above ∼ 59 µM HCl. The data point
associated with 28 µM has been omitted as no LSPR was visible (i.e. an overwhelming majority of spheres
appear to have been synthesised.)
composition due to the limited buffering capacity of the growth solution, and hence further optimisation of
the volume of the HCl concentration may actually improve these syntheses further.
3.3.2 Sodium Borohydride
The volume of the strong reducing agent added, NaBH4, used to induce nucleation will shift the LSPR
substantially. Increasing the amount of NaBH4 added has been observed in other seedless protocols to
decrease the aspect ratio of synthesised AuNRs (e.g. [302]). This is effectively the same as varying the
number of seeds used in the seeded growth of single crystalline AuNRs. Increasing in the initial NaBH4
concentration provides a greater number of nucleation sites onto which Au0 can be reduced. Hence there are
less Au ions per nucleation site, and the average particle volume will thus be lower. It has also been widely
observed that monocrystalline AuNRs grow in a two–step process, initially an anisotropic growth phase
leads to increasing aspect ratio, followed by a more isotropic growth phase where growth along the sides of
the AuNR occurs at a similar rate to the tips, leading to increased AuNR volume, but a decreased aspect ratio
[209, 367]. Hence increasing the number of AuNRs leads to the depletion of free Au ions during this initial
anisotropic growth phase and the resulting AuNRs are lower volume, exhibiting a higher aspect ratio.
This behaviour can be observed in the kinetic UV–vis studies described below in section 3.5. Providing
higher NaBH4 concentrations leads to a lower availability of Au1+ per nucleation site and provides greater
surface area to catalyse the reaction, leading this being depleted more rapidly and earlier completion of the
reaction. Hence the growth of the nascent AuNR is terminated earlier and hence the anisotropic growth
phase forms a larger fraction of the growth time cumulatively leading to the formation of smaller AuNRs
with higher aspect ratio.
As shown in fig. 3.6, AuNRs synthesised in this binary CTAB–oleate system also show an increase
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Figure 3.6: Effect of varying NaBH4 concentration on synthesised AuNRs in a 48 mM CTAB, 12.5 mM
oleate growth solution. Left: UV-vis spectra normalised to 400 nm. A general trend of increasingly red–
shifted LSPR peaks can be seen with increasing NaBH4 volumes. Low NaBH4 volumes can be seen to
lead to broader LSPR peaks (and hence more polydisperse). Right: LSPR as a function of NaBH4 volume,
demonstrating the increase in LSPR peak position with increasing NaBH4 concentration. The red data point
associated with 2 µL is not included in the fit.
in aspect ratio with increasing NaBH4 volume. A single batch of 48 mM CTAB, 12.5 mM oleate growth
solution was prepared and aliquoted in to 10 mL sub–samples; volumes of 10 mM NaBH4 between 2 and
16 µL were then added to each. A clear increase in LSPR wavelength with increasing NaBH4 volume can
be observed, indicating higher aspect ratio AuNRs were synthesised. Given that there is expected to be an
increased concentration of AuNRs and the same finite reservoir of Au ions available, it can be assumed that
these AuNRs must have a lower diameter than those synthesised using smaller volumes of NaBH4. The
spectrum associated with 2 µL NaBH4 is considerably off the general trend for other higher volumes. It is
not clear whether this is the result of experimental error, or the result of a new regime of particle formation at
low NaBH41.
Whilst this demonstrates that NaBH4 can be used to control the aspect ratio of synthesised AuNRs,
it seems that 7.5 µL is a sensible NaBH4 concentration to minimise variability between batches. This is
because 7.5 µL falls in a section of the curve which is less sensitive to change in NaBH4 concentration. The
respective gradients at low (6 µL) and high (14 µL) NaBH4 volumes are ∼ 1 nm·µL−1 and ∼ 9.7 nm·µL−1
respectively.
3.3.3 Silver Nitrate
The presence of silver ions in solution is essential to the formation of single crystalline AuNRs. Silver
appears to play two key roles in the formation process, it is critical to the initial symmetry breaking in
the formation of nascent nanorods, and beyond this is crucial to regulating the growth on the {110} facets
along the sides of AuNR through a cycle of galvanic replacement and silver deposition leading to continued
1At some point the concentration of initial nucleation sites will become so low that the reaction will not complete within 4 hours
and the LSPR wavelength measured here will no longer be representative of the ‘completed’ synthesis
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Figure 3.7: Effect of varying AgNO3 concentration on synthesised AuNRs in a 48 mM CTAB, 15 mM
oleate growth solution. Left: UV-vis spectra after inclusion of different concentrations of AgNO3. A general
trend of increasingly red–shifted LSPR peaks can be seen with increasing AgNO3 concentrations. Low
AgNO3 volumes do not form AuNRs and higher ones led to increasingly polydisperse samples. Right:
LSPR as a function of AgNO3 concentrations. Also plotted is wred/wblue which is the ratio of the widths at
half maximum above and below the LSPR peak.
anisotropic growth [348, 362]. Hence variation in the concentration of Ag in the growth solution is expected
to have a strong effect on the aspect ratio of synthesised nanorods.
As is expected in the absence of AgNO3, only AuNSs form, resulting from the fact that there are no Ag
ions present to break the symmetry during the initial rod formation [362]. The presence of some particles of
higher aspect ratio can be observed at 22 µM from the tail extending out into the NIR, but the population
is still dominated by AuNSs. There then appears to be a threshold, between 22 and 44 µM, at which point
nanorod formation becomes significantly more preferable. The AuNR aspect ratio can then be directly
increased by increasing the amount of AgNO3 added to the solution. This trend has been widely observed
elsewhere in literature (e.g. [248, 253, 267, 302, 324, 394]). Interestingly though, once the Ag concentration
increased up to ∼108 µM, the LSPR wavelength decreases and an apparent increase in the polydispersity
emerges, evident in the increasingly asymmetry in the LSPR peak.
In order to quantify this increasing asymmetry, the ratio of the widths at half maximum above and
below the LSPR peak was measured for each LSPR (wred/wblue). This ratio is an indirect measure of the
polydispersity resulting from increasing high populations of higher aspect ratio AuNRs (plotted in fig. 3.7).
It was not possible to fit peaks where the LSPR and TSPR peaks overlapped significantly, hence it is
only plotted for AgNO3 volumes ≥66 µM. The manner in which the LSPR peak becomes increasingly
weighted towards higher wavelengths is observable in the spectra of other publications, although normally
uncommented upon (i.e. ref. [152]). It presumably results from the {110} stabilising role played by the
AgNO3, preferentially stabilising these facets making higher aspect ratio AuNRs more stable, however the
limitations of this growth system seem to prevent these forming with high uniformity. It may be the case that
optimisation of the growth kinetics may allow more monodisperse high aspect–ratio AuNR populations to be
formed, although this has not been explored here.
Alongside the drop off in shape yield below 44 µM AgNO3, there is noticeable reduction in the fraction
of ionic Au that is reduced onto the particles. The reaction is also noticeably slower, taking significantly
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Figure 3.8: Samples at low AgNO3 concentrations as recorded at 4, 28, and 52 hours after NaBH4 addition.
Samples above 66 µM AgNO3 have been omitted as they showed no change after 4 hours. Inset: Absorbance
at 400 nm after apparent completion of the reaction. Results are fitted with an sigmoid.
longer than 4 hours before the absorbance at 400 nm saturates1 . This is somewhat unexpected as it has
generally been reported in the literature than increased Ag concentration in the growth solution results in
slower kinetics [43, 131, 308]. It can be see from fig. 3.8 that whilst there is little change 4 hours after
NaBH4 addition in the samples synthesised using greater than 66 µM AgNO3 solution, those containing
concentrations below this show continued particle growth during the following 24 hours. There were however
only minor changes in the shape of spectra during this time period, suggesting an increase in the volume of
the particles without any significant morphological changes.
The final values of A400 nm are lower, implying that Ag ions are some how acting as a limiting reagent in
this synthesis at lower concentrations. This is probably not occurring through the silver acting as capping
agent, as the large excess of free Au ions in solution should enable silver to be galvanically replaced on
the particle surface. This has not been observed elsewhere in the literature, and remains unexplained as it
currently stands.
It is apparent based on these measurements is that the AgNO3 concentration is a reliable parameter to
control the LSPR between ∼44 µM and ∼170 µM, but above this the polydispersity rapidly increases as the
increasingly large population of higher aspect AuNRs form.
3.3.4 Ascorbic Acid
Ascorbic acid (AA) is the primary reduction agent during the synthesis, although the precise nature of its role
is debated (see: section 1.5). Hence changes in its concentration will directly affect the kinetics of AuNR
formation. There are a number of reports in the literature suggesting that increasing AA concentration leads
to a decrease in aspect ratio (i.e. [198, 306]). However other reports, suggest that in fact the AA dependence
of the aspect ratio falls on curve with positive gradient at low AA concentrations and negative at higher
1Interband transitions for Ag fall in the UV, so it should have minimal contributions to the extinction at 400 nm, hence it can be
ignored as a reasonable approximation.
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Figure 3.9: Effect of varying AA concentration on synthesised AuNRs in a 48 mM CTAB, 15 mM oleate
growth solution. Left: UV-vis spectra of AuNRs synthesised using different concentrations of AA 4 hours
after addition of NaBH4. A general trend of increasingly red–shifted LSPR peaks can be seen with increasing
AA concentration. LSPR peaks were not visible for the 0 and 0.083 mM samples. The 0.21 and 0.42 mM
samples did not completely reduce all Au1+ in solution based on the the absorbance at 400 nm. All other
spectra appear to have reduced the majority of Au1+ in solution. Right: LSPR as a function of AA volume.
The values at 4 and 28 hours after NaBH4 addition are presented as separate series they overlap above 0.62
mM. After 28 hours the additional LSPR peak visible in the 0.083 mM spectrum and shifted resonance in
the 0.21 mM spectrum continue the linear trend seen at higher concentrations up to ∼1.43 mM, compared
with the more sigmoidal shape seen after 4 hours (see fig. 3.10 for 28 hour spectra).
concentrations [231, 399]. This relationship has been seen for other reducing agents such as hydroquinone
[248]. It is not clear whether this discrepancy results from differences in the synthetic protocols or whether
the same relationship is true in all and more syntheses at lower AA concentrations in studies suggesting a
purely negative correlation would reveal this.
It has been also reported in the literature that large excesses of AA result in rapid uncontrolled deposition
on the tips of the forming AuNR leading to the formation of ‘dog–bone’ or ‘dumb–bell’ structures [306, 399].
Although this is not immediately evident in the spectra of forming AuNRs and can only be confirmed by
electron microscopy.
In the binary surfactant system used here, the presence of oleate complicates matters slightly. Oleate
is a mild reducing agent, and during a synthesis can be observed to reduce Au3+ to Au1+, evident by the
clearing of the HAuCl4 – surfactant mixture without the addition of AA. It is also generally present at a
higher concentration than AA. The oleate–CTAB surfactant mixture alone (i.e. without the addition of Ag
and HCl), is capable of nucleating AuNSs at higher temperatures (∼60°C). It was not necessarily clear if
oleate alone could perform the role of AA in forming AuNRs (albeit very slowly) post–introduction of
NaBH4 to the growth solution. Hence the reaction was performed also without the addition of any AA to the
growth solution.
Following the same protocol as above, a single growth solution was split into several 10 mL samples
and the concentration of AA added was varied between 0 and 1.63 mM. The resulting spectra and change in
LSPR as a function of AA concentration are given in fig. 3.9. A very clear increase in the LSPR was seen
with increasing AA concentration. The change in LSPR begins to plateau at around 1.43 mM. Hence the
effect of AA concentration in this system appears to follow the behaviour reported in refs [231] and [399]
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Figure 3.10: Samples at low AA concentrations as recorded at 4, 28 and 52 hours after NaBH4 addition.
Samples above 0.62 mM AA have been omitted as they showed no change after 4 hours. It can be seen that
there is a slight change in the peak position of the 0.42 mM sample and substantial changes in the spectra of
the 0.083 and 0.21 mM samples. There was no formation of AuNRs in the 0 mM sample at any time point.
All samples showed no change between the 28 and 52 hour indicating the reaction had completed by 28
hours after NaBH4 addition. Inset: Absorbance at 400 nm after apparent completion of the reaction as a
function of AA concentration. Results are fitted with an exponential association.
in which the LSPR peak begins to drop at much higher AA concentrations, although to demonstrate this
conclusively would require repeating this experiment with concentrations in excess of 1.7 mM.
The spectra shown in fig. 3.9 were taken four hours after addition of the NaBH4, it can be seen that
at concentrations of AA below 0.62 mM lead to incomplete reduction of the Au3+ in solution within 4
hours. Hence, the solutions were further incubated at 30°C and spectra taken at 24 hour intervals after this
point. The spectra of all samples synthesised with concentrations of AA in excess of 0.62 mM showed
no further change at 28 hours. However the spectra of samples containing 0.083, 0.21, and 0.42 mM AA
continued to evolve over this time period, showing the reaction kinetics were considerably slower at these
low AA concentrations. This is most clear in the 0.083 mM spectrum where two peaks not previously present
emerged; but also in the 0.21 mM spectrum which increased considerably after this point. None of the
spectra showed any change beyond 28 hours indicating the reaction had completed. The final concentration
of reduced Au is also lower for these samples indicative of a regime where AA is the limiting reagent. The
peaks from this 28 hour time point have been added as a separate series to fig. 3.9, and suggest that a linear
change in LSPR wavelength with AA concentration is expected up to some critical value around 1.43 mM. It
seems probable that the deviation from the linear trend seen above this results from depletion of the free of
Au ions in solution (i.e. Au has become the limiting reagent) [82]; speculatively the addition of additional
HAuCl4 later in the growth may enable this trend to be extended further.
Also of note, is that the reaction does not progress at all without the presence of AA, this was also
observed in the original seeded protocols utilising oleate [396]. Oleate on its own has too low a reduction
potential to reduce Au1+ to Au0 even with the presence of a Au surface at pH ∼1.5 and T = 30°C. This
would seem to imply that the role of AA in the synthesis is the direct reduction of Au1+ in solution to Au0
74
3. Synthesis and Morphological Control of Gold Nanorods
on to the surface of the forming nanorod. Rather than acting as a scavenger of Au3+ after reduction on Au
on the surface through a disproportionation reaction as has been suggested elsewhere [154]. Instead the
conproportionation scheme suggested elsewhere seems more probable, as shown elsewhere by the inclusion
of additional mild reducing agents [307].
Conversely the increase in AA will substantially speed up the reaction, and based on the spectra here
appears to have little impact on the quality of the end–product. The synthesised rods show narrow symmetric
peaks with high ALSPR : ATSPR ratios, with no evidence of non–rodlike NPs in the spectra. This decreased
synthesis time could potentially enable these sort of seedless synthesis techniques to be use to grow AuNRs
via continuous flow methods which offers an easy method to substantially scale up such reactions for
industrial production. However experimental confirmation of this would be required via kinetic monitoring
of the UV–vis spectra of forming AuNRs at different AA concentrations allowing study of the kinetics of the
reaction and electron microscopy evaluation of the morphological changes that could potentially result from
this.
3.4 Darkfield Microscopy and Single Particle Spectroscopy
To investigate the change in the optical properties of the AuNRs at the single particle level, darkfield
microscopy was performed on several batches of AuNRs. Single particle spectroscopy was perform on
individual nanoparticles to qualitatively look at the position each AuNR’s individual LSPR mode (the
scattering and absorbance peaks are degenerate). In order to minimise background scattering signals piranha–
cleaned glass cover slips were used at the substrates. Diluted AuNR solutions were then spun–coat onto
the surface to provide well separated individual scatterers suitable for single particle spectroscopy. It was
found that AuNRs with diameters below 15 nm were below the detection threshold of the single particle
spectroscopy system, this is expected as the scattering section is proportional to V2 (as approximated by
Gans theory) [101].
Images showed sharp individual red spots with a consistent colour demonstrating the AuNPs were well
separated on the substrate and monodisperse (fig. 3.11(d)–(f)), this colour is consistent with AuNRs resonant
in the NIR [141]. Recorded single particle spectra showed distinct sharp resonance peaks for each AuNR
measured, red–shifting with increasing average aspect–ratio (fig. 3.11(d)–(e)). The signal–to–noise ratio
of the LSPR mode is noticeably improved for thicker AuNRs, in agreement with Gans theory [101]. The
observed peaks show relatively close agreement with the optical properties expected at the morphologies
given based on FEM simulations of their properties.
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Figure 3.11: Darkfield microscopy images and single particle spectra of AuNRs.(a)–(c) Darkfield mi-
croscopy images of different aspect ratio (R) AuNRs spun–coat on a glass surface, average particle dimen-
sions and standard deviation are inset on each figure (based on TEM measurements given in appendix A).
Darkfield images are given at optimum exposure and gain settings for each sample.(d)–(f): Single particle
spectra obtained for each sample, showing the expected red–shift with increasing aspect ratio. The filled
blue curve on each image is the FEM simulated–scatter spectra at an air/glass interface. The peak LSPR
wavelength is close, but overestimated in the simulations, this likely results from end–cap geometry being
presumed to be hemispherical in–silico. The shape of the spectra match the experiment relatively closely.
3.5 Kinetic UV–vis studies of AuNR formation1
To further understand the evolution of the AuNRs, their spectra during the synthesis were monitored. Spectra
were taken at two minute intervals and the change in the peak wavelength, maximum extinction and FWHM
of the LSPR recorded, as well as the extinction at 400 nm. From this we can make qualitative assessments
of the concentration of reduced Au0 in solution, and the average aspect ratio and monodispersity of the
synthesised AuNRs.
Additional kinetic spectra and their analysis are presented in appendix B.
In line with expectations, the spectra evolve in a similar fashion to those seen in silver–assisted seeded
growths [82, 273, 307, 362]. The LSPR band becomes visible from the background after around 20 minutes
and its position shows a rapid red–shift. This process slows and the peak position begins to blue–shift at
a slower rate before settling to value in the NIR fig. 3.12. Throughout both phases there is growth in the
extinction at 400 nm, indicating Au0 is still being reduced from the solution. In the literature these shifts
have largely been attributed to a rapidly anisotropic growth phase which results in a rapid increase in the
forming particles aspect ratio, followed by a slower isotropic growth phase which results in a slow drop off
in aspect ratio [273, 362].
1n.b. The work presented here is ongoing and incomplete, it is intended to be supplemented with additional spectra and data.
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Figure 3.12: Kinetic UV-vis monitoring of AuNR synthesis. (a) Kinetic UV-vis spectra of a AuNR synthesis
taken at 2 minute intervals using a growth solution containing 48 mM CTAB, 12.5 mM oleate. (b) Measured
extinction at the LSPR maximum and LSPR full–width–at–half–maximum as determined by a Gaussian fit
to the LSPR peak. (c) LSPR peak wavelength as a function of time, the stationary point of this curve at ∼65
m has been marked by a dashed line in (b) and (d) also. (d) Extinction at 400 nm and the corresponding
concentration of Au0.
Edgar et al. using a CTAB–only growth solution, observed the reduction in LSPR peak wavelength occurs
after Au0 reduction has ceased. They suggest that this blue–shift cannot therefore be caused anisotropic
growth and instead must be caused by reshaping of the AuNRs themselves, primarily through modification of
the end–caps from sharp crystalline facets to more rounded tip geometries [82]. Changes in tip morphology
can cause shifts of around 100 nm, as shown in simulations above fig. 3.3(b), so it is plausible for this be
driving the change in peak LSPR wavelength. Other studies using statistical analysis of TEM images of
AuNRs at different time points during synthesis, show that LSPR continues to blue–shift even after the length
and diameter have stopped growing, due largely to morphological changes at the tips [273].
However, the experiments here do not show the reaction completing before the blue–shift in peak
wavelength occurs. In every spectrum studied the peak LSPR wavelength was achieved at before or in
tandem with the point at which the maximum Au0 reduction rate was achieved, with extinction at 400 nm
falling at ∼40–50% of its maximum value at this point. Hence the AuNRs studied here are clearly still
growing during this period, so it is not possible to eliminate changes in aspect ratio as the primary cause of
this wavelength shift. The studies mentioned above only utilise CTAB in their growth solution, completing
within 30–40 minutes [82, 273], by comparison the reactions here take more than 2 hours to complete, and
are often significantly longer than this. The timescales for the processes which drive end–cap reshaping in
these papers, such as cycles of oxidative etching and Au deposition, and adatom migration, occur over a
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Figure 3.13: Effect of varying oleate concentration on the growth kinetics of AuNRs. Curves are normalised
to the final stable value of A400nm. NOTE: The 25 mM oleate curve is not raw data has been corrected to
account for turbidity in growth solution, see appendix B for details of this.
period of an hour, hence it seems plausible that end–cap reshaping is probably occurring in tandem to the
AuNR growth in our system.
The FWHM of the LSPR peak decreases throughout the reaction is occurring, suggesting the polydisper-
sity of the AuNRs is consistently dropping. There is a noticeable point of inflection in a number of these
curves that occurs around 90 minutes after NaBH4 addition (A notable exception to this is appendix B, in
which the reaction completed before this point). It is not clear at this point what causes this, but it seems to
be largely independent of the surfactant concentrations, it is hoped further measurements will elucidate the
cause.
Spectra were taken at a number of concentrations of oleate (CCTAB = 48 mM), inspection of the change in
the extinction at 400 nm shows a clear trend, with increasing oleate concentration leading to slower reaction
rates (fig. 3.13). It seems probable that the driving force behind this is the increasing packing density of the
surfactants on the AuNR as the molar fraction of oleate in the bilayer is increased reducing the accessibility of
ions to the surface. However it is not possible based on these measurements alone to judge whether this is the
case, this could plausibly be explained by the presence of more surfactant of any variety affecting the growth
rate. It is intended that alongside completing this series; an additional series of syntheses be monitored at
constant oleate concentration varying the CTAB concentration. If this results from the packing density on the
surface then the reverse trend should be seen, increasing CTAB molar fraction should result in more rapid
AuNR formation. Otherwise the reverse trend would indicate it results from surfactant concentration alone.
Based on the trends in the LSPR peak wavelength seen in fig. 3.2 (roughly increasing LSPR with CTAB
concentration, decreasing LSPR with oleate concentration), it seems probable that the former condition is
true. Further clarification of this would require a study of the particle morphology at different time–points
within the synthesis via electron microscopy.
The other apparent lesson learned from these experiments is that the decision to terminate the reactions
after 4 hours may have erroneously led to conclusion that some of the syntheses performed at higher
concentrations of oleate failed. When in fact synthesising for longer would have led to completion of the
reaction.
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3.6 Proposed Growth Mechanism
It is clear that the interaction between two surfactants in the system allows the synthesis of a much wider
range of AuNR sizes. It is known that the addition of a negatively–charged oleate ion to the micellular CTAB
structure screens electrostatic repulsion between the head groups allowing denser packing of the surfactant
monomers leading to preferential formation of parallel arrangements of surfactant molecules, such as bilayers
and rod–like micelles [180]. This is evident in studies of micelle formation in CTAB–oleate mixtures which
show a significant reduction in the free energy of micellisation with increasing molar fractions of oleate
[85, 229, 230]. For example, the 2nd CMC is reduced from 37 mM for 100% CTAB solutions [151] to ∼1
mM for 90% CTAB – 10% oleate mixtures [85, 229]. Whilst the formation of these micelles has been shown
to be largely irrelevant to the formation of AuNRs in the literature [104], the increasing packing implied by
these results does appear to be crucial in enabling the formation of AuNRs at lower surfactant concentrations.
We have synthesised AuNRs with high yield at CTAB concentrations as low as 20 mM, by contrast without
the presence of oleate, concentrations of CTAB of around 100 mM were required [12, 146]. The increased
packing of surfactant monomers in binary surfactant systems also appears to be crucial to accessing larger
AuNRs. Broadly speaking higher molar fractions of oleate lead to lower LSPR resonance and these are
generally achieved by synthesising higher diameter AuNRs.
It is proposed here that this change in packing density, alongside the role that Ag plays in driving
anisotropic growth, results in the observed changes in morphology. The presence of silver is key to
regulating the anisotropic growth of the AuNRs. Two competing processes lead to regulation of lateral
growth, underpotential deposition of monolayers of Ag onto to the {110} facets along the edge of the AuNR
preventing further Au deposition, and oxidative etching of this layer primarily by galvanic replacement [362].
This results in much slower growth in the lateral directions compared to the AuNR tips are not regulated by
the presence of silver. Alongside this the presence of a CTAB bilayer at the surface also limits the rate of
growth, by reducing the accessibility of Au ions to the NR surface. By incorporating oleate into this bilayer,
increasing the packing density of surfactant monomers on the surface, access to the surface can be reduced
further slowing the growth rate. Molecular dynamics studies suggest that CTAB is expected to pack on {100}
and {110} facets at similar densities [223, 224], hence it slows growth in both the lateral and longitudinal
directions to a comparable degree.
When the blocking effects of silver and the surfactants are considered in tandem, the overall effect of
increasing the surfactant density on the surface of the AuNR is to decrease the growth rate to a greater
relative extent than along the sides of the AuNR. Hence the overall result is a slower growth over which time
relatively more growth occurs in the lateral direction1.
Finally, the change in packing density of the surfactants may offer some explanation of the observed
changes in end–cap morphology. A plausible, but untested hypothesis, is that the changes in packing density
actually enable the surfactants to show increased affinity for higher index facets at the tips of the AuNRs.
This may explain the range of tip morphologies seen in the TEM images of the AuNRs synthesised here.
However changes in tip morphology are generally observed over the time–course of single crystalline AuNR
1One possible way to consider this to be the cumulative effects of two growth inhibition factors, Rsur f and RAg, due to surfactants
and Ag respectively. The ratio of cumulative effects of these on the {100} and {110} facets would thus be; Rsur f /(RAg + RAg). Hence
increasing Rsur f would lead to this ratio tending towards unity. The net result being the relative amount of lateral growth over the course
of the synthesis increases.
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syntheses [82], so time–resolved electron microscopy would be required to clarify whether these result from
point at which the synthesis was ceased, or they consistently form the tip geometries observed.
3.7 Conclusion
We have demonstrated that manipulation of the concentrations of CTAB and sodium oleate in the seedless
synthesis of AuNRs represents a reliable method for the controlled modification of the morphology of
AuNRs. The protocol has been shown to yield AuNRs of tunable dimensions with high shape yield and good
monodispersity in a scalable manner. The effects of other parameters in the system have been investigated and
also shown as controls on the optical properties of the synthesised AuNRs. Time–resolved UV–vis suggests
the primary mechanism for affecting the synthesis is regulating the growth kinetics of the synthesised AuNRs,
although this remains to be fully experimentally explored. The particles synthesised via this method will
serve as a reliable method to simply produce AuNRs in large–scale with suitable optical properties for the
theranostic applications we intend to pursue.
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Chapter 4
Surface Modification of Gold
Nanoparticles with Phospholipids
4.0.1 Motivation
The use of CTAB in the synthesis of AuNRs is problematic for their biological applications. Whilst the
optical properties of AuNRs are highly desirable and requires the used of CTAB, it is highly cytotoxic
(intraveneous LD50 = 44 mg·kg−1), and particles stabilised with it present poor colloidal stability. Since no
reliable alternative to the use of CTAB in the bulk liquid–phase synthesis of AuNRs has emerged, a large
body of work has focused on the development of novel surface functionalisations to passivate or displace
CTAB on the surface of AuNRs. These are discussed in section 1.6, and have mostly focused on thiol
displacements, or coating the CTAB layer in silica or polymers. Some work, however, has been focused on
the use of phospholipids to replace the CTAB bilayer. These are of particular interest as such coatings have
the potential to mimic surfaces already found inside the body such as cell membranes or other theranostics
moieties such as microbubbles. They also offer an easy route to improve the biocompatibility and tune
the surface functionalisation of AuNRs, enabling the straight forward inclusion of targeting ligands and or




Polyelectrolytes have become a popular method of passivating the surface of CTAB–functionalised AuNRs.
Negatively–charged electrolytes such as poly(styrene sulfonate) (PSS) or poly(acrylic acid) will electrostati-
cally self assemble on the positively charged CTAB bilayer surface. Due to the change in surface charge,
the coating process must be performed in the presence of at least 1 mM buffer to screen charge interactions
preventing rapid aggregation [109]. These methods were initially performed as a single–step, but further
studies have shown that particles treated this way still possess a relatively high cytotoxicity largely due to
the slow release of CTAB through this coating, this can be reduced much further through repeated cycles of
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Figure 4.1: (a) UV-vis spectra of AuNRs before and after surfactant exchange with DOPC – DSPE-mPEG
(19:1). (b) UV-vis spectra of AuNRs before and after functionalisation with DOPC, DOPC – DOPG (19:1),
and PSS. Spectra have been normalised to 400 nm.
passivation [196]. These techniques also afford the ability to build–up alternating layers of negatively and
positively charged polymers on the surface of the AuNR [109] and also incorporate chemotherapeutic drugs
within the polyelectrolytes as a means of achieving drug delivery [139].
For the purposes of this work, particles were treated with PSS, according to three–step coating process
detailed in ref. [196]. Which briefly consists of resuspending the as-synthesised concentrations of AuNRs
in an equal volume of 10 mg·ml−1 PSS solution (+1 mM NaCl) and left stirring overnight. AuNRs were
washed by centrifugation and resuspended in 1 mg·ml−1 PSS solution, this was repeated twice, before a final
round of centrifugation followed by resuspension in Milli–Q water.
4.1.2 Surfactant Exchange
The phrase “surfactant exchange” is used here to refer to a group of techniques that have emerged in
the literature which directly replace the CTAB bilayer on the surface of AuNRs with other surfactants,
such as phospholipids or fatty acids. These techniques generally consist of redispersing a pellet of CTAB–
functionalised AuNRs in a large excess of the desired surfactant in solution and then providing energy to
encourage exchange between the solution and the particle surface in the form of heat or sonication. These
techniques have been reported for a number of molecules including phospholipids [222, 266, 304, 339, 398]
and oleic acid [204, 364]. We have elected to focus purely on phospholipids here, as oleate is too toxic to
use for in vivo applications, having an intravenous LD50 of 150 mg·kg−1 in rats (by comparison CTAB is
44 mg·kg−1). Naturally occurring phosphatidylcholines have an LD50 in excess of 10000 mg·kg−1 and are
widely considered nontoxic comprising 20–25% of cell membranes [9, 377]
Phospholipids offer a number of benefits resulting from the highly tailorable properties of lipid mem-
branes, allowing potential surface functionalisation which offer low non–specific binding, or the inclusion of
specialist functionalised lipids, enabling the conjugation of targeting ligand and fluorophores, or inclusion of
steric–stabilising agents such as DSPE-mPEG. Phospholipids can be purchased relatively cheaply in bulk1
and the surfactant exchange procedure is straightforward, scalable and reproducible.
1For comparison, functionalisation with DOPC costs approximately £0.10 per mg of AuNRs compared with £0.05 of CTAB used
to synthesise them.
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The method followed here is similar to that published by Matthews et al. [222], although the sonication
time was significantly increased. The following lipid compositions were investigated; DOPC, DOPC – DOPG
(19:1), and DOPC – DSPE-mPEG (19:1). Whilst Matthews et al. have reported that DOPC–functionalised
AuNRs were unstable [222], our results are counter to this, and a number of other studies have found that
phosphatidylcholines can stably displace CTAB from the surface of AuNRs [50, 267, 304, 398]. In brief, the
following protocol was used for each phospholipid functionalisation; each millilitre of 75 mg·mL−1 AuNR
solution was centrifuged at 9000g for 30 m and and the precipitate resuspended in 300 µl of 10 g·L−1 lipid
SUV solution, this mixture was then sonicated in a refrigerated sonication bath overnight. It was found after
a single round of sonication that the ζ–potential of DOPC–AuNRs in 1 mM NaCl (pH 7) still presented a
positive charge (+8 mV), suggesting the continued presence of CTAB (this is consistent with the observed
ζ–potential results in refs [267] and [398]). An additional round of centrifugation, resuspension in DOPC
SUV solution, and sonication reduced this to neutral. Thorough removal of CTAB was deemed a priority
and hence a further round of phospholipid displacement was added to minimise any trace amounts of CTAB.
4.2 Nuclear Magnetic Resonance Spectroscopy
To identify the molecular species present on the surface of the AuNRs 1H NMR was employed. 1H NMR
allows identification of molecular species by observing the relative shift in the resonance of hydrogen nuclei
in a strong magnetic field. A 11.7 T magnetic field was used here producing a 500 MHz resonance for free 1H.
This resonance shifts due to spin–spin coupling between protons within a molecule. In particular, this shift is
characterised by other atoms bound to a particular 1H nucleus, and the atoms immediately neighbouring
those atoms within the molecule. Hence these shifts can be used to identify the chemical environment of
a proton within the molecule. These shifts are typically in the range of -4 – 14 ppm. Each molecule will
generate a set of measurable characteristic chemical shifts which can be used to identify it.
NMR studies of the surface coatings of AuNPs are somewhat challenging. They pose two major
challenges, firstly from the small amount of material bound to the surface of the particles, means that very
high AuNP concentrations must be used in order to achieve good SNRs. Secondly, the rotational correlation
time of the molecules of interest, typically on the order of ∼1 ps when free in solution, are significantly
increased when bound the surface of a much larger object with a rotational tumbling time on the order of
∼1 µs1. The net result of this is a broadening (and hence reduction in amplitude) of the NMR peaks which
increases with particle diameter [219], this can be particularly problematic at larger particle diameters as the
resultant peaks can be difficult to resolve. The same problem occurs for molecules which self–assemble into
larger structures such as micelles. Finally, the resonances associated with protons close to an Au surface
are expected to undergo what is known as a ‘Knight shift’ [172]. An apparent chemical shift due to the
hyperfine coupling between unpaired conduction electrons in the metal and nuclei in close proximity to the
metal surface [172, 219, 366]. These shifts have been observed elsewhere for CTAB bound to the surface of
AuNRs, for the γ–methyl protons this is normally a shift of ∼0.06 ppm relative to CTAB free in solution
[142, 266].
1Tumbling time calculated using: τR = 4πηa3/3kBT . where η is the dynamic viscosity, T is the ambient temperature, and a is the
hydrodynamic radius of the particle (η = 10−3 Pa·s, kBT = 4.1 · 10−21J). For an (11 × 45) nm AuNR, a = 10.2 nm, hence τR ∼ 1 µs
[155].
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Alternative methods of performing NMR on such samples have been deployed elsewhere, such as
complete oxidative etching of the AuNR with KCN, followed by lyophilisation and subsequent dissolution
in a deuterated solvent [310]. The resultant NMR spectra obtained by this method do not display any peak
broadening, but the harsh etching conditions cause the appearance of additional peaks associated with various
hydrolysis and oxidation products of reactions between the molecules functionalising the surface and the
etchants. These methods have been observed to result in the complete dissolution of CTAB rendering it
undetectable in the NMR spectra, which make this method completely unsuitable for use here [310].
NMR has been employed by Orendorff et al. to demonstrate the replacement of CTAB on the surface of
their AuNRs with POPC [266]. Key to demonstrating the removal of CTAB was monitoring the chemical
shifts associated with the γ–methyl protons in the trimethylammonium (3.11 ppm) and choline (3.39 ppm)
groups of CTAB and POPC respectively (see fig. 4.2 for labeled molecular diagrams). The other chemical
shifts associated with CTAB from the alkane chain broadly overlap with those expected from the hydrocarbon
chains of a phospholipid.
The system under analysis here is more complex as the surface coatings initially comprised of a CTAB –
oleate mixture and are hoped to have been replaced with a DOPC – DSPE-mPEG mixture through surfactant
exchange. Hence NMR spectra must be collected for each component molecule in the surface coatings and
peaks unambiguously associated with CTAB identified. Fortunately, oleate does not possess any chemical
shifts in the range of 3–4 ppm and DSPE-mPEG’s β and ζ chemical shifts are significantly above those
expected from those in CTAB’s γ–trimethylammonium group.
4.2.1 Results
CTAB and Oleate
The observed chemical shifts for the CTAB – oleate functionalised AuNRs and their identifications based on




a 0.94 1 (CH3) 1 (CH3)
b 1.35 2–13 (CH2) 2–7, 12–15 (CH2)
c 1.62 – – 16 (CH2)
d 1.81 15 (CH2) – –
e 2.10 – – 8, 11 (CH2)
f 2.18 – – 17 (CH2)
g 3.20 γ (CH3) – –
h 3.39 16 CH2 – –
i 5.41 – – 9,10 (CH)
Table 4.1: 1H NMR chemical shifts from CTAB – oleate (4:1) functionalised AuNRs and their identified
CTAB and oleate peaks as given in fig. 4.3(c). Peaks have been identified based on the experimentally
determined chemical shifts given in fig. 4.2(a)&(b).
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(a) CTAB
(b) Oleate




0.94 1 (CH3) 2
1.36 2–13 (CH2) 22
1.44 14 (CH2) 2
1.85 15 (CH2) 2
3.24 γ (CH3) 9
3.48 16 CH2 2




0.89 1 (CH3) 3
1.30 2–7, 12–15 (CH2) 20
1.56 16 (CH2) 2
2.05 8,11 (CH2) 4
2.17 17 (CH2) 2
5.37 9,10 (CH) 2
(c) DOPC
(d) DSPE-mPEG




0.91 1, 1’ (CH3) 6
1.35
2–7, 12–15 (CH2) 40
2’–7’, 12’–15’ (CH2)
1.60 16, 16’ (CH2) 4
2.07 8, 11, 8’, 11’ (CH2) 8
2.40 17, 17’ (CH2) 2
3.27 γ (CH3)) 9
3.70 α (CH2) 2
4.27 g3 (CH2) 2
4.35 β (CH2) 2
4.45 g1,(CH2) 1
5.35 g2 (CH) 1
5.38 9, 10, 9’, 10’ (CH) 4








1.61 16, 16’ (CH2) 4
2.35–2.40 17, 17’ (CH2) 4
3.36 ζ (CH3) 3
3.39 β (CH2) 2
3.57 δ45, ε45 (CH2) 4
3.64 ε1 (CH2) 2
3.72 δn, εn (CH2) ∼86∼
3.86–3.90 α (CH2), γ (NH2) 3
4.00 g3 2
4.21 g1a (CH2) 1
4.44 g1b, δ1 (CH2) 3
5.29 g2 (CH) 1
Figure 4.2: 1H Chemical shifts and identifications for (a) CTAB, (b) oleate, (c) DOPC, and (d) DSPE-mPEG
in D2O. The corresponding identifications for each protonated atom in each molecule are given in their
respective molecular diagrams. Identifications are based on calculated chemical shifts in MestReNova and
published values for CTAB [142, 183, 266], oleate [320], DOPC [330] and DSPE-mPEG [133]. n indicates
the number of 1H associated with each chemical shift on each molecule. The trimethylammonium groups in
CTAB and DOPC have been highlighted.
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Figure 4.3: 1H NMR spectra for (top) ∼25 nM CTAB – oleate (4:1) functionalised AuNRs, and (bottom)
∼25 nM DOPC – DSPE-mPEG (19:1) functionalised AuNRs. Chemical shifts labels are given in fig. 4.2 and
tables 4.1 and 4.2. All spectra were taken in D2O, details of sample preparation and acquisition settings for
each spectrum are given in section 2.5.3. Spectra for pure CTAB, oleate, DOPC and DSPE–PEG are given in
As shown in fig. 4.3(c) the presence of both CTAB and oleate can be seen on the surface of the AuNRs
based on the peaks given in fig. 4.3(a)&(b). The peaks are noticeably broader compared to the free molecular
solutions as a result of the reduced mobility of the molecules when bound to the surface of an AuNR. Also,
the SNR is significantly lower due to the reduced concentrations of each molecules on the surface of the
AuNR compared to the 10 mM free molecular solutions. In order to achieve the SNR seen here for the
colloidal scans averages over 384 spectra was required, this is an unusually large number of spectra, by
comparison averaging over 16 spectra was required to get the much higher SNR seen for the free molecular
solutions.
The asymmetric peaks at 0.94 and 1.36 ppm correlate well with the -CH3 and -[CH2]- 1H nuclei of the
alkyl chains. Peaks at 2.10 and 5.41 match the expected positions for 1H nuclei neighbouring and within the
alkene of the oleate chain. Shifts associated with the 1H nuclei located in the -[CH2]- monomers closest to
the carboxylic acid head group of the oleate are also visible at 1.62 and 3.39 ppm. Similarly the protons from
the equivalently positioned -[CH2]- monomers from the CTAB can also been resolved in the spectrum at 1.62
and 3.39 ppm. These peaks suggest a mixed composition of CTAB and oleate present on the AuNR surface.
Most important for the work here is the peak observable at 3.20 ppm, associated with the γ–methyl
protons in the trimethylammonium group. This is lower than observed in for the free molecular solution
of CTA+. This has been observed elsewhere and is caused by a Knight shift due to the close proximity to
the Au surface of the nanorod [142, 266, 331]. This peak falls in a different position to that expected for
the γ–methyl protons found in the choline of DOPC, unlike other peaks which are largely degenerate with
CTAB. Hence it can be used to detect the present of CTAB on the AuNR surface
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The value of 3.20 ppm seen here is slightly higher than seen elsewhere (i.e. 3.12 ppm [142], 3.16 ppm
[331], 3.11 ppm [266]), this may potentially result from the inclusion of the negatively charged headgroup
of oleate into the CTAB bilayer on the particle, such changes in the chemical shifts have been observed in
mixed micellular system [118]. Regardless this is not problematic as it is still resolvable from the observed
position of the DOPC shift at 3.27 ppm.
DOPC and DSPE-mPEG
The observed chemical shifts for DOPC – DSPE-mPEG functionalised AuNRs and their identifications
based on the chemical shifts experimentally determined for free DOPC and DSPE-mPEG are as follows:
Label Chemical Shift Identification(ppm) DOPC DSPE-mPEG
a 0.91 1,1’ (CH3) 1,1’ (CH3)
b 1.31 2–7,12–15 (CH2) 2–15 (CH2)2–7,12–15 (CH2) 2’–15’ (CH2)
c 1.60 16,16’ 16,16’ (CH2)
d 2.04 8,11,8’,11’ (CH2) – –
e 3.27 γ (CH3) – –
f 3.71 – – δn, εn (CH2)
g (5.33) 9,10,9’,10’ – –
Table 4.2: 1H NMR chemical shifts from DOPC – DSPE–mPEG (19:1) functionalised AuNRs and their
identified DOPC and DSPE–mPEG peaks as given in fig. 4.3(f). Peaks have been identified based on the
experimentally determined chemical shifts for ‘free’ DOPC/DSPE-mPEG given in fig. 4.2(d)&(e).
Unfortunately, in the spectra of the free lipids, a peak associated with the presence of contaminating
methanol at 3.36 ppm is visible. This appears to have contaminated the system during tip sonication, as a
result of residual methanol from cleaning the tip and jacketed beaker used in preparing the SUV solutions.
It also overlaps the expected position of the ζ–methyl group of the DSPE-mPEG. It is not present in the
spectrum of the phospholipid coated AuNRs and hence does not affect the viability of this measurement in
determining the presence of CTAB.
Peaks at 0.91, 1.31 and 1.60 (weak) ppm can be attributed to the alkyl chains in both DOPC and
DSPE-mPEG. Additionally peaks at 2.04 and 5.33 (weak) ppm can be attributed to the double bonds located
in the chains of DOPC. The 1H resonances of the -[CH2]- monomers in the PEG chains of DSPE-mPEG
are clearly visible at 3.71 ppm. There is no evidence of methanol contamination in the spectra of the
phospholipid–functionalised AuNRs.
Most importantly, the chemical shift associated with the CTAB γ–methyl protons is not visible in the
spectrum of the AuNRs, instead only a single peak at 3.27 ppm is visible in NMR spectra of the DOPC –
DSPE-mPEG functionalised AuNRs. While complete elimination is impossible to argue from the low SNR
of these measurements, they do suggest that substantial displacement of the CTAB from the surface of the
AuNRs by phospholipids has occurred. However this measurement on its own is limited in its sensitivity by
the low SNR and needs to be supported by additional measurements. Hence it was decided to accompany
this with with additional molecular spectroscopy in the form of surface–enhanced Raman spectroscopy.
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4.3 Raman Spectroscopy
Surface–enhanced Raman spectroscopy (SERS) was used as an additional technique to identify the species
of molecules present on the surface of our AuNRs. Raman spectroscopy is a technique based on the
measurement of inelastically scattered light from a monochromatic source off of a sample. Shifts in the
frequency of scattered light are caused by interactions between the electronic distribution around the molecule
and incident light. Vibrational modes in molecules which alter the polarisability of this distribution present
characteristic frequencies shifts which can be used to characterise the molecular species present. Additionally,
the large near–surface electric fields generated at the tips of a AuNR, when excited at their LSPR, allows
enhancement of Raman scattering by as much as 1014–1015 times [250] enabling the study of the relatively
small amount of material located there with much higher sensitivity. Hence study of molecule–specific
Stokes shifts enables identification of the species of molecule present on the particle surface.
The Raman system available offered illumination wavelengths at 532 and 785 nm, it was decided to
maximize the field enhancement at the particle surface by utilising particles synthesised with a LSPR
maximum at 800 nm. This was close to the 785 nm excitation sources and offered a resonance close to the
maximum plasmonic Q–factor for Au (see fig. 1.2(c)), and hence the largest attainable field enhancement.
After CTAB displacement coating this peak wavelength shifted to 790 nm offering a closer match to the
excitation wavelength.
4.3.1 Raman Peak Identifications
100–350 cm−1 – Bromine and Poly(ethylene glycol) Deformations
The band observed at 176 cm−1 has been attributed to the ν(Au−Br –2 ) mode [177]. This peak is not present
in solutions of pure CTAB and can be observed to shift in AuNP solutions when the counter–ion is exchanged
with other halide ions such as chloride [195]. Bromide will form a polar covalent bond with Au atoms at the
surface of the NR, enabling the weak ionic bonding of CTA+ onto the particle surface. The presence of this
peak is not unexpected, as the trimethylammonium head groups of both phosphocholine and CTA+ are both
capable of binding to AuBr– . This peak has been observed to remain in SERS studies of AuNRs coated by
DOPC displacement of the CTAB performed by Matthews et al., suggesting that phosphocholines bind to the
surface through the same ionic interaction albeit at a lower density [222]. Contradicting this, more recently
Santhosh et al published a study observing that the ν(Au−Br –2 ) peak vanishes over the course of displacing
CTAB with DMPC [304]. However, their sensitivity to the ν(Au−Br –2 ) peak is far lower than observed
here. Observing a ν(Au−Br– ) peak around half the height of the ν(C4N
+) headgroup peak at ∼ 760 cm−1.
By comparison, in this study and in Matthews et al, the ν(Au−Br– ) peak was significantly more intense,
at ∼ 22× and ∼ 60× bigger respectively. This is expected due to the SERS enhanced of material in close
proximity with the surface. Based on this disparity, it seems that tracking the amplitude of the ν(Au−Br– )
peak is not a reliable method of establishing the presence of CTAB. It is also not clear why bromine would
dissociate from the particle surface during the displacement. It will form a relatively strong polar covalent
bond with the Au surface, and should interact with the quaternary ammonium group of phosphocholines in
the same manner as the one found on CTAB. Hence, it seems unlikely the resilient of this peak is indicative
of the presence of bromine on the surface.
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4. Surface Modification of Gold Nanoparticles with Phospholipids
The presence of a monolayer of Ag is expected on the {110} facets along the sides of the AuNR [131, 405],
hence relatively high amounts of AgBr –2 is expected to be present close to the particle surface [252]. These
should present an additional SERS peak at 156 cm−1 in addition to the one from ν(Au−Br –2 ) [153], however
this is not observable in either of the spectra from CTAB– or phospholipid–functionalised AuNRs. This
probably results from the concentration of the excited field at the tips of the AuNR where there is expected
to be minimal amounts of Ag present. The selected excitation wavelength will predominantly excite the
LSPR of the particles and hence yields much higher field enhancement at the tips of the AuNR, leading to
much higher sensitivity the molecules located there, as is evident from the plots of Raman enhancement in
fig. 1.8(b) and (c).
A broad band centred at 261 cm−1 appears in the spectrum of AuNRs functionalised with DOPC –
DSPE-mPEG, and is not present in the CTAB functionalised spectrum. This has been attributed to the
δ(OCC) and δ(COC) modes of PEG [176]. The band comprises of the supposition of multiple peaks centred
on 226, 169, and 365 cm−1 associated with variations on these bending modes.
350–700 cm – Trimethylammonium Asymmetric Stretching Modes and Carboxylic Acid
In the spectrum of the CTAB – oleate AuNRs, peaks can be seen at 378, 455, and 489 cm −1 associated
with the asymmetric stretching modes of the trimethylammonium group of CTAB. Only one of these modes
can be resolved in the spectrum of the DOPC – DSPE-mPEG functionalised AuNRs at 489 cm−1. A peak
can be seen in both spectra at 610 cm−1, this can be identified as the ν(OC−O) mode of the carboxylic acid
headgroups and carboxylic acid esters of the oleate and phospholipids respectively.
In addition to these, a distinct peak at 676 cm−1 can be seen on the CTAB – oleate functionalised
AuNR spectrum. There are no functional groups in CTAB which would produce a vibrational mode at this
wavenumber. For oleate, there are two potential candidates the out-of-plane δ(R1HC−CHR2 mode (665–730
cm−1) and the in–plane δ(C−O) mode (630–800 cm−1) associated with carboxylic acid headgroup [325].
The latter seems more probable, both vibrational modes are only weakly Raman active, hence a significant
field enhancement would be required to give the peak seen in the spectrum. Given that the negatively charged
headgroups of oleate are expected to intercalated amongst the positively charged headgroups of CTAB, they
should be in close proximity to the particle surface explaining this enhancement. However some studies
of micelle–structure have suggested that the double–bond of oleate can also sit in this layer, although it
is unclear that this would be true for a supported bilayer on the surface of a particle [85, 229]. This peak
has been tentatively identified as the δ(C−O) mode. It is not present in the phospholipid–stabilised AuNR
spectrum, whilst DOPC does contain carboxylic acid esters they will sit further from the particle surface,
and hence will receive significantly less field enhancement. The removal of this peak does suggest that the
oleate is removed from the particle surface during the displacement process.
700–800 cm−1 – Trimethylammonium Symmetric Stretching Modes
The peak observed at 763 cm−1, in the spectrum of the CTAB – oleate AuNRs, has been widely recognized
to be associated with the symmetric ν(C4N
+) mode of the CTAB headgroup. The position of this peak is
consistent across a range of n–alkyl trimethylammonium cations1. It has become a useful diagnostic for the
1i.e. for n–alkyl trimethylammoniums where; n = 6, νCN+ ∼ 760 cm−1 (from FTIR [SpectraBase]), n = 7, νCN+ = 762 cm−1 [177],
n = 8, νCN+ ∼ 760 cm−1 [ChemBook], n = 9, νCN+ = 760 cm−1 (from FTIR [SpectraBase]), n = 10, νCN+ = 761 cm−1 [106], n = 12,
νCN+ = 762 cm−1 [ChemBook], n = 14, νCN+ = 761 cm−1 [106], n = 16, νCN+ = 761 cm−1 [106]
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presence of CTAB in SERS studies of surface coatings [202, 222, 304, 342], due to the high sensitivity to
this peak resulting from its close proximity when binding to a metallic surface.
By comparison the trimethylammonium group found in the choline headgroup of DOPC has a associated
symmetric ν(C4N
+) peak at 720 cm−1 [329]. The difference in wavenumber between the ν(C4N
+) symmetric
shifts between these two molecules stems from the presence of the electronegative negative oxygen located
in the choline. This can be seen from the sensitivity of this shift to conformational changes in the headgroup.
With the trans conformation yielding a peak of ∼770 cm−1 and the gauche conformation yielding a peak of
∼715 cm−1 [6, 22]. This is a common method to measure the population of conformations within bilayers (e.g.
refs. [6, 7, 88, 120, 170, 358]). This sensitivity to conformation is suggested to originate from electrostatic
interactions between the electronegative oxygen atom and positively-charged quaternary ammonium, both
contained with the choline group [20, 22]. By comparison, the trimethylammonium group found on CTAB is
insensitive to conformational changes seen in choline despite the close similarities between the two functional
groups and consistently presents a Stokes shift of ∼ 760 cm−1[259]. Even though the trans conformation is
the predominant conformer of DOPC found in bilayers, a small population of the choline headgroups are
typically observed in the gauche conformation regardless, leading to the observation of a small peak around
770 cm−1 [6, 293]. Due to the close proximity of this peak to one associated with the symmetric ν(C4N+)
CTAB peak, resulting in residual CTAB being more difficult to distinguish from the this small population of
gauche conformers. However, a significantly higher SNR, than achieved here, would be required to resolve
this gauche peak in these experiments.
Finally, DSPE-mPEG presents a weak band at 759 cm−1 associated with the ν(C−N) mode of the amide
linker [182, 257]. This will overlap the ν(C4N
+) peak of CTAB at 763 cm−1. This is not a major concern
given how weak this peak is, and also that DSPE-mPEG is expected to sit in the outer leaflet of the surface
bilayer leading to relatively minor electric field enhancement at this bond.
Despite these potential additions at this wavenumber, there is no obvious peak that can be observed in the
Raman spectrum of the DOPC – DSPE-mPEG at 768 cm−1, suggesting that the majority of the CTAB has
been removed from the surface of the AuNR. However the strong background signal attributed to the PEG
chains of the DSPE-mPEG makes it difficult to make any further assertions beyond this. The numbers of
counts at the DOPC ν(C4N
+) is 1380 compared to 360 at 760 cm−1 quantitatively putting an upper limit for
CTAB content at 26%. However it seems more probable, given that the presence of any peak at 760 cm−1 is
impossible to distinguish from the background that the amount of CTAB present has been reduced to below
the threshold of detection.
800–1500 cm−1 – Phosphate Group and Alkyl/Poly(ethylene glycol) Chains
A peak is visible in both spectra at ∼959 cm−1 this is attributable to two degenerate asymmetric ν(C4N
+)
modes, associated with the trimethylammonium in both CTAB and DOPC. This peak position is insensitive to
conformation and hence appears in the same place for all conformers of DOPC [6]. An additional asymmetric
ν(C4N
+) mode is expected to have a peak at 870 cm−1 and 910 cm−1 for DOPC and CTAB are also expected,
but these are not resolvable in either spectrum [6, 75].
The rest of the observable peaks are either present in both spectra (i.e. from the alkyl chains), or only
found in spectra of the phospholipids used here (e.g. phosphate and poly(ethylene glycol)). Hence they are
not particularly useful as a diagnostic for the presence of CTAB. Peaks in the spectrum of CTAB – oleate
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AuNRs at 1029, 1080, 1196, 1304, and 1449 cm−1 are all associated with the alkyl chains of CTAB. The
observable peaks in the DOPC–DSPE-mPEG AuNRs at 1088, 1300, and 1445 cm−1 are all associated with
the alkyl chains of the lipids and are close to peaks seen in the CTAB – oleate AuNR spectrum. It is probable
that the ν(O−P−O) mode from the phosphate also contributes to the peak at 1080 cm−1. Also, a peak at
1646 cm−1 associated with the ν(C=C) mode is evident and associated with the alkene bond in the chains of
DOPC.
Finally, there is clearly a strong contribution from poly(ethylene glycol), which has make the background
appear very uneven. Inspection of the Raman spectra of poly(ethylene glycol)s shows that these charac-
teristically have strong bands resulting from overlapping peaks in the following regions: 770–900 cm−1,
1015–1170 cm−1, 1230–1330 cm−1, 1410–1480 cm−1 [176]. These bands are marked on fig. 4.4 and the
various peaks that contribute to them are summarised in table 4.3.
4.3.2 Summary
The absence of the trimethylammonium asymmetric stretching modes in the DOPC – DSPE-mPEG AuNR
spectrum gives another good indication that the quantity of residual CTAB has been reduced to a very small
population. It is difficult to provide absolute quantification, due to the strong background resulting from other
components in our surface. All the peaks identified are consistent with the expected species of molecules
present on the surface of our particles.
4.4 Zeta Potential – pH Response of Surface Functionalisations
In addition to the molecular spectroscopy performed, a pH–dependent ζ–potential study was undertaken. The
electrostatic properties of the coatings of colloids can be directly measured via their ζ–potential. Different
surface ligands will provide nanomaterials with varying different surface charges dependent on their surface
packing density and the functional groups comprising the molecule. The charge of which are dependent on
the surrounding medium pH, with different groups becoming ionised at their respective pKa values. The
ionised fraction of a given functional group can be expressed in terms of its pKa and the bulk pH. This is
expressed by the Henderson–Hasselbalch equation [122, 123], which gives the ionised fraction of anionic















where H and OH, are cationic and anionic counterions respectively (i.e. they do not necessaily have to
be a proton or hydroxyl ion). According to Gouy–Chapman theory the ζ–potential of a given particle is
related to the surface charge density, σ by an sinh−1(σ) function [105]. Hence ζ increases with |σ|, and the
change in σ due to ionisation/deionisation of functional as a result of a change in pH can be seen in the
measured ζ–potential. Hence the pKa values of individual molecules comprising the surface coating can
be used to assess the species of molecules present on the surface of a particle, by observing changes in the
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Molecule Functional Group pKa












Phosphate 1.86 (1) R1 P
O
OH









Phosphate 1.89 (2.8) R1 P
O
OH












PSS Sulphonic acid -1.92 R S
O
O





Phosphate 1.88 R1 P
O
OH










Table 4.4: Functional groups of the various molecules used to functionalise AuNRs in this section and their
associated pKa values. pKa values were calculated using ChemAxon. The pKa values in brackets for DOPC
and DOPG are observed shifts due to inclusion in a bilayers or liposomes.
ζ–potentials as a function of medium pH. The pKa values of the important functional groups found in the
various molecules used to functionalised AuNRs in this section are given in species used in table 4.4. More
importantly the presence of CTAB can be determined by measurement of a positive ζ–potential at pH values
which should induce a net neutral surface charge in other species of capping agents. Alongside the DOPC –
DSPE-mPEG functionalised AuNR discussed above; PSS, DOPC and DOPC – DOPG functionalised AuNRs
have also been characterised by this technique.
As no single buffer can span the entire range of pH used here, a range of buffers were used (detailed
in section 2.5.1). No unusual effects came about of as a result of this and the behaviours of measured
ζ–potentials were consistent between buffers and with theory. All buffers used were diluted to 10 mM from
the stock concentrations given in section 2.5.1 using degassed Milli–Q grade water. It is worth remembering
that the stability thresholds for the magnitude of the ζ–potential specified in the same section have little
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meaning for particles which are sterically stabilised or stabilised using zwitterions.
The embedding of molecules within a bilayer structure will lead to shifts in the pKa values and a
broadening of the pH response [266]. This results from the close packing of headgroups attracting counter–
ions in solution creating a locally different pH compared to bulk solution [387]. For instance, positively
charged functional groups will attract negatively charged ions from solution creating a local environment
which is effectively lower in pH than in the bulk solution.
4.4.1 Results
CTAB
In order to provide a basis for assessing the presence of residual CTAB on the surface of the surface–modified
AuNRs a single batch of AuNRs were synthesised using 100 mM CTAB (no oleate was added and the HCl
concentration was also reduced by 75%). Resulting in AuNRs stabilised by CTA+ ions only.
The positively charged trimethylammonium group in CTA+ is permanently ionised in solution, hence
particles stabilised with it should present a constant positive ζ–potential so long as the background ion
concentration is maintained. This behaviour was witnessed for CTAB-capped AuNRs across all pH (fig. 4.5).
However the actual surface charge presented by the CTAB coating was also dependent on the background
concentration of CTAB, as it exists in a dynamic equilibrium with the background concentration of free
CTA+ ions [296]. As this background concentration drops the packing density of CTA+ on the surface drops
and the resultant ζ–potential also drops. In this experiment, the particles were washed twice by centrifugation
before being resuspended in 10 mM buffer, reducing the concentration of CTAB in the bulk solution to
approximately 0.1 mM, close to the limit of stability (further washing resulted in irreversible aggregation).
The measured value of ζ ∼ 20.5 mV, while low, reflects the depletion of the surface bound CTAB due to
repeated washing. It would be expected to increase if additional CTAB were added to the colloidal dispersion
(or alternatively a lower buffer concentration were used) to values in line with the higher zeta potentials
reported elsewhere (e.g. refs. [11] and [410]).
CTAB – Oleate (4:1)
By comparison AuNRs prepared by the method outlined in chapter 3, using a 38 mM CTAB and 10 mM
oleate growth solution (∼ 4:1 molar ratio) yield a ζ–potential which changes dynamically with pH. The
ζ–potential is positive at all pH values consistent with a higher surface concentrations of CTA+ than oleate-,
however the presence of the negatively charged oleate ions in the surface coating has substantially suppressed
the ζ–potential below the threshold for electrostatic stability in 10 mM buffer (they are stable in water for at
least two years).
The pKa of the –COOH head group of the oleate leads to a positive shift of the ζ–potential at lower pH.
The estimated pKa for a free molecule is 5.0, however the measured shift in ζ–potential indicates a pI of 4.3
suggesting a shift in the pKa of the oleate relative to the bulk pH. This is not unexpected due to the packing of
the negatively charge headgroups of oleate in amongst an excess of positively charged trimethylammonium
headgroups, leading to localised repulsion of cations in the vicinity of the water/bilayer interface and an
apparent pH shift of ∼ 0.7 locally based on these measurements [387].
Also notable is the ratio of the ζ–potentials above (12.2 mV) and below (29.2 mV) the apparent pKa,
is actually not reflective of the ratio of surfactants used to the synthesis the AuNRs (4:1), but more closely
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Figure 4.5: Left: Experimentally determined ζ–potentials for AuNRs coated with 100% CTAB and PSS as
a function of buffer pH (10 mM). Right: Theoretically predicted charge for a population of CTAB and PSS
monomers, where n is the ionisation number and Xn is the ionised fraction.
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Figure 4.6: Left: Experimentally determined ζ–potentials for AuNRs synthesised in a CTAB – oleate (4:1)
mixture as a function of buffer pH (10 mM). Right: Theoretically predicted charge for a population of CTAB
and oleate monomers, where n is the ionisation number and Xn is the ionised fraction. Also presented are the
predicted curves for 4:1 and 3:2 CTAB – oleate mixtures.
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Figure 4.7: Left: Experimentally determined ζ–potentials for AuNRs functionalised using DOPC, DOPC
– DOPG (19:1), and DOPC – DSPE-mPEG; as a function of buffer pH (10 mM). Right: Theoretically
predicted charge for a population of DOPC and DOPG, where n is the ionisation number and Xn is the
ionised fraction. Also presented are the predicted curves for 19:1 and 1:1 DOPC – DOPG mixtures.
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resembles the curve predicted for a 3:2 molar ratio of CTAB and oleate. This implies the formed bilayer
does not necessarily contain the same surfactant ratio as the original growth mixture and may instead reflect
some more energetically preferable configuration of surfactants on the surface.
PSS
The primary functional group of PSS, a sulphonic acid has a pKa of -1.92, hence it outside the range of
the buffers used here and would only become protonated under the extremes of concentrated acids. Hence
PSS should present a constant negative ζ–potential at all pH measured here, which is matched closely
by our experimental observations fig. 4.5. Because PSS functionalisation passivates the CTAB layer, the
positive charge is obscured by the PSS layer, despite still being present on the surface of the particle, it is not
detectable by measurement of the AuNR ζ–potential measurements, which sensitive only to the external
surface charge.
DOPC
Due to the zwitterionic character of DOPC, it is neutrally charged at physiological pH. The phosphate group
has a pKa of 1.88 when the molecule is free in solution, but this shifts to around ∼pH 1 inside a DOPC
bilayer [221]. Hence the pH response of the molecular charge is expected to be positive around pH 1 and
decay to neutral as the pH is increased. This means that the pI for the DOPC–coated AuNRs cannot be
determined from the pH range covered here because fitting accurately would require bulk pH values where
all phosphate groups were completely protonated. However, the observed pH response of DOPC coated
AuNRs correlates strongly with that described above. The neutral ζ–potential observed above ∼pH 4 is
consistent with this and suggests reduction of the residual CTAB to only trace amounts.
For comparison, other published phospholipid surfactant exchange methodologies (which utilise only
a single round of sonication in phospholipid SUV solution) still present a positive charge at neutral pH,
suggesting incomplete removal of the CTAB [267, 339, 398]. The work of Orendorff et al presented the pH
dependence of the zeta potential their POPC–functionalised AuNRs, displaying a similar pH response to that
seen in fig. 4.7, albeit declining to a ζ–potential of 10 mV at higher pH values, which the authors attributed to
an estimated inclusion of ∼10% CTAB in the surface coating [266]. Confusingly, other work have reported
negative zeta–potentials for DMPC–functionalised AuNRs of -9 mV, which is difficult to explain with the
functional groups that could potentially be present on the particle surface [304]. Comparatively, we observe
neutral surface potential (to within ±3 mV) suggesting the additional rounds of sonication in phospholipid
SUV solution deployed here are effective at removing this residual CTAB from the surface coating.
DOPC – DOPG (19:1)
The observed pH response of AuNRs functionalised in a DOPC – DOPG (19:1) lipid SUV solution is
consistent with a surface coating containing two negatively charged groups with pKas at around ∼pH 1 (hard
to determine reliably) and ∼pH 3. This is not inconsistent with the known pKa values for the phosphate
groups of DOPC and DOPG which both fall at around pH ∼1.9 when free in solution. As stated above the
pKa of DOPC is expected to shift to around pH 1 when embedded in a bilayer [221], and DOPG has been
observed to have a pKa of 2.7 embedded in liposomes [383]. Hence the observed behaviour is consistent with
that expected for a DOPC – DOPG mixture on the surface. The excess negative charge of the DOPG will
obscure the presence of residual CTAB in the ζ–potential measurement. It seems reasonable to assume that
the residual CTAB will might be expected to be similarly low as in the pure DOPC system. The theoretically
expected curves are given in fig. 4.7 alongside the combined curves for a 19:1 and a 1:1 mixture of the
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two lipids. As can be seen the shape of the combined curve for a 1:1 DOPC – DOPG is considerable more
consistent with the experimentally measured ζ–potential curve. This suggests, alongside the results from
the mixed CTAB – oleate coatings that the ratio of different surfactant species adsorbed on the surface of a
AuNP do not necessarily reflect the ratio of surfactants in the bulk solution.
DOPC – DSPE-mPEG (19:1)
Whilst the phosphate groups of DOPC and DSPE-mPEG both have pKa values of around 1.8, they are
not expected to have an apparent effect on the pH response of particles functionalised with a significant
number of PEGylated phospholipids. Since ζ–potential measurements are only sensitive to the functional
groups exposed at the surface of the particle, the extended PEG brush structure will effectively screen the pH
response of the phosphate, choline and amide groups present on these molecules. Hence we would expect
based on the protonation dynamics of PEG that the particles would present a neutral ζ–potential at all pH.
This is not what is observed, instead the particles show a slightly negative ζ–potential at low pH, which
grows increasingly negative with increasing pH, this behaviour has been observed elsewhere (e.g. [35, 226]).
This can likely be explained by the preferential absorption of anionic species into the PEG layer, which has
been observed to occur for oligo(ethylene glycol) monolayers [184].
4.4.2 Summary
The observed shifts in the ζ–potential are consistent with the known pKa values of the molecules we have
functionalised our AuNRs with. The absence of any positive charge on our DOPC–functionalised AuNRs
implies that the level of CTAB on the surface of the AuNRs is being successfully reduced to trace levels
during the phospholipid exchange process described above. This is also supported by the NMR and Raman
spectroscopy performed above.
4.5 Stability in Biorelevant Media
The body presents a particularly challenging environment for the maintenance of colloidal stability, hu-
man plasma exhibits a relatively high salinity of around 300 mOsm·L−1 and contains a wide variety of
biomolecules which will non-specifically bind to particles, often undermining any specific surface function-
alisation bestowed on the particle. This is extremely problematic for most targeting strategies as protein
corona are typically 10–100 nm in thickness [178], in excess of the size of most targeting ligands (i.e.
antibodies are ∼10–15 nm), leading to corona completely obscuring such molecules. Whilst such measure-
ments have been performed for the more common AuNR coatings such as CTAB and PSS, the stability
of phospholipid–coated AuNRs outside of the idealised environment of deionised water has received no
attention (i.e. [50, 267, 304, 398]). Hence, it was decided to explore the stability of each of the surface
functionalisations in a variety of ‘biorelevant media’, such as buffers, cell culture medium, serum and blood
plasma.
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Electrolyte
Reference Values Dulbecco’s Plasma-lyte Pseudo-plasma
RPMI 1640 FBS
Human Plasma PBS 148 Buffer
(mM) (mM) (mM) (mM) (mM) (mM)
Sodium Na+ 133 - 146 152 140 141 124.27 137
Chloride Cl− 95 - 105 144 98 98 100.16 103
Potassium K+ 3.5 - 5.3 4.2 5 5 5.33 11
Calcium
ionised Ca2+ 1 - 1.3 0.9 – – 1.3 0.42 3.4
total – – 2 - 2.6 – – – – – – – – – –
Phosphate PO3−4 0.8 - 1.5 9.5 – – 1.3 5.63 1
Magnesium Mg2+ 0.7 - 1 0.5 – – 1 0.42 0.1
Sulphate SO−4 1 – – – – 1 0.41 <0.0001
Ammonia NH+4 0.011 - 0.051 – – – – – – – – 0.5
Nitrate NO−3 0.0013 - 0.013 – – – – – – 0.85 – –
Copper Cu2+ 0.011 - 0.022 – – – – – – – – <0.0001
Zinc Zn2+ 0.011 - 0.024 – – – – – – – – <0.0001
Organic acids (lactate) C3H5O
–
3 0.5 - 2.2 – – 2 – – – – – –
Bicarbonate HCO –3 22 - 29 – – 23 – – – – 16.8
Carbonate CO –3 23 - 30 – – 26 – – – – <23?
Acetate H3CO
–
2 2.5 – – – – 27 23.81 0.4
Gluconate C6H11O
–
7 – – – – – – 23 – – – –
Table 4.5: Comparison of the various ion concentrations of the prepared buffers and media used in measuring
the stability of various nanoparticle functionalisations alongside typical ranges for a healthy human adult.
Human reference values taken from ref. [100] RPMI 1640 and foetal bovine serum are complex mixtures
containing a large number of additional molecules, such as vitamins, amino acids and proteins, an incomplete
summary of these are detailed in table 4.6.
Three buffers were selected as surrogates to test the impact of similar ion concentrations to those seen
in human plasma on the stability of AuNPs. Firstly, Dulbecco’s PBS (DPBS) was used as a commercially
available buffer at a suitable pH and osmolarity, due to its ubiquity in the literature as a stability testing
medium. DPBS has Na+, Cl−, K+, Ca2+, Mg2+ and SO−4 concentrations within the expected reference ranges
for human plasma. But it has around an eightfold excess of PO3−4 ions compared to human plasma. Higher
valency electrolytes such as PO3−4 are significantly more detrimental to colloidal stability than monovalent
electrolytes, this is expressed by the Schulze–Hardy law 1 [119, 312]. For instance, the critical coagulation
concentration is typically ∼100× lower for divalent counterions and ∼1000× for trivalent counterions,
compared with monovalent counterions [255]. Variation in concentration of phosphate will thus have a
disproportionate effect of the stability of particles compared with the other common ions in blood plasma.
Secondly, Plasma–Lyte 148 (PL–148), an isotonic intravenously administered fluid replacement which is
designed to resemble the electrolytic composition of human plasma was chosen as additional commercially
available product with a standardised recipe. It contains sodium, chloride and potassium at normal human
reference values, but also contains acetate and gluconate ions significantly well above these, they are included
for medicinal purposes as alkinising agents and are metabolised to bicarbonate by muscle and peripheral
tissues or renally excreted from the body [375]. It is also missing a the vast majority of electrolytes found at
lower concentrations, limiting its potential as a plasma mimic somewhat.
Thirdly, a bespoke buffer was created to reflect the homeostatic concentrations of the most common
electrolytes in human plasma (Cion ≥ 1 mM) dubbed ‘pseudo–plasma’ buffer (PP). The recipe for this is
given in table 2.3. The pH of the buffer was measured to be ∼pH 7.4, 1 hour after preparation.
1This law is normally stated as the critical coagulation concentration of an oppositely charged colloid is ∝ z−6, where z is the
valency of the counterion [45]
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The ion concentrations of each buffer are given in table 4.5
In addition to these electrolyte mixtures, mixtures of RPMI 1640 cell culture medium (CCM) and
foetal bovine serum (FBS) were also used. CCM is commonly used in the literature as a stability–testing
medium for AuNPs. It is a useful preliminary experiment to demonstrate colloidal stability throughout
in vitro testing of NPs. Although it is somewhat limited in its similarity to the in-vivo environments in
which theranostic AuNPs are expected to be deployed. CCM is a mixture of electrolytes, vitamins, free
amino acids and nutrients (detailed in table 4.5 and table 4.6) and is intended to function as an optimal
environment for the in-vitro growth of cells. Hence, its composition is selected to encourage indefinite
proliferation of mammalian cells. It contains substantially elevated levels of PO3−4 and NO
−
3 compared
with human plasma (PO3−4 being particularly problematic to colloidal stability due to its high valency), and
the bicarbonate–carbonate buffering system of the blood is entirely missing. It also contains a free amino
acids profile that does not reflect that found in plasma, and elevated levels of B vitamins, glucose, and
para–aminobenzoic acid. Reflecting its purpose as an artificial environment designed to nourish immortalised
cells, but it is one into which these particles will be placed and hence should be considered on those grounds.
Foetal bovine serum (FBS) is a by–product of the beef industry, and is prepared from blood collected
from bovine fetuses. It is a complex (and ill–defined) mixture of molecules, including electrolytes, amino
acids, proteins, antibodies, enzymes and peptides. The electrolyte content is detailed in table 4.5 and other
commonly identified components are given in table 4.6. Hence FBS is a close match in many regards to
the composition of human blood plasma. But it presents its own problems, due to the manner by which
it is collected from many individual cattle, there is a large amount of batch–to–batch variability, limiting
the amount of information that can reliably be gained from a single batch. Also the method by which it is
prepared changes the composition compared with that of blood plasma. Collected blood is allowed to clot
at low temperature and then the clotted fraction removed by centrifugation. This leads to fibrinogen and
coagulant proteins being reduced to a small fraction of their normal levels. It is also not an exact match to
human sera, not only because it contains the bovine–variants of proteins, but also because it is harvested
from foetuses, concentrations of growth factors are much higher and and antibody and complement protein
concentrations are much lower than would be found in an adult. This is beneficial in its use as an additive to
CCM for encouraging cell growth, but does make it less ideal in testing the stability of our particles. It is
also notable that most studies do not report the presence of lactate in FBS. Lactate is almost certainly present
in FBS at the point of collection, with presumably the presence of lactic dehydrogenase in serum leading to
breakdown of lactate before its use in labs.
Regardless of the above potential issues, FBS is much closer to the in vivo environment in which the
particles will be utilised than the simple buffers and CCM discussed above. It will also be used to enrich
the media used in in vitro studies and hence demonstrating colloidal stability in that environment is also
important. It was decided to test ratios of CCM and FBS at 100% RPMI, 90% RPMI – 10% FBS, 50% RPMI
– 50% FBS, and 100% FBS, allowing some assessment of the increasing impact of serum proteins on AuNR
stability.
Finally, in addition to the above media, it was decided to test AuNR stability in mouse plasma, because
this would be the closest possible match to the in vivo models in which these particles would be tested. Plasma
is different from serum as it has not been allowed to clot and hence still contains all the coagulant proteins
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and fibrinogen. In order to prevent coagulation the blood was collected in a tube containing the chelation
agent tripotassium ethylenediaminetetraacetic acid (K3EDTA) and the cells removed by centrifugation. This
will affect the ionic make up of the sample, K3EDTA which will disproportionately chelate divalent cations,
hence a number of electrolytes will have been removed from the plasma (i.e. Ca2+, Cu2+, Mg2+, Zn2+,
Fe2+) and replaced with K+. K3EDTA is not expected to interact with the particles given that it should
be rendered chemically inert by divalent cations in the plasma. Whilst this does mean that the harvested
plasma is not a perfect replicate of in vivo plasma, these ions make up a relatively small fraction of the
electrolytes in solution and the impact of them without the presence of plasma proteins will be assessed by
the ‘pseudo–plasma’ buffer discussed above. This collected plasma represents the closest match to the in
vivo environment in which our NPs will operate, and would be usable over the timescale of the experiment
(i.e. whole blood will clot).
4.5.1 Results
Particles were suspended at a concentration of 75 µg·ml−1 in 200 µl of the desired medium in a 96-well
plate and the spectra of each well read at the desired time–points using a well plate–reader. This allowed
a large number of samples to be processed simultaneously, reducing the time required considerably, but
came at the cost of a lower SNR and occasional artefacts appearing in the data. Additionally problems were
encountered, due to the inclusion of phenol red in RPMI 16401 with its strong absorbance peaks at 443 and
570 nm, which made baseline correction of the spectra difficult below 600 nm, and prevented normalisation
of the spectra for Au0 concentration at 400 nm. This was also true for the plasma harvested from mice which
also showed strong absorbance bands below 600 nm associated with a small amount of haemoglobin and
oxyhaemoglobin which entered the sample during processing. Instead, it was found that normalising to the
minimum between TSPR and LSPR for each spectrum where the plasmonic contributions to the optical
properties were minimised worked well as an alternative, this also meant that the effect of some of the optical
artefacts at lower wavelengths in the buffer spectra could safely be ignored.
The spectra obtained are available in appendix D, and have been summarised in fig. 4.8. In number
of the spectra the LSPR was observed to drop in intensity which no accompanying increases in extinction
at higher wavelengths normally ascribed to aggregation. This is highly likely to be caused by AuNRs in
solutions losing stability and adhering to the walls of the well-plate over the long time-scale of the experiment,
leading to them effectively disappear from the measured spectra. Results are discussed for each surface
functionalisation below:
CTAB – Oleate functionalised AuNRs
CTAB–functionalised particles possess an inherent instability, due to the way in which molecules dynamically
exchange with the surrounding environment. Repeatedly washing of the particles by centrifugation will result
in depletion of the free CTAB in the bulk solution and hence encourage the dissolution of the surface–bound
CTAB, reducing the stability of these particles. Hence, two experiments with CTAB–capped AuNRs were
run in parallel, one in which the CTAB – oleate stabilised particles were washed threefold and suspended
in the media of interest and the other in which an additional 1 mM CTAB was added to the well. Making
1Phenol red free RPMI 1640 CCM is available, but it was decided that since the LSPR (λLSPR > 600 nm) was the primary means
by which aggregation would be assessed, it was not worth repeating the measurement with alternative CCM.
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4. Surface Modification of Gold Nanoparticles with Phospholipids
it possible to distinguish between aggregation induced by degradation of the CTAB bilayer and charge
screening due to ions in solution.
The effects of this are easily visible in the results; the presence of 1 mM free CTAB increased the stability
of the particles in solution in higher osmolarities in all cases. Particles without additional CTAB were
unstable in 96, 20, and 188 mOsm·L−1 in DPBS, PL148 and PP1 buffers respectively. The addition of 1
mM free CTAB improved stability at higher concentrations of DPBS although aggregation was still visible.
In PL148 and PP buffers the particles were stable at increased concentrations of 98 and 282 mOsm·L−1
respectively. Both sets of experiments showed worst stability in PO−34 rich environments such as DPBS and
RPMI 1640 CCM, which is expected given the interaction between the trivalent negative charge of the PO−34
and the positive charge of the N+–(CH3)3 headgroup of CTAB.
Both sets of CTAB–capped AuNRs were unstable in 100% RPMI CCM. However, the addition of serum
stabilises the particles in the presence of CTAB, suggesting proteins in the serum were providing stability to
the particles through the formation of a corona. These particles also showed better stability in mouse plasma,
presumably also resulting from corona formation. They still aggregated over the course of 24 hours though.
The well containing plasma without additional CTAB became visibly cloudy, suggesting the formation of
large aggregates which scattered light strongly. This additional signal meant that the normalisation performed
on the other spectra became unreliable, the TSPR and LSPR are visible in these spectra, but much weaker
than this scattering signal. The formation of these large aggregates would imply some interaction between
molecules in the media and the less stable CTAB–AuNRs, which is otherwise prevented by maintaining a
higher surface charge in the presence of 1 mM CTAB.
The results for the triply washed samples containing an additional 1 mM CTAB in PBS, pure RPMI, and
RPMI + 10% FBS are consistent with those reported elsewhere for singly–washed CTAB–AuNRs [137].
Demonstrating the clear requirement to maintain a high background concentration of CTAB to maintain
colloidal stability.
Poly(styrene sulfonate) functionalised AuNRs
PSS–AuNRs was observed to aggregate at 289, 98, and 94 mOsm·L−1 in DPBS, PL148, and PP, respectively.
Faster and more complete aggregation was observed above these concentrations. The variation in the
maximum concentration is difficult to explain, being negatively charged the stability of PSS–stabilised NPs
should be much less affected by the presence of PO−34 due to it being a co–ion
2. It is also not consistent with
the presence of small concentration the divalent counterions in Ca2+ and Mg2+ in DPBS and PP.
PSS–AuNRs were also unstable in RPMI 1640 culture medium. This has been observed elsewhere,
where the presence of serum proteins was required to maintain stability [289]. The particles here were
not stable in 10% serum–enriched RPMI 1640 (which have been observed to be stable in elsewhere (i.e.
[289, 393])). However, increasing the serum content further did convey stability and PSS–functionalised
AuNRs show good stability in 50% and 100% serum, suggesting corona formation can stabilise the particles,
consistent with these other results.
1 The case of 10 mOsm·L−1 PP buffer has been deemed to be an artefact. The drop–off in LSPR peak intensity is paired with a
blueshift in peak position, a trend that is more consistent with directional oxidative etching of the AuNRs [294]. Given that the same
trend is not seen for higher concentrations of the buffer, it seems more likely that this results from an optical artefact, due to the presence
of something strongly refractive in the well such as a bubble. Hence this result has been ignored in further discussion.
2The effect on the critical coagulation concentration of co–ions is given by the inverse Schulze–Hardy law, which states that it is
proportional to z−1, where z is the valency of the co–ion [45].
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The particles aggregate at a faster rate than CTAB–coated particles in mouse plasma. Over the course of
the experiment the LSPR decreased to the point of being virtually undetectable, accompanied by an increase
in the extinction at higher wavelengths consistent with the formations of aggregates.
DOPC functionalised AuNRs
DOPC showed relatively poor stability in DPBS, relative to PL-148 and PP, and is also have poor stability
in RPMI 1640 CCM suggesting that the higher concentrations of PO−34 has a disproportionate impact
on the stability of DOPC functionalised AuNRs. There was little–to–no reduction in LSPR intensity of
DOPC–functionalised AuNRs in PL–148 or PP.
Whilst the DOPC–AuNRs were not stable in RPMI 1640, enriching with serum stabilises the NPs,
suggesting either the formation of a corona or the reduction in the PO−34 concentration stabilised the particles.
It is more likely primarily driven by corona formation, given that a 10% reduction in RPMI concentration led
to near complete stability, but both effects are likely to be occurring to some extent. DOPC–AuNRs were
stable in the presence of serum.
As with all other functionalisations the particles showed worse stability in mouse plasma, compared with
pure FBS. As is visible in the drop in LSPR intensity and growth in extinction at higher wavelengths. The
LSPR intensity dropped to around 60% of its initial intensity, so they performed marginally worse than the
other phospholipid coated AuNRs.
DOPC – DOPG (19:1) functionalised AuNRs
The DOPC – DOPG AuNRs were relatively stable in all buffers tested. A small drop off in LSPR intensity
was seen in some cases, although it did not correlate with ionic strength. They were also stable in all
combinations of media and FBS and will almost certainly be forming a corona in the presence of serum, due
to charge interactions between the PSS and serum proteins.
Some aggregation in plasma was visible over the course of the experiment, but they retained the around
80% of their absorbance peak over the course of the first 24 hours, making them suitable NIR–absorbent for
in vivo use over this period.
DOPC – DSPE-mPEG functionalised AuNRs
The spectra associated with the DOPC – DSPE-mPEG AuNRs in each media are given in fig. 4.9. The
spectra in buffers are given at the highest concentrations tested.
No aggregation was visible in the spectra of DOPC – DSPE-mPEG in any of the buffers, in media or in
serum. The optical properties were consistent across all concentrations and time points.
Again, as with the other phospholipid–functionalised AuNRs some aggregation was displayed in mouse
plasma however and it is fairly consistent with the results seen for the other phospholipid coated AuNRs.
The intensity of the LSPR is around 80% of its initial value after 24 hours, which is still high enough to
utilise for photo–thermal therapy, suggesting they are stable enough for in vivo use.
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4.5.2 Discussion
All varieties of phospholipid–functionalised AuNRs showed higher stability than the CTAB– and PSS–
AuNRs. The DOPC functionalised AuNRs faired worse in DPBS and RPMI media, but worked similarly
well in all other cases, suggesting they should be suited to in vivo use. The DOPC – DOPG and DOPC
– DSPE–mPEG AuNRs showed similar stability in FBS and mouse plasma, with the DOPC – DSPE–
mPEG showing marginally better stability in some of the buffers, likely resulting from the additional steric
stabilisation. All three of these show potential for in vivo use.
The measured stability of CTAB – oleate AuNRs in the presence of 1 mM free CTAB is somewhat
redundant in the context of their use in theranostics, given the high toxicity of free CTAB. However
it does provide some insight into maintaining their stability in higher salinity conditions. PSS AuNRs
showed worse stability than CTAB – oleate functionalised AuNRs under a number of conditions, which
is somewhat unanticipated, as it generally reported that PSS functionalisation is used provides additional
stability alongside higher biocompatibility [134, 318]. Given the large number of publications surrounding
theranostic applications of PSS–AuNRs, they will continue to be used in this study as a reference point for
comparison as biocompatible surface functionalisation.
All coatings performed considerably worse in mouse plasma compared with FBS, this probably results
from a non–specific interaction between the AuNRs and the fibrinogen/coagulant proteins that are removed
during the processing of FBS. If it is the presence of fibrinogen and coagulant proteins that are root cause
of this increased instability, it could have important implications for the applications of nanoparticles in
in vivo applications. In order to definitely establish this though further experiments are needed observing
nanoparticles in a range of sera, plasma, and more simple protein suspensions.
In an ideal world, these stability measurements would be accompanied by additional characterisation of
corona formation during incubation in media, serum and blood plasma. This would involve the monitoring
the change in size and surface charge the particles after incubation via techniques such as dynamic light
scattering, electron microscopy, fluorescence correlation spectroscopy and measurement of the ζ–potential.
Characterisation of the population of proteins on the particles surface via methods such analytical ultra-
centrifugation, isothermal titration calorimetry, liquid chromatography – mass spectroscopy and molecular
spectroscopy (i.e. FTIR, Raman or NMR). However, resources are finite and time is limited, and these
experiments were deemed outside the feasible scope of this project.
4.6 Conclusion
In this chapter, we have demonstrated that the displacement of CTAB with a variety of phospholipids can be
achieved through repeated rounds of sonication and cleaning through centrifugation. This repeated process
appears to be more effective at removing CTAB from the surface of AuNRs than other published methods.
We have shown this through characterisation of the surface through NMR spectroscopy, surface–enhanced
Raman spectroscopy and pH–dependent ζ–potential measurements, in all cases we were unable to identify the
presence of CTAB on the surface of the phospholipid–functionalised AuNRs. The ζ–potential measurements
in particular do not show any residual positive charge from CTAB at pH values where we would expect the
AuNRs to be otherwise neutral.
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We have also shown they display superior colloidal stability compared with alternative surface coatings,
such as CTAB and PSS, in the presence of wide range of ‘biorelevant’ media, such as buffers, cell culture
media, serum and blood plasma. We have elected to focus on DOPC – DSPE-mPEG AuNRs going forward
on the basis that the additional steric stabilisation should be of benefit. Hence, in the next chapter we
proceeded to assess the potential of these as theranostic agents, by measuring their photothermal properties,
biocompatibility, cellular uptake and biodistribution in mice.
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Chapter 5
Theranostic Application of Gold
Nanoparticles
5.1 Motivation
In this chapter the potential of the particles synthesised in chapter 3 and modified with phospholipids in
chapter 4 for use in theranostics will be explored. Whilst their stability in a variety of biologically relevant
media was explored in section 4.5, a large number of other questions remain around their biocompatibility
and suitability for use as photothermal conversion agents. Here we investigate their inherent toxicity to
human colorectal cell lines and their interactions with these cells, as well as whether they induce lysis. We
also characterise the ability of these particles to generate heat under NIR illumination, their usefulness as
photoacoustic contrast agents, and the ability of these particles to induce cell death through photothermal
heating. Finally, we assess their biocompatibility in vivo and measure the biodistribution of our particles
after intravenous injection, with and without a conjugated targeting affimer.
5.2 Gold Nanorods in this Chapter
As discussed section 1.4.1 (and also shown in fig. 1.11), the optimum wavelength range for in vivo light
penetration is 650–850 nm, with the optimum contrast in multispectral optoacoustic tomography (MSOT)
being achieved between 800 and 850 nm. Hence it was decided that to utilise particles with an LSPR
maximum in this region. A 1 L batch of AuNRs were synthesised in a growth solution containing 48 mM
CTAB and 13.5 mM sodium oleate, yielding AuNRs with an LSPR maximum of 811 nm (fig. 5.1(d)). TEM
measurements gave the average dimensions of these AuNRs as (57 ± 7) nm in length with an average diameter
of (13.1 ± 1.2) nm (fig. 5.1(a)–(c)&(e)). These were then functionalised with DOPC – DSPE-mPEG (19:1),
which led to the LSPR blueshifting to 801 nm (fig. 5.1(d)). These particles were used for all experiments in
this chapter unless otherwise stated.
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Figure 5.1: Characterisation of the AuNRs used in this chapter. (a)–(c) Distribution of diameters, lengths
and aspect ratios of AuNRs based on measurements from 500 AuNRs. Dimensions are given as the median
size ± the measured standard deviation. (d) UV–vis spectra before and after functionalisation with DOPC –
DSPE-mPEG (19:1). (e) TEM image of a (425 × 425) nm region of AuNRs representative of the sample.
5.3 Biocompatibility
5.3.1 Selection of Cell Lines
For the purposes of targeting these AuNRs it was decided to use human carcinoembryogenic antigen (CEA)
as the target protein. In healthy individuals, CEA is typically only found at high levels of expression during
foetal development in the gastrointestinal (GI) tract (and also the liver to a much lesser extent) [360]. It was
first identified as a specific marker of colorectal cancer in 1965 [107], and has since become recognized
as one of the most reliable biomarkers for monitoring the treatment of colorectal cancers [378]. It is over
expressed in 90% of GI cancers, 70% of lung cancers, and 50% of breast cancers [108], and hence can be
used as a highly specific marker for use in targeting cancerous tumours.
The targeting molecule of interest was a cysteine terminated CEA–specific affimer, provided by the
Millner group1, which has been shown to be effective in targeting CEA–positive tumours in mice with silica
NPs [163, 346]. This could be conjugated to the surface of our AuNRs through simple maleimide–thiol
linker chemistry, through the replacement of DSPE-mPEG with DSPE-PEG-Maleimide in our phospholipid
surface coatings [125].
Two cell lines were selected based on reports in the literature, LS174T, a human colorectal adeno-
carcinoma (Dukes’ type B) and SW620, a human colorectal adenocarcinoma (derived from a metasta-
sis) (Dukes’ type B). CEA has been widely reported in the literature to be over expressed by LS174T
[114, 136, 319, 345, 346]. By comparison SW620 has been reported to only produce minimal levels
1School of Biological Sciences, University of Leeds
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Figure 5.2: In vitro cell viabilities of SW620, HEK293, HCT116 and LS174T cells after 24 hours incubation
with AuNRs. Cells incubated with increasing concentrations of (a) PSS–AuNRs and (b) DOPC – DSPE-
mPEG (19:1) coated AuNRs. Results are expressed as a percentage of the control plates (0 µg·ml−1))
and is the mean result from three plates at different passage numbers. Results are fitted with a Hill-type
dose–response curve.
[136, 285, 319]. This was confirmed experimentally by our collaborators in the Leeds Institute for Medical
Research by flow cytometry and immunofluorescence staining (data not shown). Hence going forward
LS174T was selected as our CEA–positive cell line and SW620 as our negative control.
5.3.2 In Vitro Toxicity
Based on the cell–lines identified in the previous subsection; the cytotoxicity of the DOPC – DSPE-
mPEG functionalised AuNRs was assessed on four cell lines; three CEA–negative (SW620 colorectal
adenocarcinoma, HEK293 embryonic kidney, HCT116 colorectal adenocarcinoma) and one CEA–positive
(LS174T colorectal adenocarcinoma).
The toxicities for phospholipid–functionalised AuNRs in the literature are limited to two studies, the
first in HeLa cells using phosphatidylcholine–functionalised AuNRs up to concentrations of 2.9 µg·ml−1
and reported 20% cell death (although this is likely due to high residual levels of CTAB) [339]. The second
using DMPC–functionalised AuNRs measured cell viabilities up to 20 µg·ml−1 in MCF–7 and HMEC–1
cells, with no drop off in viability [304]. Neither of these are particularly high doses and the IC50 was not
reported in either case. Hence the upper limit to the cytotoxicity of these particles, whilst expected to be
significantly lower than CTAB–functionalised AuNRs, remains an open question. An extremely high upper
concentration of 200 µg·ml−1 was decided upon hoping that the IC50 could be determined. Viabilities were
compared with those seen for PSS–functionalised AuNRs, due to their ubiquity in the literature and the
relative ease of preparation. PSS–coated NPs typically present IC50 values in in vitro cell studies between 1
and 100 µg·ml−1 [196, 278, 289, 393], the values are highly variable between cell lines, hence assays had to
be performed for each potential cell–line under consideration to provide a direct comparison.
The results of the cell viability assays are presented in fig. 5.2. In all cases, the DOPC – DSPE-mPEG–
coated AuNRs showed higher viabilities than their PSS–coated equivalents. For three cell lines, SW620,
HCT116 and LS174T, the IC50 could not be determined as ∼100% cell viability was seen even at the highest
dose. HEK293 cells showed some toxicity, reaching 50% viability at (55 ± 1) µg·ml−1, by comparison when
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treated with PSS–AuNRs this dose was found to be (4 ± 1) µg·ml−1. The IC50 for the SW620, HCT116 and
LS174T cells treated with PSS–AuNRs were (102 ± 1), (186 ± 1), and (81 ± 1) µg·ml−1 respectively.
Hence these particles appear to be highly biocompatible and are safe for use at the concentrations we
expect to achieve in vivo.
5.3.3 Cellular Uptake
One potential concern that remained after these assays was that the higher viabilities may arise through a
lack–of–uptake by the cells. If the particles were not interacting with the cells at all and sitting inertly in the
surrounding media then we would expect higher viabilities through this alone. Qualitative concentration–
dependent studies of the uptake by colorectal cells. This was undertaken twofold firstly, by optical microscopy
using darkfield and differential interference contrast (DIC) techniques (fig. 5.3) and secondly through electron
microscopy imaging of sections taken through the cells. Due to time restraints, only a single cell–line was
investigated, SW620, it seems reasonable to assume similar interactions in all cell lines.
Cells were incubated in media containing AuNRs at concentrations between 0 and 200 µg·ml−1 for 24
hours (i.e. spanning the range of concentrations and incubation period used in the viability assays above).
And the cell fixed and embedded in mounting medium. The resultant darkfield and DIC images are show in
fig. 5.3. Not much uptake can be seen at 0.32 µg·ml−1 and below. At 1.6 µg·ml−1 a small number of green
spots can be seen inside the cells in the darkfield image. At the higher concentration increasing amounts
of these bright spots can be seen inside the cells. The amount of bright objects inside the cells correlates
strongly with the particle concentration (this method is not quantitative however). The positions of these
also correlate with what appear to be small ‘ball–like’ objects in the DIC images. Hence, these signals have
been attributed to uptake of particles by the cells. Curiously, at 200 µg·ml−1, huge numbers of AuNRs seem
to be being up taken by the cells, with no noticeable impact on the functioning of the cells visible in the
viability assays above. This would seem to suggest that these coatings are inherently biocompatible and
support the conclusions from chapter 4 that the CTAB concentration in the particles has been reduced to only
trace levels.
However, some problems are evident from these figures. We know from the darkfield experiments in
chapter 3 that the colour of scattered light from these AuNRs is red (fig. 3.11). The spots visible at 1.6
and 8 µg·ml−1 are green and at higher concentrations a variety of colours are visible. These colours are
more consistent with that expected for AuNR aggregates due to plasmonic coupling between many particles.
Based on the observed stability in serum–enriched CCM in section 4.5, this aggregation is unlikely to be
occurring outside of the cells and intracellular aggregation is the most likely cause of this. This is extremely
problematic to their potential use in photothermal therapy as it renders the optical properties of these particles
useless for this purpose.
To complement this, it was decided to use electron microscopy to investigate what the state of the AuNRs
in the intracellular environment. Pellets of the SW620 cells incubated with AuNRs for 4 hours were prepared
for imaging, by fixing, embedding in resin, and microtoming. Two example images are given in fig. 5.4,
showing AuNRs that had been up–taken into cells. No AuNRs were observed in isolation and in the lower
figure a relatively large cluster was observed. Only a limited number of images of the AuNRs inside cells
were able to be acquired in the time available, so the conclusions that can be drawn from these images are
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5. Theranostic Application of Gold Nanoparticles
Figure 5.4: TEM micrographs of cell sections containing endocytosed AuNRs. Cells were incubated with
DOPC – DSPE-mPEG AuNRs for four hours, before fixing, embedding in resin, and sectioning. Cells were
stained with osmium tetroxide and uranyl acetate for contrast.
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D O P C  -  D S P E - m P E G
Figure 5.5: Measured haemolysis frac-
tions for DOPC – DSPE-mPEG (19:1),
PSS and CTAB – oleate functionalised
AuNRs at 100 µg·ml−1 and 20 µg·ml−1.
The lysis values for the supernatant ex-
tracted from 100 µg·ml−1 AuNRs is also
presented.
limited, but these images would seem to support the case that intracellular aggregation is being observed.
Based on the staining of the cells it would appear that these particles are also contained within endosomes,
suggesting uptake through endocytosis, which is consistent with what is expected for NPs of this size.
5.3.4 Haemolysis
Another concern relating to the use of nanoparticles in vivo is that of haemolysis, the rupture or destruction
of red blood cells. Free CTAB being a positively charged amphiphile can disrupt the negatively charged
membrane of red blood cells (or any other cell) inducing haemolysis [191]. This membrane disruption is
one of the primary mechanisms by which CTAB is toxic. Hence a sensible prerequisite of in vivo testing
of AuNRs of any novel surface functionalisation is that of haemolysis testing. Particles were tested at 100
µg·ml−1 and 20 µg·ml−1. The presence of free CTAB is a primary concern, hence the supernatant of the 100
µg·ml−1 concentrations of each functionalisation were also tested. If these came back at similar values to
the 100 µg·ml−1 AuNR samples, the supernatant itself could be concluded to be the cause of any observed
haemolysis (this was not observed to be the case for the PSS and DOPC – DSPE-mPEG AuNRs).
It was found that the absorbance from the transverse mode prevented accurate calculation of the lysis
fraction at 540 nm, the wavelength typically used for these assays. instead the Soret band at 420 nm was
used. This solution has also been implemented for other AuNP haemolysis assays elsewhere in the literature
(i.e. ref. [191]).
The haemolysis assay showed lysis fractions below 10 % for all DOPC – DSPE-mPEG AuNR con-
centrations. The PSS AuNRs showed higher lysis values, but were relatively low. Where as the CTAB
functionalised AuNRs showed very high lysis values above 75% at 100 µg·ml−1, and 40% for the 20 µg·ml−1
case, as well as the supernatant. Hence functionalisation with PSS and phospholipids has significantly
improved the in vivo toxicity of the AuNRs, with the phospholipid–functionalised AuNRs performing better
at higher doses. This is consistent with the cytotoxicity data collected above.
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Figure 5.6: (a) – (e) Temperature profiles of 200 µl AuNR solutions (5 to 200 µg·ml−1) heated at by CW
laser irradiation at the LSPR (811 nm) for 10 min at a variety of intensities: (a) 0.32 W·cm−2, (b) 0.5
W·cm−2, (c) 1 W·cm−2, (d) 2 W·cm−2, (e) 3 W·cm−2. The legend in (b) applies to figures (a) – (e). (f)
Max temperature as a function of Au0 concentration. The maximum temperature achievable plateaus as the
nanoparticles effectively absorb all light incident on the sample at concentrations above ∼50 µg·ml−1.
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Figure 5.7: (a) Heating profile of a sample heated to increasingly high temperatures in 5°C increments.
The time required to achieve this are given in the legend; the time required increases asymptotically as ∆T
approaches 35.3°C. (b) ∆Tmax at 200 µg·ml−1 as a function of laser intensity. The data is fitted with an
exponential association curve. Increasing heat losses to the environment at higher ∆T result in the curve
saturating at ∼64°C. All measurements were taken at a background temperature of 37°C
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5.4 Photothermal Heating with AuNRs
To confirm that the prepared phospholipid–functionalised AuNRs could generate suitable temperatures to
induce cell death, preparatory studies measuring the temperature increase of the AuNRs under continuous–
wave illumination were performed. Measurements were carried out on a bespoke experimental rig assembled
with the express purpose of monitoring the effects of photothermal heat generation by plasmonic nanoparticles
on cells. Samples were prepared on a 96–well plate in 200 µL aliquots and temperatures measured by directly
placing a thermocouple into the well. Neighbouring wells to those containing samples were left empty
to provide better thermal insulation, and minimise the rate of heat flow out of the illuminated well (and
simultaneously prevent indirect heating of other sample–containing wells). All measurements were taken at
a background temperature of 37°C.
Figure 5.6(a)–(e) shows the temperature response of colloidal AuNR solutions ranging in concentration
between 0 and 200 µg·ml−1 at light intensities between 0.32 W·cm−2 and 3 W·cm−2. The maximum
temperature observed at each laser intensity as a function of concentration is summarised in fig. 5.6(f).
Illustrated in fig. 1.12 are the effects of increased temperatures on human tissue, it can be seen that
an increase in temperature of +10°C is required in order to achieve cell death over short exposure times.
Higher temperatures are far more effective at achieving cell death with +23°C providing energy to induce
instantaneous protein coagulation resulting in incredibly rapid cell death.
Hence, by comparison an increase in temperature of +9°C is achievable at 0.32 W·cm−2 at concentrations
of above 50 µg·ml−1, which close to the lower threshold for inducing cell death. 0.32 W·cm−2 is significant
because the maximum permissible exposure (MPE) at 811 nm with a CW source, hence in an ideal world it
would not be exceeded. However, 50 µg·ml−1 is a concentration that could not be realistically achieved in
vivo without resorting to intratumoural injections. Beyond this the heating in this set-up is occurring in an
idealised set–up, it is not limited by the high attenuation of human tissue (i.e. this is the temperature increase
we could achieve at the skin surface). Under these conditions a +9°C increase is not large enough, regardless
of the high concentration required to achieve it.
If the MPE is ignored, on the justification that the small amount of potential collateral damage that
could occur due to the beam is a worthwhile price for the potential therapeutic benefits of the treatment, the
higher beam powers do offer temperature increases which look significantly more promising. For instance
at 1 W·cm−2, a +10°C can be achieved at 5 µg·ml−1 and a +23°C increase at 20 µg·ml−1. At 2 W·cm−2,
+23°C is achievable at 5 µg·ml−1. At these higher powers the temperature increases even at relatively low
concentrations are high enough that they would be therapeutically relevant. The fact that we have to exceed
the MPE to achieve these however is problematic. However, considering the large collateral damage that
is associated with with treatment via current generation chemotherapeutic agents, a cost–benefit argument
would be relatively easy to present to justify using such beam powers. The potential damage to tissue at
these powers is not particularly severe compared with the potential benefits of cancer therapy. Alternatively,
other laser sources could be utilised such as nanosecond pulsed lasers which use much lower total fluences
to generate highly–localised high–temperature transient heating around the nanoparticle. Although these
have not been explored here due to time constraints, but are of considerable interest.
The heat profiles of each curve can reliably be recreated, and heating to desired max temperature will
consistently produce a curve which matches the shape of the initial shape of the heating response (fig. 5.7(a)).
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The time required to achieve a particle temperature increases asymptotically as the temperature increase
approaches the saturation value.
Finally, the limitations of the experimental set–up can be seen. Heat losses to the environment become
increasingly dominant at higher values of ∆T , leading to a maximum realisable value of ∆T . Plotting the
maximum temperature achieved at the highest concentrations of AuNRs as function of laser intensity reveals
that the highest value of ∆T we can achieve is ∼64°C (fig. 5.7(b)). Increasing ∆T beyond this would require
better thermal isolation of the illuminated site, although this would not offer any significant insight into the
therapeutic potential our AuNRs.
We can also compare our observed heating rates with those predicted in section 1.3.2, where an estimate
of the initial heating rate (i.e. with minimal losses to the environment) of 2.4 °C·s−1 was calculated based
on FEM simulations of the extinction cross-section of a AuNR with an LSPR of 800 nm under 1 W·cm−1
illumination. The equivalent case here (∼75 µg·, 1 W·cm−1) has an initial heating rate of 0.8 °C·s−1. The
calculations are likely overestimating, because they (a) assume a perfectly monodisperse sample (i.e. all
AuNRs are perfectly matched to the excitation wavelength) and (b) the FEM simulations fail to account for
plasmonic damping effects such as electron–surface scattering. The numbers are relatively close however,
suggesting that inclusion of these factors would likely bring them into closer agreement.
5.4.1 Thermal Stability Under CW Illumination
A commonly raised concern about the potential of AuNRs as therapeutic agents is that of thermal stability.
This is not an unjustified concern, however the nature of problem is seems to be misunderstood in the
literature. For instance a number of publications have offered the ‘low thermal stability’ of nanorods as
a reason to utilise other novel NIR–absorbing nanomaterials, whilst using a continuous–wave lasers to
demonstrate the ‘higher’ stability of such materials (for example refs. [27] and [49]). This seems to stem
from a misunderstanding of the nature of the heating generated by continuous wave lasers versus that of
nanosecond–pulse lasers. The maximum local temperature increase achieved under continuous–wave heating
is significantly lower than that achieved under pulsed illumination.
Calculated solutions the heating of single nanorods under typical continuous wave and nanosecond
pulsed illumination conditions are presented in fig. 1.10. Continuous–wave illumination will result in bulk
heating and can achieve macroscopic increases in temperature of several 10°C, but it is very difficult to
achieve temperatures that will cause rapid reshaping of AuNRs. By comparison, individual AuNRs are
expected to instantaneously achieve temperatures well in excess of 300°C under a typical pulse from a
nanosecond–pulsed laser (see fig. 1.10 & ref. [279]). This is not in excess of the melting point of Au, but
will provide sufficient energy to atoms to enable significant migration of atoms from the AuNR tips towards
the centre of the rod, lowering the aspect ratio [341]. Hence, a relatively short train of pulses is capable
of reducing the maximum LSPR wavelength below that of the illumination source, significantly reducing
photothermal efficiency.
Both regimes present opportunities, the higher temperatures achievable with nanosecond–pulsed lasers,
offer much more efficient photothermal killing, the high temperatures will instantaneously denature proteins,
and can potentially induce cavitation, providing mechanical stress, which is even more effective at damaging
cells. But this comes with the potential downside of photothermal reshaping and the higher cost of Nd:YAG
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Figure 5.8: (a) Heating curves of 200 µL 75 µg·mL AuNR solution illuminated at its LSPR maximum (801
nm) in repeated cycles. Cycles consisted of 10 minute of laser exposure at 1 W·cm−2, followed by 20 minutes
of cooling (no laser exposure). 30 minutes sections corresponding to each heating cycle have been overlaid.
Dashed lines mark every 20 cycles. (b) The maximum temperature achieved as a function of cycle number,
it can be seen to decrease roughly linearly with time. (c) UV-vis spectrum before and after laser exposure,
the extinction at the laser illumination wavelength for each spectrum have been marked.
laser systems. At typical fluences continuous–wave lasers do not face this issue, but they require significantly
longer periods of exposure and high concentrations of AuNRs to achieve temperatures likely the induce
the death of surrounding cells. Non–tunable continuous wave sources are significantly cheaper that the
nanosecond–pulsed systems typically used in these applications. At higher fluences (12 W·cm−2), it has been
reported that CW illumination can induce significant thermal reshaping [121].
No discernible change in the optical properties of the AuNRs was observed during the experiments
performed in fig. 5.6, the resultant spectra from the 75 µg·ml−1 after illumination at each laser intensity are
given in fig. 5.8(a). To further test the stability of our particles under repeated CW photothermal heating
the LSPR resonance and measuring the maximum temperature increase over time. A 200 µL solution was
sealed airtight inside a single well of a 96–well plate at 37°C and then heated in cycles of 10 minutes at
1 W·cm−2 laser exposure followed by 20 minutes unilluminated. To demonstrate that degradation of the
optical properties under CW illumination is not a concern, this was tested to excess and allowed to run over
the course of 3.5 days (∼160 cycles). The resultant temperature responses have been compiled in fig. 5.8(b).
Over the course of this time period a reduction in ∆Tmax was visible, reducing from ∆Tmax = 35°C to ∆Tmax
= 25 °C (fig. 5.8(c)). This this drop was achieved over a cumulative total illumination time of 26 h 40 m,
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well in excess of what would be used in treatment. This represents an average drop of 0.06°C per cycle,
which is negligible. Inspection of the spectra of the AuNRs before and after these photothermal heating
cycles showed a drop in the LSPR intensity and blueshift in the peak position (fig. 5.8(c)). There was a drop
in absorbance at the laser wavelength of ∼29% (consistent with the drop in ∆Tmax of ∼26%). The change
in the shape of the spectrum is consistent with that seen for reshaping of AuNRs when heated in solution
due to surface migration of atoms [247, 341, 411], as compared to the highly selective reshaping of AuNRs
resonant close to the laser wavelength seen under high intensity pulsed systems [110, 174].
Hence it seems that these particles show good thermal stability under CW illumination and this should
not be considered a concern going forward. Their stability under pulsed illumination is another matter and is
discussed further in the next section.
5.5 Photoacoustics
AuNRs represent some of the most promising agents for use in photoacoustics, the combination of large
absorbance crosssections (which are tunable and spectrally narrow) as well as their extremely high photother-
mal conversion efficiency, meaning that they are well suited as targets which produce a large signal and can
be spectrally deconvoluted with relative ease. The theory behind signal generation is well understood and
the existing challenges surrounding their use lie largely in problems surrounding maintaining their stability
in vivo and the thermal stability of AuNRs under the high peak powers seen during nanosecond–pulsed
illumination [382].
With regards to the thermal stability of AuNRs, in many ways AuNRs are victims of their own success,
the very properties which make them appealing; the large absorbance crosssections and high efficiencies of
heat generation, leads to the generation of temperatures high enough to induce thermal reshaping. Smaller
diameter AuNRs (similar in dimensions to the ones used here) with their higher surface–to–volume ratios
and lower heat generation per NP have been reported to be less likely to undergo thermal reshaping than
larger AuNRs [51, 173]. The only reported study on the thermal stability of phospholipid–functionalised
AuNRs, observed minimal reshaping of phosphatidylcholine–capped AuNRs of similar dimensions to those
utilised here under 10 Hz pulsed nanosecond illumination at 127 mJ·cm−2 over the course of several minutes
[127]. Hence whilst this is a commonly reported problem, it was not clear whether this would be an issue
that would affect our particles.
As an initial proof of concept, AuNRs were synthesised with LSPR maxima approximately 100 nm apart
(630 nm, 750 nm, 847 nm and 935 nm) across the tunable range of the laser source (680 – 950 nm) and their
photoacoustic response measured as a function of illumination wavelength. The samples were placed in an
agar phantom to replicate the expected illumination condition in vivo and measured using a pre–clinical
MSOT imaging system. The photoacoustic (PA) response is expected to scale linearly with the absorbance
of the sample (eq. (1.24)), hence the measured PA response should correlate strongly with the absorbance
spectrum of the sample. However the sensitivity of the system to individual absorbers components is limited
by the surrounding components. In particular the absorbance of water increases substantially between
850 and 980 nm, hence samples which display similar increasing absorbance in this region are difficult to
deconvolute from the water signal. There is a large amount of water in the system, the phantom is suspended
in a water bath (enabling acoustic transmission), the agar phantom is self is ∼96% water by weight and the
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Figure 5.9: (a) UV–vis extinction spectra of AuNRs with a resonances at 630 nm, 750 nm, 850 nm and
935 nm. Samples were diluted to have an absorbance of 5 at their LSPR maximum. AuNR spectra are
normalised to their maximum extinction in the range 680–950 nm. Also plotted is the absorbance spectra of
H2O (right axis), showing the increasing absorbance from 850 nm to 950 nm. Absorbance values for water
taken from ref. [270]. (b) Photoacoustic spectra, as determined from MSOT images reconstructed using a
back projection algorithm. PA intensity values were calculated by averaging the intensity of the top 5% of
pixels in the region of interest (3 mm circle placed over the position of the sample). Spectra were corrected
by subtracting the PA response of the water control from that of the AuNR suspensions and normalised to
the maximum PA intensity in the range 680–950 nm. The PA spectra show good qualitative similarity to the
UV–vis spectra below 850 nm. At higher wavelengths the increasing absorbance of water (and hence that in
the surrounding water bath) reduces the intensity of light reaching the sample and hence suppresses the PA
signal, leading the spectra above 850 nm to become increasingly unreliable.
AuNRs themselves are suspended in water. This all contributes to a large increases in light attenuation before
it reaches the sample (reducing the intensity of the PA signal), and creates a much stronger background
PA signal. Hence samples which display an absorbance below 850 nm are optimal for use within these
phantoms.
In vivo there are additional absorbance signals which need to be considered such as haemoglobin (Hb),
oxyhaemoglobin (HbO2), melanin and fat. At typical in vivo concentrations these components combined
these have a minimum absorbance in the visible–NIR at ∼800 nm (see fig. 1.11). Hence PA contrast agents
which absorb here can be more easily deconvoluted from Hb, HbO2 and H2O, and thus typically present the
best contrast in reconstructions.
The UV-vis and recorded PA spectra are presented in fig. 5.11(a)&(b). It can be seen that all four
spectra correlate relatively strongly below 850 nm, consistent with what is stated above. Above 900 nm
it becomes apparent that the spectra have become more unreliable, as it becomes increasingly difficult to
distinguish between the sample and background H2O signal. This is particularly apparent in the λLS PR = 935
nm spectrum, which presents an apparent maximum closer to 890–900 nm in its PA spectrum. Regardless of
this, it is relatively easily to distinguish between the spectra of each set of AuNRs and clearly demonstrates
that these particles are suitable PA conversion agents.
To optimise the AuNRs for use in vivo, it was decided to work as close to 800 nm as possible. Hence,
the AuNRs described above in section 5.2 were used going forward (λLSPR = 801 nm after phospholipid
exchange). In order to find the required AuNR concentrations to reliably image them in vivo, AuNR phantoms
were measured at a variety of concentrations between 0.32 µg·ml−1 and 1000 µg·ml−1. Five spectral runs
were taken on the samples at a single position in the phantom. The reconstructed PA intensity maps recorded
by the MSOT scanner are given in fig. 5.10 and the spectra reconstructed from these scans are given in
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Figure 5.10: MSOT intensity maps of a single plane through an agar phantom containing a variety of
AuNR concentrations. Images were reconstructed using a linear reconstruction algorithm which calculated
the spatial distribution of the AuNR solution based on an extinction spectrum measured using a UV-vis
spectrometer. The reconstructions have been cropped to the region of interest around the AuNR solution;
an example of a non–cropped image is give in fig. 2.7. Each row consists of a single measurement, with 5
repeats measured in series (displayed left to right). The linear regression algorithm struggles to reconstruction
the sample distribution at lower concentrations, which is evident from the signal visible in the background of
the 1.37, 4.11, and 12.33 µg·ml−1 images. For concentrations of 111 µg·ml−1 and above, it is evident that
light is no longer penetrating the interior of the sample, leading to a ring of single from the surface particles
which are effectively screening the interior AuNRs. There is also a noticeable drop off in intensity after the
first measurement for all concentrations below 37 µg·ml−1 indicating that the spectral properties of the probe
have changed (i.e the AuNRs have thermally reshaped).
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Figure 5.11: (a) Photoacoustic spectra, as determined from MSOT images reconstructed using a back
projection algorithm. PA intensity values were calculated by averaging the intensity of the top 5% of pixels
the region of interest (3 mm circle placed over the position of the sample). The values shown are those
obtained during the first of the five runs show in fig. 5.10. (b) Comparison of the photoacoustic spectra
obtained for the 37 µg·ml−1 concentration and the UV-vis of the sample prior to laser exposure. (c) UV–vis
spectra of samples before and after being exposed to the laser source inside the MSOT scanner for the images
give in fig. 5.10. Lower concentration samples clearly undergo thermal reshaping. Gray lines indicate the
wavelengths used to measure the photoacoustic response of the particles. (d) The maximum pixel intensity
measured by the MSOT as a function of AuNR concentration. Samples were prepared by serial dilution from
1000 µg·ml−1. Fitted with a linear function below ∼360 µg·ml−1 (with an assumed maximum achievable PA
intensity value of 3500 a.u.). Inset is the same data plotted using a logarithmic x–axis.
fig. 5.11(a). In the spectra it can be see for the 333 and 1000 µg·ml−1 samples, the intensity of the PA
response has begun to become increasingly saturated, leading to the top of the spectral response of the
particles to become flattened. This saturation could be attributed to either complete absorption of all incident
light by the sample, or the reaching the peak negative pressure of the transducers in the system. The former
seems more likely based on the reconstructions seen in fig. 5.10, which show minimal signal generation
inside the the phantom, suggesting complete absorption of the light at the surface of the phantom.
The spectral response of the 111 µg·ml−1 phantom correlates very strongly with the UV–vis spectrum
fig. 5.11(b), however below this the correlation becomes increasingly weak. The spectra of the 37 µg·ml−1
phantom has a blue–shifted peak, this is presumed to result from thermal reshaping. The wavelength of
the laser source was swept from 660 to 960 nm, hence reshaping could occur below the LSPR maximum,
reducing the PA intensity at the original LSPR once the laser had been tuned to it, leading to a reduced signal
and a apparent blueshift in the maximum PA intensity.
Below 37 µg·ml−1 it was not possible to clearly distinguish the spectrum of the AuNRs, this also attributed
to thermal reshaping at lower wavelengths. This is supported by UV–vis spectra taken of the samples after
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measurement on the MSOT imaging system (fig. 5.11(c)), which show significant reduction in the absorbance
of the particles over the wavelength range of the laser exposure. There is also a noticeable increase in the
absorbance between 600 and 660 nm consistent with the observed reshaping behaviour of AuNRs under
high intensity pulsed lasers [110, 174, 207, 208]
Some reshaping can be inferred from the 111 µg·ml−1 spectrum, by the increased absorbance below
680 nm and reduced intensity of the LSPR maximum. These features are not present in the spectra of
concentrations above this, and there was no reduction in the strength of the PA signal in later scans, leads to
the conclusion that they do not appear to undergo significant reshaping. It is unclear whether this results
from any reshaped AuNRs making up a very small proportion of the total population of AuNRs or the higher
concentrations somehow providing a shielding effect. The potential benefits of this are quite limited, given
that such particle concentrations cannot be achieved in vivo without intratumoural injections.
The reshaping can be seen more clearly through inspection of the reconstructed images of the AuNR
PA signal distribution shown in fig. 5.9, in it can be seen that the AuNR signal intensity drops dramatically
after the second spectral scan for concentrations below 37 µg·ml−1. Reconstructions are generated based on
spectral data for the AuNRs obtained by UV–vis prior to the measurement, which enables the response of the
particles to be deconvoluted from the background signal. However the change in spectral properties caused
by thermal reshaping is preventing the reconstruction algorithm from being able to identify their presence,
meaning the spatial distribution cannot be reliably reconstructed. Equally the signal from the 1.37 µg·ml−1
phantom was so weak that it could not reliably be reconstructed, leading to the system presenting a near
meaningless intensity profile.
At higher concentrations, light cannot penetrate the centre of the sample leading to the reconstructed
image resembling a ring. The width of this ring decreases with increasing concentration as the penetration
depth of incident light is further reduced. Hence any heating is confined to relatively narrow shell around
the outside of the sample, which could potentially leave only a relatively small fraction of the sample to
thermally reshape. If this is occurring it is not evident in the post–MSOT UV-vis spectrum though.
It was planned that further studies of the AuNRs in the MSOT imaging system would be performed,
however technical issues with the system prevented further measurements, including its use for in vivo
measurements, alongside time restrictions. It was also planned that these additional measurements would be
supported by TEM images of the particles post–exposure, but these were prevented by the same technical
difficulties and hence this dataset does not exist.
The PA signal intensity is expected to scale linearly with concentration up to a saturation value at which
all light incident on the sample is absorbed. The short duration of the laser pulses here and the small
length scales involved in heating, means that macroscopic heat flow out of the system can be assumed to be
negligible1. Hence, the concentration dependence of the heat–generation–per–pulse (and hence PA signal
intensity) is described by a linear function up to some saturation value fig. 5.11, unlike the exponential
association function used to describe the CW heating above (fig. 5.7(f)).
The fact that these particles reshape under pulsed illumination presents another major hurdle, which will
remain unaddressed by this thesis due to time restraints. As stated earlier this problem was not unanticipated,
and has been widely recognized in the literature [51, 341, 351], although it was unclear whether it would
1The width of the generated pulse is defined by the stress relaxation time and is typically ∼1 µs (see section 1.4.3), hence the
thermal diffusion length can be calculated as dth = 2
√
αt ∼0.7 µm. Hence macroscopic transfer of heat generated by the particles to the
environment during pulse generation will be negligible.
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be the case for the particles used here. The fluences observed inside phantoms are also likely to be higher
than those achieved in vivo, where tissue is likely be more attenuating, as the phantoms only replicate the
scattering seen in tissue, but not the absorbance. Hence, these AuNRs may still be usable in vivo.
The solution to preventing reshaping that has gained most traction is the use of silica coating to prevent
thermal reshaping of AuNPs during PA imaging or photothermal therapy utilising pulsed lasers [31, 53, 59,
60, 157, 216, 382]. If the silica layer is made thick enough it also offers the potential benefit of preventing
plasmonic coupling between particles that have undergone aggregation [62]. This represents a potential
avenue for future work as these phospholipid coatings will readily bind to the silica surfaces, enabling any
benefits of them to still be realised.
5.6 In vitro Photothermal Studies
The bespoke rig used in section 5.4 for solution heating was deployed here to measure the effects of laser
ablation on colorectal cells prepared in a 96–well plate. No temperature monitoring was performed during
these assays, as introducing a thermocouple into the media would undermine the sterility of the plate. A
thermal imaging camera was an alternative option, but 96–well plates are not transparent at the wavelengths
that such cameras use. Hence, any temperatures recorded by such devices are the external temperature of the
plate, not temperature of the well itself, hence the information garnered is not particularly useful other than
confirming heating is occurring (which can be fairly reliably assumed).
As an initial experiment was performed to demonstrate that laser exposure at 801 nm (the LSPR maxima
of the AuNRs to be used) was not detrimental to the cells. SW620 cells were plated in 96–well plates and
exposed to light at maximum achievable laser intensity from our laser source, for times between 0 and 10
minutes. The intensity was 3.85 W·cm−2, which is 12 times higher than the MPE. Each exposure time was
repeated across six wells and the viability measured by the CCK–8 assay was expressed as a percentage of
that of the control.
No drop in viability was seen at any exposure time (fig. 5.12 hence the background effect of irradiating
the cells at this laser intensity or below were deemed to have no effect on cells in vitro. The expected
heating should come entirely from RPMI 1640 CCM, the most absorbing component of which at 801 nm is
water. Figure 5.6 shows that we only expect a temperature increase of ∼4°C in the absence of AuNRs at this
intensity, which is consistent with the observed lack of cell death.
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Figure 5.12: Viability of SW620 exposed to 3.85
W·cm−2 CW laser light at 801 nm (maximum output
power). Experiments were performed in the absence
of AuNRs to demonstrate no negative effects on cell
viability due to laser exposure. The background
temperature was maintained at 37°C during laser
exposure.
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Figure 5.13: Viabilities of SW620 cells exposed to 1 W·cm−2 CW laser light. Cells were incubated with
40 µg·ml−1 for 4 hours before illumination. (a) shows cell viabilities if the media is replaced with fresh
RPMI 1640 CCM and (b) shows cell viabilities with the original AuNR–enriched media still present (i.e.
non–internalised AuNRs are still in solution). Both figures are calculated from the results of separate assays
repeated in triplicate. All viabilities are expressed as a percentage of the control (i.e. cells that received no
Au and no laser exposure).
5.6.1 Cells Incubated With AuNRs
It was decided to proceed to testing photothermal ablation of cells using of AuNRs. Cells were incubated
with AuNRs for four hours prior to illumination. In order to slightly more closely match the uptake conditions
we expect in vivo. The media was removed, the cells washed with PBS and the media replaced after four
hours of incubation prior to the laser exposure, removing free AuNRs in solution, and relying only on the
particles that had been endocytosised by the cells.
At the MPE (0.32 W·cm−2) no cell death was observed (results not shown). It was thus decided to repeat
the experiment at an increased laser intensity of 1 W·cm−2, the resultant assay is shown in fig. 5.13(a). Again,
no cell death was observed for any exposure time.
As an initial demonstration that the heat generation from AuNRs at this concentration and laser intensity
could induce cell death. The entire experiment was repeated without replacing the media prior to laser
exposure. The results of this assay are shown in fig. 5.13(b). A reduction in viability to 80 % is seen after 1
minute of exposure and is reduced to with error of 0% after 5 minutes. The lack of cell death seen above
therefore does not seem to emanating from aggregation in solution induced as a result of an unforeseen
interaction by the cells.
Two probable explanations for the issues seen have been postulated:
1. Cells are not being incubated long enough for significant AuNR uptake to occur.
2. The particles are undergoing intracellular aggregation (loss of optical properties).
To eliminate incubation time as a cause, another photothermal viability assay was run, this time varying the
incubation time after the addition of AuNR enriched media. The laser power was also increased to 2 W·cm−2
to increase the chances of observing cell death. The results of this assay are presented in fig. 5.14. Again
all viabilities are within error of (or above) 100%, based on the darkfield images presented in fig. 5.3, it
can reasonably be concluded that limited uptake is not the problem causing the lack of observed cell death.
Ideally this data would be supported by a more quantitative measurement of AuNR uptake, such as ICP–MS
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Figure 5.14: Viabilities of SW620 cells exposed to 2 W·cm−2 CW laser light for 5 minutes. Cells were
incubated with 40 µg·ml−1 for varying amounts of time. Cell viabilities are expressed as a percentage of the
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Figure 5.15: Photothermal viability assay of SW620 cells treated using a Nd:YAG nanosecond–pulsed laser.
Cells were incubated with 40 µg·ml−1 for 4 hours prior to the AuNR–containing media being removed, the
cells washed with DPBS and supplied with fresh non-AuNR containing media. The cells were then exposed
to the laser tuned to 800 nm, with a pulse fluence of 13 mJ·cm−2 and repetition of 10 Hz for between 0 and
60 seconds. Cell viabilities were expressed as a percentage of the control. Only the results from a single well
plate are presented.
which have been performed elsewhere (i.e. ref [262]), but this was not feasible within the limited time frame
available at the end of this project.
As discussed in section 5.3.3, the green colour of the AuNRs located within cells is suggestive of
intracellular aggregation, this is the most likely cause of the lack of cell death. It would seem that particles
are entering the cell through endocytosis, aggregating into clusters within cytosomes, resulting in the
complete loss of the longitudinal LSPR required to generate heat from our NIR laser source. In a final
attempt to induce cell death through photothermal ablation, an alternative nanosecond–pulsed Nd:YAG OPO
laser located within the McLaughlan group lab1 was utilised. As has already been discussed, these lasers
enable much higher temperatures to be achieved in a volume highly localised to the AuNRs. Hence, such
lasers should be able to induce cell death if the AuNRs are absorbent in the NIR.
1School of Electronic and Electrical Engineering, University of Leeds
127
5. Theranostic Application of Gold Nanoparticles
The assays in fig. 5.13(a) were repeated with the new laser source. A pulse fluence of 13 mJ·cm−2 was
selected as this has been shown to induce cell death in other viability assays on this system [174, 393]. Cells
were incubated with AuNRs at 40 µg·ml−1 for 4 hours, before removal of the media, washing with DPBS
and addition of fresh AuNR–free media. Samples were exposed to the laser between 0 and 60 seconds (up to
600 pulses and 7.8 J·cm2 total fluence). No decreases in viability was observed as a result of any length of
exposure, suggesting that AuNRs up taken by the cells are no longer absorbent in the NIR.
These results are pretty devastating for the potential of AuNRs functionalised with DOPC – DSPE-mPEG
(19:1) alone to be used a photothermal agents. It is not as if the particles incapable of generating the heat
required to kill cells as is evident from fig. 5.14(b), and it is also apparent the particles are being up taken by
the cells based on the darkfield images in fig. 5.3 and the EM images in fig. 5.4. Hence the most reasonable
explanation is that of intracellular aggregation, which seems to be largely unavoidable with the current
particles. A new strategy will be required in order to make such phospholipid coatings a viable option, such
as pre–coating with silica to prevent plasmonic coupling if intracellular aggregation was to occur.
5.7 Murine Models
Murine models were used to assess the in vivo toxicity, and the efficacy of targeting our AuNRs to CEA.
16 nude BALB/c mice, 5 females and 11 males, were prepared with subcutaneous tumours of LS174T
colorectal adenocarcinoma (positive CEA–expression). The murine experiments were completed as two
separate experiments, the five females in the first experiment and 11 males in the second. The mice were
assigned groups based on the whether the particles were functionalised with affimer or not and the time point
at which they would be sacrificed. These have been summarised in the following table:
Administered Mouse Time Point
AuNRs Gender 24 h 48 h 72 h 9 d
Untargeted
F 2 1 – 2
M – 2 – –
Targeted
F – – – –
M 3 3 3 –
It was originally planned that there would be three time points in total at 24 h, 48 h and 9 d. However the
planned experiments were postponed after the laser inside the MSOT scanner suffered a mechanical fault, in
order for an attempt to repair it to be made. It was not possible to repair the MSOT scanner during this delay.
But it did mean that the 9 d time point fell outside of the expiry date of the project license. This meant 3 of
the mice were sacrificed prematurely relative to the planned schedule of experiments, at 72 h. Whilst not
ideal, this has not affected our ability to draw conclusions from the ex vivo distribution data we collected.
The MSOT scanner had major technical faults immediately prior to both in vivo experiments. Because the
mice had been prepared with subcutaneous tumours in preparation for these experiments, it was not possible
to delay in time for repairs to be carried out on the scanner. Hence no in–vivo imaging of the mice after
DOPC – DSPE-mPEG AuNRs administration was performed and the only information on biodistribution
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Figure 5.16: Ex vivo biodistribution of phospholipid–functionalised AuNRs as determined by ICP–MS. (a)
as percentage of the injected dose, and (b) as a percentage of injected dose per gram of tissue/sample.
was obtained ex vivo after the mice were sacrificed.
Targeted AuNRs
Targeted particles were prepared by replacing the 5% DSPE-mPEG in the phospholipid mixture used
to displace the CTAB with DSPE-PEG-Mal and preparing the particles in the same manner as previously
discussed. The maleimide in DSPE-PEG-Mal allowed conjugation of thiolated targeting agents. In this case
we used a cysteine terminated CEA–specific affimer, which had been shown to be effective in targeting silica
NPs in vivo [163, 346]. The DOPC – DSPE-PEG-Mal (19:1) AuNRs were washed once more, and then
mixed with a solution containing 18 mM CEA affimer + 23 mM TCEP, such that there was 3.3× excess of
affimer relative to the number of expected maleimide sites (calculated to be approximately 90 per AuNR).
The mixture was left under gentle stirring for 2 hours, before cleaning by centrifugation and sterilisation
using a syringe filter.
In vivo Biocompatibility
Mice were administered with 2 mg of AuNRs suspended in 200 µl PBS at 0 h via tail vein injection, and
observed intermittently over the following 9 d/72 h. All mice survived post–injection to the planned time
point at which they would be sacrificed. There were no noticeable detrimental effects to their health during
this period, and no noticeable differences between the mice injected with targeted and untargeted AuNRs.
This further supports the conclusion that these particles demonstrate good biocompatibility based on the in
vitro experiments performed above.
5.7.1 Ex vivo Biodistribution
In order to assess the biodistribution of the particles ex vivo analysis of the organs was undertaken by
ICP–MS. The following organs were harvested in their entirety; the brain, colon, heart, kidneys, liver, lungs,
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sex organs, spleen. In addition the tumour was harvested and samples of the skin and colonic faeces were
also taken. It was expected that the tissues which would show the highest uptake were the liver, spleen and
tumour. As a result of them being cleared by the mononuclear phagocyte system (MPS), with AuNRs being
filtered out by the liver and spleen, and ultimately cleared from the body via faeces. Each of the samples was
lyophilised, and digested in aqua regia to liberate any gold into solution. The samples were then centrifuged
to remove undigested particulate matter and processed by ICP–MS to determine the Au concentration in
solution.
The results of this study are presented in fig. 5.16, and are given as a fraction of the injected dose (%ID)
of AuNRs and as %ID per gram of tissue/sample processed. The error on some of the %ID per gram values
are quite large, due to the low masses of some of the recovered samples, often close to the sensitivity of the
scales use to measure them (∆m = ±1 mg), this is particularly true for some of the tumour masses.
It can be seen that the majority of the sample is ending up in the liver and spleen, with 15 – 30% being
observed there. There were differences between the mice administered with targeted and untargeted AuNRs.
In the untargeted case, the total amount of AuNRs in the liver was much higher than the spleen, but the overall
concentration (%ID per gram) was fairly similar. This distribution is consistent with reported biodistribution
values for PEGylated particles more generally [5, 102, 251, 299]. The introduction of a targeting ligand
increased the uptake into the spleen significantly, when expressed in %ID per gram it can be seen that the
concentration of gold in the spleen is around 5–6× higher than that seen in the liver. It is not clear what drives
this increased uptake, the mice in this study were immuno–compromised, and hence could not produce the
T–cells required to drive uptake of foreign tissues into the spleen. There is little in the literature to suggest
that CEA would be expected to be at elevated levels within the spleen, and other studies targeting CEA
with nanoparticles did not report significant uptake in to the spleen (i.e. [163, 346] although neither study
provided quantitative biodistribution measurements). It is not clear what is driving this increase in spleenic
uptake, and further studies would be required to properly explore it.
More worryingly, the concentrations of these particles in the liver and spleen are not changing significantly
with time. The untargeted AuNRs are still present in the liver at similar concentrations after 9 days. The same
is true for the concentrations of targeted AuNRs in the liver after 72 h. This also paired with the observation
of relatively low quantities of Au in the colonic faeces, suggesting a very low rate of clearance. This is
extremely problematic, as it indicates that the body is not clearing these particles after they are collected
by the MPS system. This is also consistent with time dependent studies of the clearance of PEGylated
particles, which have found similarly high levels of PEGylated particles in the liver and spleen 15 months
after administration of the original AuNPs [11]. In the vast majority of cases, there are no reported cases of
long–term toxicity emerging from this continued presence. It does however remain an open question whether
the persistence of such particles in vivo should be tolerated as part of any treatment
No residual Au is seen in any of the other organs, the %ID measured for the brain, colon, heart, kidneys,
lungs, sex organs and skin are all close to the detection limit of the ICP–MS. This is expected, but also good
as it indicates that these coatings are not being unexpectedly retained by any of the other major organs.
Tumour Up Take
Figure 5.16 shows only a marginal increase in uptake, when the targeted AuNRs are administered, with
the average %ID falling below 0.7% at all times points. However inspection of the individual data for each
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Figure 5.17: Observed %ID values for each tumour
measured using ICP–MS. Each bar is data from the
subcutaneous tumour(s) of a separate mouse. In a
single case a metastasized tumour site was found, this
has been stacked above the main tumour bar. A red ×
indicates the ‘absence’ of a data point (i.e. the dataset
was n = 2). Errors are instrumental.
tumour shows a high degree of variability between the mice. Plotted in fig. 5.17 are the measured %ID values
for each tumour. It can be seen that the majority of tumours measured showed %ID < 0.5%, indicating low
uptake similar to the other non–liver and non–spleen samples.
There are notably two tumours which showed increased uptake of targeted AuNRs into the the tumours at
48 h and 72 h (%ID ∼ 0.5%) by comparison with the other tumours (typically %ID ∼ 0.1%). In two instances
the amount of targeted AuNRs located in the tumour was considerably increased with % ID = 2.7% and
3.5%. These are both well above the 0.7% median value for %ID for the delivery of targeted nanoparticles to
tumours identified by Wilhelm et al. in 2016 [379], although it is below the highest uptakes observed by
them at ∼10.5%.
In the 48 h case, the tumour had metastasized, suggesting that the tumour was vascularised. Because we
did not have access to real–time MSOT imaging the mice, we were no able to ascertain which tumours were
vascularised, through imaging of the biodistribution of Hb and HbO2. Tentatively, based on this, it might be
speculated that that tumour vascularisation is a prerequisite of successfully deploying a targeting strategy.
This offers a potential future line of inquiry, and the use of in vivo MSOT might help elucidate this with its
ability to image both haemoglobin and oxyhaemoglobin (although unfortunately we were unable to perform
these measurement in tandem with the ICP–MS quantification).
It’s also worth remarking on that fact that in the combined data (fig. 5.16), the 24 h time–point showed
higher uptake for the mice administered with untargeted AuNRs. It can be seen from the data in fig. 5.17
that this originates from a unusually high uptake from a single mouse, combined with the low number of
repeats at this time-point (n=2). It seems probable that this individual result is an outlier, although there is
little basis to completely exclude it, and other explanation such as the enhanced permeability and retention
effect could be offered plausibly (although it would fail to explain why it never appeared in any of the other
untargeted cases).
5.7.2 In vivo Biodistribution of PSS–AuNRs
As mentioned repeatedly, it was planned that the above ex vivo studies would be supported by in vivo MSOT
imaging, but this was prevented by technical issues with the scanners and the time limitations surrounding
the experiments. However, earlier work has looked the mapping the in–vivo biodistribution of the control
PSS–AuNRs. These measurements were taken prior to the decision to functionalise the AuNRs with an
affimer (and hence change the the control particles to AuNRs functionalised with no DSPE-PEG-Mal). These
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Figure 5.18: Reconstructed photoacous-
tic intensity map measured using a MSOT
scanner of c/BALB nude mouse injected
with PSS–functionalised AuNRs and pre-
pared with a subcutaneous tumour. The
image was taken 24 hours after injection
of 100 µg of AuNRs. The observed cross–
section is taken through a plane contain-
ing the tumour, kidneys, liver, and spleen.
The AuNR signal is predominantly found
in the spleen/liver, with little–to–no up-
take into the tumour. The outlines of or-
gans have been added as a guide based
on the positions seen in a cryo–slice of
a mouse given in the MSOT software,
hence they are not definitively correct, but
represent a best guess.
experiments were performed over a year earlier with PSS–AuNRs synthesised with a LSPR maximum of
900 nm. The mice were also administered with a lower dose of 100 µg AuNRs in 100 µL PBS based on the
lower observed cytotoxicity for these particles (fig. 5.2(a)).
This data has some relevance in that it showed a very similar in vivo biodistribution to what we would
expect based on the DOPC – DSPE-mPEG AuNR ex vivo distribution data shown in fig. 5.16. An example
MSOT image 24 hours after injection is shown in fig. 5.18. It has been annotated with ‘suggested’ positions
of the organs, based on organ distributions seen in mouse cryo–slices shown with the reconstruction software
and the structures seen within the image itself. However these should not be treated as the definitive
positions of the organs, there is a lot of variation between individuals and the reconstructed images are fairly
ambiguous, making organ identification difficult. What can be seen is that the majority of AuNRs have ended
up the spleen (or liver) in the lower–left part of the image.
The results also suggest that aggregation may not as larger issue in vivo, compared with the problems
seen in vitro. A strong, spectrally deconvolutable, MSOT signal was still detectable after 24 hours, which
is highly indicative that the AuNRs had not aggregated and undergone plasmonic coupling. It is worth
remembering that when tested PSS–AuNRs showed poor stability relative to the DOPC – DSPE-mPEG
AuNRs under all conditions (fig. 4.8). Which might suggest that the DOPC – DSPE-mPEG would maintain
stability to similar extent in the in vivo. When stored in 100% FBS, PSS–AuNRs showed good stability,
presumably through the formation of a corona. So this in vivo stability is not necessarily such a surprise.
Unfortunately, the lack of MSOT images of the DOPC – DSPE-mPEG AuNRs in vivo means that the
usefulness of these comparisons are fairly limited, and we know very little about the state of them in vivo,
other than where they has accumulated at the time of sacrifice. Although there is some basis to believe they
might maintain their plasmonic properties in vivo, but further work would be required to determine this.
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5.8 Conclusion
These surface coatings show excellent biocompatibility both in vitro and in vivo. They also demonstrate the
ability to generate a good level of heat under CW illumination and are able to maintain thermal stability
over multiple ‘treatment cycles’. However images of the particles after uptake by cells suggests they are
undergoing intracellular aggregation, destroying their plasmonic properties and rendering them inert as a
photothermal treatment modality. This conclusion is supported by the failed attempts at in vitro photothermal
treatment using only the AuNRs ingested by cells, whereas AuNRs free in the culture medium could easily
induce cell death.
The thermal stability of the AuNRs under pulsed illumination is also a problem. Whilst these shown
initial strong contrast under PA imaging, they rapidly underwent thermal reshaping preventing there further
use. The lack of thermal stability under these systems is particularly problematic, as it will prevent them
being used as an imaging modality.
The obvious solution to these issues is silica coating, providing a stabilising silica layer in excess of 10
nm should prevent plasmonic coupling during aggregation and prevent the particles from reshaping under
typical nanosecond pulses. This would simultaneously solve the issues surrounding the inability to thermally
ablate cells in vitro and make them much more robust photoacoustic contrast agents. Silica coated AuNRs
could easily be modified with phospholipids, allowing them to achieve a wide range of surface properties
through control of the lipid composition. The phospholipid coatings still offer potential benefits, but they
will need to used in addition to other surface functionalisation techniques.
The in vivo distribution of our particles is very similar to that seen for other nanoparticles, with large
uptake into the spleen and liver. The conjugation of a targeting ligand unexpectedly increased uptake into
the spleen. There was increased uptake into the tumour in two cases, suggesting that the targeting strategy
may have potential, although significant questions remain about the reliability of it as a technique. These
experiments would need to be supported by additional experiments, including real–time in vivo imaging to
better understand what is occurring.
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Chapter 6
Conclusion and Future Work
The aim of this project was to develop gold nanomaterials for use in the photothermal treatment of cancer.
This work was split into three key areas; developing methods to synthesise suitable particles for use in
the treatment of cancer, investigation of suitable surface functionalisations for use in this application and
exploration of the potential of these particles as theranostic agents through in vivo and in vitro experiments.
This chapter summarises the results of each chapter and discusses the future work which would extend and
improve upon the results obtained in this thesis.
In Chapter 3, focus was given to the synthesis of AuNRs. The role of oleate as a co–surfactant in the
seedless synthesis of AuNRs was investigated. It was shown that through variation of the concentrations of
oleate and CTAB in the growth solution provided good and reproducible control over the morphology of
synthesised AuNRs. This is important as control over the morphology of AuNRs is crucial to controlling
their optical properties and hence optimising them for use as photothermal conversion agents. It was also
demonstrated that the presence of oleate in seedless synthesis presented the additional benefits of significantly
improving the shape yield and monodispersity compared to traditional seedless syntheses performed using
only CTAB. This is also beneficial to their application as photothermal conversion agents as the more intense
and narrower LSPR band leads more efficient heat generation from the population of AuNRs as a whole.
This synthesis was scaled up to 2 L with no appreciable drop in the quality of the end–product, potentially
making industrial scale syntheses more possible.
Experiments were also run characterizing the effects of varying other parameters in the synthesis in the
presence of oleate. Additionally, initial experiments were performed looking at the dynamic changes in the
spectrum of the particles during the synthesis as a function of oleate concentration. It was observed that
increasing oleate concentration dramatically slowed the growth kinetics, suggesting that oleate plays a role
regulating the rate at which gold is reduced onto the forming nanoparticle surface in this synthesis.
This protocol as offers a facile method synthesise high quality AuNR samples with good control over the
particle morphology.
In Chapter 4, the development of phospholipid based surface coatings for AuNRs was explored. A
protocol was developed to ensure the thorough removal of CTAB, improving the biocompatibility and
stability of the particles. The removal of CTAB was demonstrated through a combination of NMR, SERS
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and pH–dependent zeta potential measurements. The level of CTAB was reduced to such an extent it was
not detectable by any of these techniques, suggesting reduction to trace amounts. These coatings offer a
straightforward method to replace the CTAB coating at low cost with highly tunable surface properties (in
this chapter particles were stabilised with anionic, zwitterionic and steric phospholipids), which can easily be
decorated with other components through the inclusion of specialist lipids decorated with functional groups
such as maleimide.
The stability of these particles was also investigated and compared to that of CTAB and PSS function-
alised AuNRs. The phospholipid coated particles shown superior stability to these alternative coatings in a
variety of biologically relevant media selected to replicate conditions within the body. This suggests that
particles once functionalised in this manner can be used reliably in a wide variety of environments.
In Chapter 5, initial experiments looking to use these particles in medical contexts were performed.
Foremost it was shown that particles functionalised in this manner show very low cytoxicities, compared
with PSS coated AuNRs. This is despite a large number of AuNRs being internalised by the cells (as demon-
strated using darkfield and EM). There was little to no observed lysis in the presence of the phospholipid
functionalised AuNRs and no toxic effects seen in any of the in vivo tests. Combined these results suggest
that these particles are biocompatible and thus represent a facile method to achieve the detoxification of
AuNRs. It also gives credence to the conclusion from Chapter 4 that the CTAB used in the synthesis of these
particles has been successfully displaced.
They also were shown to generate the expected levels of heat for AuNRs of this size upon illumination
with NIR light and were relatively stable under extended CW laser exposure. The AuNRs initially showed
good contrast when measured using a preclinical MSOT scanner, but evidently underwent thermal reshaping
under the nanosecond pulses of the laser source used in this system, preventing their further use as contrast
agents.
Attempts at killing cells in vitro under CW laser exposure showed mixed results. Cells illuminated
in cell culture medium containing AuNRs died very quickly under NIR illumination, demonstrating the
potential efficacy of PPTT using these AuNRs. However when relying only on AuNR that were internalised
by cells, little–to–no cell death was observed. This was true for illumination with continuous wave lasers
and nanosecond pulsed lasers. It seems highly probable that the particles that are internalised by cells are
undergoing intracellular aggregation, this view is supported by the darkfield and electron microscopy images
of AuNRs within cells.
Finally, the AuNRs were tested in vivo in murine models prepared with subcutaneous LS174T tumours.
The particles showed no toxic effects in any of the mice. Unfortunately, no in vivo imaging was possible
during these experiments. However, the final biodistribution was determined ex vivo via elemental analysis,
showing significant uptake into the liver with minimal uptake into the tumour. This is consistent with
clearance via the MPS system. Additional AuNRs conjugated with an affimer targeted to CEA, showed a
similar biodistribution to the untargeted particles, albeit with significantly increased uptake in to the spleen.
Two of the nine tumours treated with targeted AuNRs showed significantly increased uptake, with minimal
uptake into the others. Additional experiments are needed before interpretation can be drawn on this data.
Combined this data shows potential for phospholipid functionalised AuNRs as theranostics agents, with
their low toxicity, good heat generation and good initial contrast in PAI. But it also highlights problems
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that will need to addressed before they can be realised as a cancer treatment strategy. Primarily, these are
intracellular aggregation and thermal reshaping. There remain open questions about the efficacy of the
targeting strategy deployed here. The strategies with which these are intended to be addressed are discussed
in the next section.
6.1 Future Work
Some of the work in Chapter 3 remains unfinished, primarily that of the kinetic spectra taken during the
growth. Work is ongoing to collect more of these in order to elucidate the impact of both surfactants on the
growth. Currently all of the collected spectra were taken at a single concentration of CTAB, whilst varying
the oleate concentration alone. In order to distinguish whether the changes that have been observed result
from purely changing the concentration of surfactant in the solution (rather than just the oleate concentration);
more measurements are needed also varying the concentration of CTAB. This should help provide more
information on the actual effects on the growth kinetics that we are witnessing. Ideally these measurements
will be supported by TEM of the particles at various points during the growth. It is possible to halt the growth
of AuNRs instantaneously through the injection of strong solution of thiolated polystyrene [273] enabling a
snapshot of the particles at single point during the growth to be achieved. This should allow the building
up of an understanding of the mechanism by which the presence of oleate effects the growth, which could
potentially enable further improvements in the synthesis of AuNRs.
Additional experiments taking this synthetic protocol forward are planned, attempting to implement it
under continuous flow conditions. This should enable the volume of particles that can be synthesised to
be scaled up considerably. The ease with which we can tune the optical properties of our AuNRs means
that such methods can utilise the relative concentrations of NaOL and CTAB as direct inputs with which to
control the morphology of AuNRs, providing a simple, industrially applicable method for the bulk production
of AuNRs.
The issues with intracellular aggregation and thermal reshaping do seem to have an obvious solution,
silica coating. This has been repeatedly demonstrated as an effective strategy against thermal reshaping
[31, 53, 59, 60, 157, 216, 382]. Whilst it does not prevent intracellular aggregation it can act to mitigate
the problematic parts of it, by separating the AuNR cores and preventing plasmonic coupling [62]. This
does not negate the potential advantages of phospholipid coatings, as they offer a simple method to easily
tune the surface properties of silica–coated AuNRs. Phospholipids will readily form a bilayer on silica and
hence such particles can be imbued with the same surface functionality. This should significantly improve
the efficacy of photothermal treatment with these AuNRs and improve their stability during photoacoustic
imaging.
It would also be a good idea to test the other lipid compositions tested in Chapter 4 in in vitro and in
vivo conditions to demonstrate the versatility of this method. It is highly probable that these would present
similarly low toxicities, and as such would be a facile method of fine–tuning the surface properties of AuNRs.
It was always intended that the in vivo targeting work would be accompanied by in vitro studies of the
targeting. However events conspired to prevent this from happening. The following experiments should
be performed to demonstrate the validity of the targeting strategies. The CEA–negative (SW620) and
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CEA–positive (LS174T) should be prepared with concentrations of both targeted and non-targeted AuNRs
and then a time dependent study of the uptake be performed. There are three core methods by which the
difference in uptake can be assessed. Firstly, darkfield imaging of the cells fixed at different time points will
give a qualitative assessment of the particle uptake into each cell line. Secondly, this can be accompanied by
EM imaging of the cells fixed at the same time–points can provide information on the relative changes in
the particles positions within the cells. Finally, elemental analysis can be performed on pellets of the cells
incubated under the same conditions will provide a quantitative assessment of the average mass of Au per
cell. These combined would allow a good understanding of the efficacy and nature of targeting in each cell
line.
Additionally, it would be beneficial to obtain the missing in vivo imaging that was prevented by me-
chanical failure of the preclinical MSOT scanner. This would provide addition insights into the dynamic
biodistribution immediately after administration of the AuNRs. It is also possible to conjugate a thiolated
fluorophore to the AuNR through the same protocol as the targeting ligand was attached. This would provide
a method to image the distribution of AuNRs within tissue sections, enabling a qualitative understanding of
the distribution of the AuNRs within individual organs.
Taken together these improvements would both provide of greater understanding of how these particles
behave both in vitro and in vivo, and would also simultaneously significantly improve the efficacy of these




Particle sizes obtained from analysis of TEM images.
Shape yields were based on counting all particles in a each EM image analysed and expressing the AuNR
number as percentage of total number of particles observed.
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60 mM CTAB, 20.2 mM NaOL – 99.0% AuNRs, LSPR = 727 nm, N = 258
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Kinetic UV–vis Measurements of AuNR
Synthesis
Presented here is the analysis of all current kinetic spectra, as discussed in in section 3.5. For each figure,
(a) contain the kinetic UV-vis spectra. (b) contains the LSPR extinction and FWHM . (c) contaoins the
LSPR peak wavelength as a function of time. (d) contains the extinction at 400 nm and the corresponding
concentration of Au0; inset into this panel is the derivative of the Au0 concentration giving the rate of
Au0 reduction. The dashed vertical lines in (b)–(d) are the times of peak reduction (blue) and the time of
maximum LSPR wavelength (red). In the instances where these two times coincided the line is black.
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The synthesis solution containing 48 mM CTAB, 25 mM NaOL presented an issue. The growth solution
became was cloudy upon preparation indicating the formation of structures that scattered light strongly such
as vesicles or bubbles. In the spectra presented (a) the formation of plasmonic peaks is apparent, but an
additional spectrum, which evolves with time is present also limiting the usefulness of the kinetic spectra.
The spectrum of the final product after washing via centrifugation is given as the thick black in this panel,
without the scatter spectrum resulting from the growth solution. We cannot reliably extract the LSPR peak
extinction and FWHM values from these spectra. In panel (b) an attempt at correcting the extinction value at
400 nm has been made. The correction was made by subtracting the extinction value at 1100 nm (where
there is minimal plasmonic and no interband contribution) multiplied through by a scaling factor, to give a
final extinction value of ∼ 1.2 at 400 nm. The recovered values broadly fit in with the trends seen in fig. 3.13,
but should still be treated with skepticism. Panel (c) presents the position of the peak LSPR wavelength as a
function of time.
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1H NMR spectra for (a) 10 mM CTAB, (b) 10 mM oleate, (c) ∼25 nM CTAB – oleate (4:1) functionalised
AuNRs; (d) 10 mM DOPC, (e) 10 mM DSPE-mPEG and (f) ∼25 nM DOPC – DSPE-mPEG (19:1)
functionalised AuNRs. Chemical shifts labels are given in fig. 4.2 and tables 4.1 and 4.2. Line overlapping
the peaks associated with the AuNR spectra have been extended across all associated spectra as a visual aid.
All spectra were taken in D2O, details of sample preparation and acquisition settings for each spectrum are
given in section 2.5.3
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Appendix D
Stability in Biorelevant Media
D.1 Aqueous
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C T A B  -  O l e a t e  ( 4 : 1 )  ( +  1  m M  f r e e  C T A B )
2 8 2  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h





W a v e l e n g t h  ( n m )
C T A B  -  O l e a t e  ( 4 : 1 )  ( +  1  m M  f r e e  C T A B )
1 8 8  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
C T A B  -  O l e a t e  ( 4 : 1 )  ( +  1  m M  f r e e  C T A B )
8 4  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
C T A B  -  O l e a t e  ( 4 : 1 )  ( +  1  m M  f r e e  C T A B )
1 9  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
C T A B  -  O l e a t e  ( 4 : 1 )  ( +  1  m M  f r e e  C T A B )
1 0  m O s m · L - 1  ' P s e u d o - P l a s m a '
W a v e l e n g t h  ( n m )
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4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 1 0 0 0
P S S
2 8 2  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w




W a v e l e n g t h  ( n m )
P S S
1 8 8  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
P S S
9 6  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
P S S
1 9  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
P S S
1 0  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
DOPC





4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 1 0 0 0
D O P C
2 8 2  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w




W a v e l e n g t h  ( n m )
D O P C
1 8 8  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
D O P C
8 4  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
D O P C
1 9  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
D O P C
1 0  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
DOPC – DOPG (19:1)






4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 1 0 0 0
D O P C  -  D O P G  ( 1 9 : 1 )
2 8 2  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w




W a v e l e n g t h  ( n m )
D O P C  -  D O P G  ( 1 9 : 1 )
1 8 8  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
D O P C  -  D O P G  ( 1 9 : 1 )
8 4  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
D O P C  -  D O P G  ( 1 9 : 1 )
1 9  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
D O P C  -  D O P G  ( 1 9 : 1 )
1 0  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
DOPC – DSPE-mPEG (19:1)









4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 1 0 0 0
D O P C  -  D S P E - m P E G  ( 1 9 : 1 )
2 8 2  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w




W a v e l e n g t h  ( n m )
D O P C  -  D S P E - m P E G  ( 1 9 : 1 )
1 8 8  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
D O P C  -  D S P E - m P E G  ( 1 9 : 1 )
9 4  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
D O P C  -  D S P E - m P E G  ( 1 9 : 1 )
1 9  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
D O P C  -  D S P E - m P E G  ( 1 9 : 1 )
1 0  m O s m · L - 1  ' P s e u d o - P l a s m a '
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
D.3 Media and Serum
CTAB – Oleate (4:1)







4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 1 0 0 0
C T A B  -  O l e a t e  ( 4 : 1 )
1 0 0 %  R P M I  1 6 4 0
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w





W a v e l e n g t h  ( n m )
C T A B  -  O l e a t e  ( 4 : 1 )
9 0 %  R P M I  1 6 4 0
1 0 %  F B S
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
C T A B  -  O l e a t e  ( 4 : 1 )
5 0 %  R P M I  1 6 4 0
5 0 %  F B S
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
C T A B  -  O l e a t e  ( 4 : 1 )
1 0 0 %  F B S
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
CTAB – Oleate (4:1) + 1 mM free CTAB in solution.






4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 1 0 0 0
C T A B  -  O l e a t e  ( 4 : 1 )  ( + 1 m M  f r e e  C T A B )
1 0 0 %  R P M I  1 6 4 0
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w





W a v e l e n g t h  ( n m )
C T A B  -  O l e a t e  ( 4 : 1 )  ( + 1 m M  f r e e  C T A B )
9 0 %  R P M I  1 6 4 0
1 0 %  F B S
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
C T A B  -  O l e a t e  ( 4 : 1 )  ( + 1 m M  f r e e  C T A B )
5 0 %  R P M I  1 6 4 0
5 0 %  F B S
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
C T A B  -  O l e a t e  ( 4 : 1 )  ( + 1 m M  f r e e  C T A B )
1 0 0 %  F B S
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
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4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 1 0 0 0
P S S
1 0 0 %  R P M I  1 6 4 0
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w





W a v e l e n g t h  ( n m )
P S S
9 0 %  R P M I  
1 0 %  F B S
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
P S S
5 0 %  R P M I  1 6 4 0
5 0 %  F B S
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
P S S
1 0 0 %  F B S
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
DOPC







4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 1 0 0 0
D O P C
1 0 0 %  R P M I  1 6 4 0
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w





W a v e l e n g t h  ( n m )
D O P C
9 0 %  R P M I  1 6 4 0
1 0 %  F B S
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
D O P C
5 0 %  R P M I  1 6 4 0
5 0 %  F B S
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
D O P C
1 0 0 %  F B S
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
DOPC – DOPG (19:1)







4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 1 0 0 0
D O P C  -  D O P G  ( 1 9 : 1 )  
1 0 0 %  R P M I  1 6 4 0
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w





W a v e l e n g t h  ( n m )
D O P C  -  D O P G   ( 1 9 : 1 )
9 0 %  R P M I  1 6 4 0
1 0 %  F B S
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
D O P C  -  D O P G   ( 1 9 : 1 )
5 0 %  R P M I  1 6 4 0
5 0 %  F B S
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
D O P C  -  D O P G  ( 1 9 : 1 )
1 0 0 %  F B S
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
DOPC – DSPE-mPEG (19:1)








4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 1 0 0 0
D O P C  -  D S P E - m P E G  ( 1 9 : 1 )
1 0 0 %  R P M I  1 6 4 0
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w





W a v e l e n g t h  ( n m )
D O P C  -  D S P E - m P E G  ( 1 9 : 1 )
9 0 %  R P M I  1 6 4 0
1 0 %  F B S
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
D O P C  -  D S P E - m P E G  ( 1 9 : 1 )
5 0 %  R P M I  1 6 4 0
5 0 %  F B S
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
D O P C  -  D S P E - m P E G  ( 1 9 : 1 )
1 0 0 %  F B S
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w
 2  w
W a v e l e n g t h  ( n m )
D.4 Plasma
















































C T A B  -  O l e a t e  ( 4 : 1 )
P l a s m a
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w





W a v e l e n g t h  ( n m )
C T A B  -  O l e a t e  ( 4 : 1 )   ( +  1  m M  f r e e  C T A B )
P l a s m a
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w




W a v e l e n g t h  ( n m )
P S S
P l a s m a
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w




W a v e l e n g t h  ( n m )
D O P C
P l a s m a
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w





W a v e l e n g t h  ( n m )
D O P C  -  D O P G  ( 1 9 : 1 )
P l a s m a
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w





W a v e l e n g t h  ( n m )
 0  h
 4  h
 8  h
 2 4  h
 4 8  h
 7 2  h
 1  w




D O P C  -  D S P E - m P E G  ( 1 9 : 1 )
P l a s m a
W a v e l e n g t h  ( n m )
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desselben, und die Sauerstoffbindung des Blutes als Funktion der Wasserstoffzahl [German] (The calculation of
blood pH from free and bound carbonic acid, and blood oxygen binding as a function of pH). Biochem. Z. 78
(1916), 112.
[123] Henderson, L. J. Concerning the relationship between the strength of acids and their capacity to preserve neutrality.
Am. J. Physiol. 21 (1908), 173.
[124] Henry, D. C. The Cataphoresis of Suspended Particles. Part I. The Equation of Cataphoresis. Proc. Royal Soc. A
133 (1931), 106.
[125] Hermanson, G. T. Bioconjugate Techniques, 3rd Edition. Academic Press, London, UK, 2013.
[126] Holmlin, R. E., Chen, X., Chapman, R. G., Takayama, S., and Whitesides, G. M. Zwitterionic SAMs that resist
nonspecific adsorption of protein from aqueous buffer. Langmuir 17 (2001), 2841.
[127] Horiguchi, Y., Honda, K., Kato, Y., Nakashima, N., and Niidome, Y. Photothermal reshaping of gold nanorods
depends on the passivating layers of the nanorod surfaces. Langmuir 24 (2008), 12026.
[128] Hosios, A. M., Hecht, V. C., Danai, L. V., Johnson, M. O., Rathmell, J. C., Steinhauser, M. L., Manalis, S. R.,
and Vander-Heiden, M. G. Amino acids rather than glucose account for the majority of cell mass in proliferating
mammalian cells. Dev. Cell 36 (2016), 540.
[129] Hotchkiss, J. W., Lowe, A. B., and Boyes, S. G. Surface modification of gold nanorods with polymers synthesized
by reversible addition–fragmentation chain transfer polymerization. Chem. Mater. 19 (2007), 6.
[130] Hotchkiss, J. W., Mohr, B. G. R., and Boyes, S. G. Gold nanorods surface modified with poly(acrylic acid) as a
template for the synthesis of metallic nanoparticles. J. Nanopart. Res. 12 (2010), 915.
[131] Tong, W. and Walsh, M. J. and Mulvaney, P. and Etheridge, J. and Funston, A. M. Control of symmetry breaking
size and aspect ratio in gold nanorods: Underlying role of silver nitrate. J. Phys. Chem. C 121 (2017), 3549.
[132] Hu, Q., Nielsen, M. H., Freeman, C. L., Hamm, L. M., Tao, J., Lee, J. R. I., Han, T. Y. J., Becker, U., Harding,
J. H., Dove, P., and De Yoreo, J. The thermodynamics of calcite nucleation at organic interfaces: Classical vs.
non–classical pathways. Faraday Discuss. 159 (2012), 509–523.
[133] Hu, W., Mao, A., Wong, P., Larsen, A., Yazaki, P., Wong, J. Y. C., and Shively, J. E. Characterization of
1,2-Distearoyl-sn-glycero-3-phosphoethanolamineN-[Methoxy(polyethylene glycerol)-2000] and its complex
164
REFERENCES
with doxorubicin using nuclear magnetic resonance spectroscopy and molecular dynamics. Bioconjugate Chem.
28, 6 (2017), 1777.
[134] Hu, X., and Gao, X. Multilayer coating of gold nanorods for combined stability and biocompatibility. Phys.
Chem. Chem. Phys. 13 (2011), 10028.
[135] Hu, Z., Wang, X., Wang, W., Zhang, Z., Gao, H., and Mao, Y. Raman spectroscopy for detecting supported planar
lipid bilayers composed of ganglioside–GM1/sphingomyelin/cholesterol in the presence of amyloid–β. Phys.
Chem. Chem. Phys. 17 (2015), 22711.
[136] Huang, E. Y., Chang, J. C., Chen, H. H., Hsu, C. Y., Hsu, H. C., and Wu, K. L. Carcinoembryonic antigen as a
marker of radioresistance in colorectal cancer: a potential role of macrophages. BMC Cancer 18 (2018), 321.
[137] Huang, H. C., Barua, S., Kay, D. B., and Rege, K. Simultaneous enhancement of photothermal stability and gene
delivery efficacy of gold nanorods using polyelectrolytes. ACS Nano 3 (2009), 2941.
[138] Huang, H. C., Rege, K., and Heys, J. J. Spatiotemporal temperature distribution and cancer cell death in response
to extracellular hyperthermia induced by gold nanorods. ACS Nano 4 (2010), 28920.
[139] Huang, J., Jackson, K. S., and Murphy, C. J. Polyelectrolyte wrapping layers control rates of photothermal
molecular release from gold nanorods. Nano Letters 12 (2012), 2982–2987.
[140] Huang, Q., Zou, Y., Zhong, S., Yang, X., Li, J., Huang, W., Zhu, H., Cheng, C., Ding, M., Zhu, L. G., and Shi, Q.
Silica–coated gold nanorods with high photothermal efficiency and biocompatibility as a contrast agent for in
vitro terahertz imaging. J. Biomed. Nanotechnol. 15 (2019), 910.
[141] Huang, X., El-Sayed, I. H., Qian, W., and El-Sayed, M. A. Cancer cell imaging and photothermal therapy in the
near-infrared region by using gold nanorods. J. Am. Chem. Soc. 128 (2006), 2115.
[142] Hubert, F., Testard, F., and Spalla, O. Cetyltrimethylammonium bromide silver bromide complex as the capping
agent of gold nanorods. Langmuir 24, 17 (2008), 9219–9222.
[143] Jackson, S. R., McBride, J. R., Rosenthal, S. J., and Wright, D. W. Wheres the silver? Imaging trace silver
coverage on the surface of gold nanorods. J. Am. Chem. Soc. 136 (2014), 5261.
[144] Jain, P. K., and El-Sayed, M. A. Plasmonic coupling in noble metal nanostructures. Chem. Phys. Letts. 487
(2010), 153.
[145] Jain, P. K., Lee, K. S., El-Sayed, I. H., and El-Sayed, M. A. Calculated absorption and scattering properties of
gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine.
J. Phys. Chem. B 110 (2006), 7238.
[146] Jana, N. R. Gram–scale synthesis of soluble, near–monodisperse gold nanorods and other anisotropic nanoparticles.
Small 1 (2005), 875.
[147] Jana, N. R., Gearheart, L., and Murphy, C. J. Wet chemical synthesis of high aspect ratio cylindrical gold
nanorods. J. Phys. Chem. B 105, 19 (2001), 4065.
[148] Jana, N. R., Gearheart, L., and Murphy, C. J. Seed–mediated growth approach for shape–controlled synthesis of
spheroidal and rod-like gold nanoparticles using a surfactant template. Adv. Mater. 13 (2001), 1389.
[149] Jaque, D., Maestro, L., del Rosal, B., Haro-Gonzalez, P., Benayas, A., Plaza, J., Martı́n Rodrı́guez, E., and
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[412] Zsigmondy, R. Uber wässrige Lösungen metallischen Goldes [German] (On aqueous solutions of metallic gold).
Justus Liebig’s Ann. Chem. 301 (1898), 29.
181
